<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:dcterms="http://purl.org/dc/terms/"
     xmlns:media="http://search.yahoo.com/mrss/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:cf="https://www.futureplc.com/rss/content-flags"
>
    <channel>
                    <atom:link href="https://theweek.com/feeds/tag/health" rel="self" type="application/rss+xml" />
                            <title><![CDATA[ TheWeek feed ]]></title>
                <link>https://theweek.com/health</link>
        <description><![CDATA[  ]]></description>
                                    <lastBuildDate>Fri, 20 Nov 2026 07:00:00 +0000</lastBuildDate>
                            <language>en</language>
                                <item>
                                                            <title><![CDATA[ More parents are refusing vitamin K shots, putting babies at risk ]]></title>
                                                                                                <dc:content><![CDATA[ <p>With vaccine hesitancy on the uptick, doctors are sounding the alarm about a worrying trend of parents also declining a vitamin K injection recommended for newborns. More infants are experiencing dangerous bleeding, which the shot curtails. </p><h2 id="why-parents-are-refusing-vitamin-k">Why parents are refusing vitamin K</h2><p>For decades, the American Academy of Pediatrics has suggested that every newborn receive a vitamin K shot, helpful for getting <a href="https://www.theweek.com/environment/rising-co2-levels-human-blood-climate-change">blood</a> to clot. The injection can protect against “sudden, catastrophic bleeding” that could occur “even in otherwise healthy babies,” said <a href="https://www.nytimes.com/2026/11/05/well/live/vitamin-k-shot-newborn-bleeding.html" target="_blank">The New York Times</a>. It is “not a vaccine,” but as mistrust in medicine has grown and Health Secretary <a href="https://www.theweek.com/1025265/rfk-jr-controversies">Robert F. Kennedy Jr.</a> and other “prominent health figures” cast doubt on <a href="https://www.theweek.com/health/trump-administration-aims-to-limit-childhood-vaccines">childhood vaccinations</a>, “more parents have started forgoing it.” Some parents cite misinformation from a since-debunked 1990 study linking vitamin K to childhood cancer.</p><p>Doctors saw an increase in infants with serious hemorrhages as far back as 2017, but the problem has worsened significantly in recent years, according to two new studies published in the journals <a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.21764?guestAccessKey=ba1b2c0d-d9ac-402b-a249-30212fc97f5b" target="_blank">JAMA</a> and <a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.5794?guestAccessKey=9e7d703f-15b8-40b1-adec-cd11233cc736" target="_blank">JAMA Pediatrics</a>. Between 2017 and 2025, the rate of newborns who did not receive a vitamin K shot more than doubled, from 3.1% to 6.8%, according to the JAMA study. The overall rate of vitamin K deficiency bleeding rose nearly 350% to 107.4 cases per 100,000 during that time period, according to the JAMA Pediatrics study.</p><h2 id="why-the-studies-matter">Why the studies matter</h2><p>These are the first published peer-reviewed studies to “investigate increased infant bleeding” and “vitamin K shot refusal over the past decade,” said <a href="https://www.usatoday.com/story/news/health/2026/11/10/more-parents-rejecting-newborn-vitamin-k-shots/92710769007/">USA Today</a>. The CDC does not track rates of vitamin K refusals or associated bleeding. Lawmakers in July “urged the agency to begin keeping such records” after a <a href="https://www.propublica.org/article/more-parents-decline-vitamin-k-shot-newborns" target="_blank">ProPublica</a> investigation found that babies were dying after their parents refused the injections. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/more-parents-are-refusing-vitamin-k-vaccine-putting-babies-at-risk</link>
                                                                            <description>
                            <![CDATA[ The number of newborns facing life-threatening bleeding is on the rise ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">PvGK7zPUVHag3scfHUE5fS</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/jtrG4uH59B6iMkJhUZE6DV-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 20 Nov 2026 07:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/jtrG4uH59B6iMkJhUZE6DV-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images ]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The vitamin K shot isn’t a vaccine]]></media:description>                                                            <media:text><![CDATA[Illustrative collage of a baby, a syringe and a giant letter K. ]]></media:text>
                                <media:title type="plain"><![CDATA[Illustrative collage of a baby, a syringe and a giant letter K. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/jtrG4uH59B6iMkJhUZE6DV-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>With vaccine hesitancy on the uptick, doctors are sounding the alarm about a worrying trend of parents also declining a vitamin K injection recommended for newborns. More infants are experiencing dangerous bleeding, which the shot curtails. </p><h2 id="why-parents-are-refusing-vitamin-k">Why parents are refusing vitamin K</h2><p>For decades, the American Academy of Pediatrics has suggested that every newborn receive a vitamin K shot, helpful for getting <a href="https://www.theweek.com/environment/rising-co2-levels-human-blood-climate-change">blood</a> to clot. The injection can protect against “sudden, catastrophic bleeding” that could occur “even in otherwise healthy babies,” said <a href="https://www.nytimes.com/2026/11/05/well/live/vitamin-k-shot-newborn-bleeding.html" target="_blank">The New York Times</a>. It is “not a vaccine,” but as mistrust in medicine has grown and Health Secretary <a href="https://www.theweek.com/1025265/rfk-jr-controversies">Robert F. Kennedy Jr.</a> and other “prominent health figures” cast doubt on <a href="https://www.theweek.com/health/trump-administration-aims-to-limit-childhood-vaccines">childhood vaccinations</a>, “more parents have started forgoing it.” Some parents cite misinformation from a since-debunked 1990 study linking vitamin K to childhood cancer.</p><p>Doctors saw an increase in infants with serious hemorrhages as far back as 2017, but the problem has worsened significantly in recent years, according to two new studies published in the journals <a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.21764?guestAccessKey=ba1b2c0d-d9ac-402b-a249-30212fc97f5b" target="_blank">JAMA</a> and <a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.5794?guestAccessKey=9e7d703f-15b8-40b1-adec-cd11233cc736" target="_blank">JAMA Pediatrics</a>. Between 2017 and 2025, the rate of newborns who did not receive a vitamin K shot more than doubled, from 3.1% to 6.8%, according to the JAMA study. The overall rate of vitamin K deficiency bleeding rose nearly 350% to 107.4 cases per 100,000 during that time period, according to the JAMA Pediatrics study.</p><h2 id="why-the-studies-matter">Why the studies matter</h2><p>These are the first published peer-reviewed studies to “investigate increased infant bleeding” and “vitamin K shot refusal over the past decade,” said <a href="https://www.usatoday.com/story/news/health/2026/11/10/more-parents-rejecting-newborn-vitamin-k-shots/92710769007/">USA Today</a>. The CDC does not track rates of vitamin K refusals or associated bleeding. Lawmakers in July “urged the agency to begin keeping such records” after a <a href="https://www.propublica.org/article/more-parents-decline-vitamin-k-shot-newborns" target="_blank">ProPublica</a> investigation found that babies were dying after their parents refused the injections. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Scientists are working to develop an acne vaccine ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A vaccine could soon make you acne-free. Rather than just treating the skin condition, a vaccine would target acne-causing bacteria to prevent the ailment from developing altogether.</p><h2 id="vaccine-two-ways">Vaccine, two ways</h2><p>Acne is “caused by the immune system overreacting to proteins released by skin bacteria,” said <a href="https://www.newscientist.com/article/2595926-how-vaccines-could-be-about-to-revolutionise-acne-treatments/" target="_blank"><u>New Scientist</u></a>. The most common bacterium that causes acne is Cutibacterium. It is “present on just about everybody,” even “those that don’t have acne.” </p><p>Several strains of the bacteria are “known to ramp up the body’s immune system, while others don’t appear to provoke the same response,” said <a href="https://www.bostonglobe.com/2026/06/18/metro/acne-vaccine-treatment-breakouts/" target="_blank"><u>The Boston Globe</u></a>. Two companies, Sanofi and Armora Biosciences, are currently developing acne <a href="https://theweek.com/health/kennedy-anti-vaccine-speech-measles"><u>vaccines</u></a>.</p><p>Sanofi is working on an mRNA vaccine that targets Christie-Atkins-Munch-Petersen factor (CAMP), a toxin secreted by Cutibacterium acnes that can cause an immune response. “We basically remove the bad guys” while leaving <a href="https://theweek.com/health/tips-for-gut-microbiome-health-sleep-avoiding-antibiotics-less-alcohol"><u>beneficial skin bacteria</u></a> intact, said Jean-François Toussaint, the global head of vaccine research and development at Sanofi, to the Globe. </p><p>Armora Biosciences is taking a different approach. C. acnes “secretes two forms of an enzyme called hyaluronidase: Hyl-A and Hyl-B,” said <a href="https://www.menshealth.com/grooming/a74132344/acne-vaccine-treatment-prevention/" target="_blank"><u>Men’s Health</u></a>. Hyl-A “plays a central role in the development of acne by causing inflammation,” whereas “Hyl-B is an anti-inflammatory that can be beneficial for skin.” Armora’s vaccine “aims to teach the immune system to block just Hyl-A, leaving the benefits of Hyl-B.”</p><h2 id="new-options">New options</h2><p>These vaccines could “do wonders for chronic acne sufferers and help save hundreds of dollars per year on acne products and medications,” said Men’s Health. Current acne treatments tend to be antibiotics that kill all C. acnes strains and can worsen <a href="https://theweek.com/health/nightmare-bacteria-what-are-they"><u>antibiotic resistance</u></a>. The other common treatment, isotretinoin (Roaccutane), is “more effective than antibiotics but has a long list of nasty side effects,” said New Scientist.  </p><p>It is still not certain how effective a vaccine will be because a variety of factors affect whether someone develops acne. “In the case of the skin, it’s very difficult to form your own immunity,” said Dr. Abigail Waldman, a dermatologist at Mass General Brigham, to the Globe. This means it’s “going to be difficult for them to get a very focused, effective” vaccine. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/scientists-are-working-to-develop-an-acne-vaccine</link>
                                                                            <description>
                            <![CDATA[ Two companies are taking different approaches ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">pz4NqsCQs3T4DsrTZAen3L</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/uYNRrtexM5VQpvj3bJMFQQ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 18 Nov 2026 07:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 18 Nov 2026 16:40:12 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/uYNRrtexM5VQpvj3bJMFQQ-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images ]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Acne vaccines can have fewer side effects than traditional treatments]]></media:description>                                                            <media:text><![CDATA[Photo collage of a young man inspecting his cheek, peppered with numbered red dots.]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a young man inspecting his cheek, peppered with numbered red dots.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/uYNRrtexM5VQpvj3bJMFQQ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A vaccine could soon make you acne-free. Rather than just treating the skin condition, a vaccine would target acne-causing bacteria to prevent the ailment from developing altogether.</p><h2 id="vaccine-two-ways">Vaccine, two ways</h2><p>Acne is “caused by the immune system overreacting to proteins released by skin bacteria,” said <a href="https://www.newscientist.com/article/2595926-how-vaccines-could-be-about-to-revolutionise-acne-treatments/" target="_blank"><u>New Scientist</u></a>. The most common bacterium that causes acne is Cutibacterium. It is “present on just about everybody,” even “those that don’t have acne.” </p><p>Several strains of the bacteria are “known to ramp up the body’s immune system, while others don’t appear to provoke the same response,” said <a href="https://www.bostonglobe.com/2026/06/18/metro/acne-vaccine-treatment-breakouts/" target="_blank"><u>The Boston Globe</u></a>. Two companies, Sanofi and Armora Biosciences, are currently developing acne <a href="https://theweek.com/health/kennedy-anti-vaccine-speech-measles"><u>vaccines</u></a>.</p><p>Sanofi is working on an mRNA vaccine that targets Christie-Atkins-Munch-Petersen factor (CAMP), a toxin secreted by Cutibacterium acnes that can cause an immune response. “We basically remove the bad guys” while leaving <a href="https://theweek.com/health/tips-for-gut-microbiome-health-sleep-avoiding-antibiotics-less-alcohol"><u>beneficial skin bacteria</u></a> intact, said Jean-François Toussaint, the global head of vaccine research and development at Sanofi, to the Globe. </p><p>Armora Biosciences is taking a different approach. C. acnes “secretes two forms of an enzyme called hyaluronidase: Hyl-A and Hyl-B,” said <a href="https://www.menshealth.com/grooming/a74132344/acne-vaccine-treatment-prevention/" target="_blank"><u>Men’s Health</u></a>. Hyl-A “plays a central role in the development of acne by causing inflammation,” whereas “Hyl-B is an anti-inflammatory that can be beneficial for skin.” Armora’s vaccine “aims to teach the immune system to block just Hyl-A, leaving the benefits of Hyl-B.”</p><h2 id="new-options">New options</h2><p>These vaccines could “do wonders for chronic acne sufferers and help save hundreds of dollars per year on acne products and medications,” said Men’s Health. Current acne treatments tend to be antibiotics that kill all C. acnes strains and can worsen <a href="https://theweek.com/health/nightmare-bacteria-what-are-they"><u>antibiotic resistance</u></a>. The other common treatment, isotretinoin (Roaccutane), is “more effective than antibiotics but has a long list of nasty side effects,” said New Scientist.  </p><p>It is still not certain how effective a vaccine will be because a variety of factors affect whether someone develops acne. “In the case of the skin, it’s very difficult to form your own immunity,” said Dr. Abigail Waldman, a dermatologist at Mass General Brigham, to the Globe. This means it’s “going to be difficult for them to get a very focused, effective” vaccine. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Longer estrogen exposure may help women’s brain health ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Women’s estrogen production and exposure may be contributing to the development of Alzheimer’s disease. But hormone therapy could help keep estrogen levels raised in the body, improving brain health and reducing dementia risk.</p><h2 id="hormonal-health">Hormonal health</h2><p>Estrogen levels in women fluctuate over time, and those changes can affect <a href="https://theweek.com/health/growing-a-brain-in-the-lab"><u>brain</u></a> health, according to a study published in the journal <a href="https://www.neurology.org/doi/10.1212/WNL.0000000000218706" target="_blank"><u>Neurology</u></a>. Women are “disproportionately affected by Alzheimer’s disease (AD), a vulnerability that may relate to estrogen fluctuations across the lifespan,” said the study. However, estrogen also has “neuroprotective and vasoprotective effects,” suggesting that steady lifetime exposure may benefit “both AD-related neurodegeneration and cerebrovascular health.”</p><p>The study conducted MRIs on 352 healthy Swedish women at age 70 and again at age 75. It discovered that those with longer reproductive spans, which is the time between the first menstruation and menopause, showed less damage to the brain’s “tiny blood vessels and better-preserved white matter, the tissue that allows different parts of the brain to communicate,” said <a href="https://www.washingtonpost.com/health/2026/11/05/can-hormone-therapy-lower-risk-alzheimers-dementia/" target="_blank"><u>The Washington Post</u></a>. The study also found that “women who had used both oral contraceptives and hormone therapy had the healthiest brain profiles of all.” However, “data on hormone use were self-reported,” and there was a “lack of detailed information” about “when treatment began, the dose and the type of treatment,” said a <a href="https://www.eurekalert.org/news-releases/1150173" target="_blank"><u>release</u></a> about the study.</p><h2 id="reassessing-hormone-therapy">Reassessing hormone therapy </h2><p>Women account for two-thirds of Alzheimer’s cases, and the sharp drop in <a href="https://theweek.com/health/the-fdas-estrogen-warning-had-a-blind-spot-menopausal-women-dying-from-utis"><u>estrogen</u></a> production that occurs at menopause could be a contributing factor. <a href="https://theweek.com/health/women-hormonal-health-allergy-drugs-antacids-tiktok-trend"><u>Hormone</u></a> therapy could keep such a sharp drop from happening, but the treatment has been controversial because of an old study linking it to “higher risks of breast cancer, heart disease and stroke,” said the Post. That study has since been reexamined, with researchers concluding that the “age at which women begin hormone therapy appears to change the balance of its risks and benefits.”</p><p>Despite estrogen’s effect on the brain, the recent study does not prove that estrogen or hormone therapy caused the brain differences. “Other hormones, which also fluctuate with menopause,” may be “contributing to the associations,” said <a href="https://www.sciencealert.com/longer-estrogen-exposure-linked-to-less-blood-vessel-damage-in-womens-brains-later-in-life" target="_blank"><u>ScienceAlert</u></a>. Also, “with a relatively small, single-country cohort, it’s unclear whether these trends would apply to broader populations.” The study, though, “adds a new piece of evidence to a much broader reassessment of hormone therapy,” said the Post, a “treatment whose risks and benefits have been fiercely debated for more than two decades.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/longer-estrogen-exposure-may-help-womens-brain-health</link>
                                                                            <description>
                            <![CDATA[ The hormone can affect blood flow to the brain ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">9Q3j92VxYapLZZwwXr69JK</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/oJf8pvdDjkrooD9aXaPbvC-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 17 Nov 2026 07:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/oJf8pvdDjkrooD9aXaPbvC-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Stephen P. Kelly / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Women account for two-thirds of Alzheimer’s cases]]></media:description>                                                            <media:text><![CDATA[Photo collage illustration of a human brain, pills and women&#039;s faces]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage illustration of a human brain, pills and women&#039;s faces]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/oJf8pvdDjkrooD9aXaPbvC-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Women’s estrogen production and exposure may be contributing to the development of Alzheimer’s disease. But hormone therapy could help keep estrogen levels raised in the body, improving brain health and reducing dementia risk.</p><h2 id="hormonal-health">Hormonal health</h2><p>Estrogen levels in women fluctuate over time, and those changes can affect <a href="https://theweek.com/health/growing-a-brain-in-the-lab"><u>brain</u></a> health, according to a study published in the journal <a href="https://www.neurology.org/doi/10.1212/WNL.0000000000218706" target="_blank"><u>Neurology</u></a>. Women are “disproportionately affected by Alzheimer’s disease (AD), a vulnerability that may relate to estrogen fluctuations across the lifespan,” said the study. However, estrogen also has “neuroprotective and vasoprotective effects,” suggesting that steady lifetime exposure may benefit “both AD-related neurodegeneration and cerebrovascular health.”</p><p>The study conducted MRIs on 352 healthy Swedish women at age 70 and again at age 75. It discovered that those with longer reproductive spans, which is the time between the first menstruation and menopause, showed less damage to the brain’s “tiny blood vessels and better-preserved white matter, the tissue that allows different parts of the brain to communicate,” said <a href="https://www.washingtonpost.com/health/2026/11/05/can-hormone-therapy-lower-risk-alzheimers-dementia/" target="_blank"><u>The Washington Post</u></a>. The study also found that “women who had used both oral contraceptives and hormone therapy had the healthiest brain profiles of all.” However, “data on hormone use were self-reported,” and there was a “lack of detailed information” about “when treatment began, the dose and the type of treatment,” said a <a href="https://www.eurekalert.org/news-releases/1150173" target="_blank"><u>release</u></a> about the study.</p><h2 id="reassessing-hormone-therapy">Reassessing hormone therapy </h2><p>Women account for two-thirds of Alzheimer’s cases, and the sharp drop in <a href="https://theweek.com/health/the-fdas-estrogen-warning-had-a-blind-spot-menopausal-women-dying-from-utis"><u>estrogen</u></a> production that occurs at menopause could be a contributing factor. <a href="https://theweek.com/health/women-hormonal-health-allergy-drugs-antacids-tiktok-trend"><u>Hormone</u></a> therapy could keep such a sharp drop from happening, but the treatment has been controversial because of an old study linking it to “higher risks of breast cancer, heart disease and stroke,” said the Post. That study has since been reexamined, with researchers concluding that the “age at which women begin hormone therapy appears to change the balance of its risks and benefits.”</p><p>Despite estrogen’s effect on the brain, the recent study does not prove that estrogen or hormone therapy caused the brain differences. “Other hormones, which also fluctuate with menopause,” may be “contributing to the associations,” said <a href="https://www.sciencealert.com/longer-estrogen-exposure-linked-to-less-blood-vessel-damage-in-womens-brains-later-in-life" target="_blank"><u>ScienceAlert</u></a>. Also, “with a relatively small, single-country cohort, it’s unclear whether these trends would apply to broader populations.” The study, though, “adds a new piece of evidence to a much broader reassessment of hormone therapy,” said the Post, a “treatment whose risks and benefits have been fiercely debated for more than two decades.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Imported produce has an inspection gap ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Approximately 34% of fresh vegetables and 59% of fresh fruit in the U.S. are imported from other countries. And there’s a shocking lack of inspection of the facilities and farms that process these imported crops. This dearth of oversight can lead to more food contamination and disease outbreaks.</p><h2 id="where-are-inspections-falling-short">Where are inspections falling short?</h2><p>A major <a href="https://theweek.com/health/first-two-deaths-reported-cyclosporiasis"><u>cyclosporiasis</u></a> outbreak earlier this year caused more than 20,000 lab-confirmed cases across 49 states, according to the <a href="https://www.cdc.gov/cyclosporiasis/cases/index.html" target="_blank"><u>CDC</u></a>. The source was traced to contaminated iceberg lettuce from a farm in Mexico. The country is the biggest supplier of produce to the U.S., yet “since 2009 the FDA has inspected only about 2% of the facilities in Mexico that ship produce to the United States,” said an analysis by <a href="https://www.washingtonpost.com/health/2026/10/27/were-eating-more-imported-fruits-veggies-fda-inspections-arent-keeping-up/" target="_blank"><u>The Washington Post</u></a>. </p><p>The problem goes beyond <a href="https://theweek.com/culture-life/property/6-lavish-homes-in-mexico"><u>Mexico</u></a>. Only 7.6% of global facilities accounting for 90% of produce shipped to the U.S. have been inspected since 2009. “We don’t have a robust system in place to go verify that these foreign producers are following the rules,” said Sarah Sorscher, the director of regulatory affairs at the nonprofit Center for Science in the Public Interest, to the Post. “That’s a big concern for anybody who eats food in America.”</p><p>The lack of oversight in this area is especially concerning because produce is often eaten raw. That makes it “particularly vulnerable to bacterial and parasitic contamination from sources like machinery or the water supply,” said the Post. </p><h2 id="why-are-inspections-so-infrequent">Why are inspections so infrequent?</h2><p>Several former officials attributed the inspection gap to “chronic underfunding, severe understaffing and high travel costs,” said <a href="https://www.independent.co.uk/news/world/americas/us-imported-produce-inspections-cyclosporiasis-b3074230.html" target="_blank"><u>The Independent</u></a>. Oversight dropped “even further after federal cuts in early 2025 briefly disrupted international travel planning.”</p><p>After the <a href="https://theweek.com/business/economy/trump-accounts-a-nest-egg-with-strings-attached"><u>Trump administration’s funding</u></a> cuts at the beginning of the presidential term, 65% of the FDA staff “responsible for coordinating travel and budgets” were culled, requiring investigators to “book their own flights and hotels, obtain diplomatic passports and visas and coordinate with foreign authorities,” said <a href="https://www.propublica.org/article/foreign-food-safety-inspections-historic-low-fda" target="_blank"><u>ProPublica</u></a> in 2025. The FDA has argued that site visits are “just one component of its strategy,” and “border testing, record audits and predictive algorithms” are also used to test food safety, said The Independent. However, “physical testing at the border catches only a sliver of imports.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/imported-produce-inspection-gap</link>
                                                                            <description>
                            <![CDATA[ Fruits and vegetables could be coming from unsafe facilities ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">kgRf6LRKGAD3MEQCrckgV</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Y9dHga4bNfXafYikRcLJZg-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 16 Nov 2026 21:08:58 +0000</pubDate>                                                                                                                                <updated>Mon, 16 Nov 2026 21:49:06 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Y9dHga4bNfXafYikRcLJZg-1920-80.jpg">
                                                            <media:credit><![CDATA[dusanpetkovic / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Raw produce is the most at risk for contamination and potentially causing illness]]></media:description>                                                            <media:text><![CDATA[Apples and pears in shipment crates]]></media:text>
                                <media:title type="plain"><![CDATA[Apples and pears in shipment crates]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Y9dHga4bNfXafYikRcLJZg-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Approximately 34% of fresh vegetables and 59% of fresh fruit in the U.S. are imported from other countries. And there’s a shocking lack of inspection of the facilities and farms that process these imported crops. This dearth of oversight can lead to more food contamination and disease outbreaks.</p><h2 id="where-are-inspections-falling-short">Where are inspections falling short?</h2><p>A major <a href="https://theweek.com/health/first-two-deaths-reported-cyclosporiasis"><u>cyclosporiasis</u></a> outbreak earlier this year caused more than 20,000 lab-confirmed cases across 49 states, according to the <a href="https://www.cdc.gov/cyclosporiasis/cases/index.html" target="_blank"><u>CDC</u></a>. The source was traced to contaminated iceberg lettuce from a farm in Mexico. The country is the biggest supplier of produce to the U.S., yet “since 2009 the FDA has inspected only about 2% of the facilities in Mexico that ship produce to the United States,” said an analysis by <a href="https://www.washingtonpost.com/health/2026/10/27/were-eating-more-imported-fruits-veggies-fda-inspections-arent-keeping-up/" target="_blank"><u>The Washington Post</u></a>. </p><p>The problem goes beyond <a href="https://theweek.com/culture-life/property/6-lavish-homes-in-mexico"><u>Mexico</u></a>. Only 7.6% of global facilities accounting for 90% of produce shipped to the U.S. have been inspected since 2009. “We don’t have a robust system in place to go verify that these foreign producers are following the rules,” said Sarah Sorscher, the director of regulatory affairs at the nonprofit Center for Science in the Public Interest, to the Post. “That’s a big concern for anybody who eats food in America.”</p><p>The lack of oversight in this area is especially concerning because produce is often eaten raw. That makes it “particularly vulnerable to bacterial and parasitic contamination from sources like machinery or the water supply,” said the Post. </p><h2 id="why-are-inspections-so-infrequent">Why are inspections so infrequent?</h2><p>Several former officials attributed the inspection gap to “chronic underfunding, severe understaffing and high travel costs,” said <a href="https://www.independent.co.uk/news/world/americas/us-imported-produce-inspections-cyclosporiasis-b3074230.html" target="_blank"><u>The Independent</u></a>. Oversight dropped “even further after federal cuts in early 2025 briefly disrupted international travel planning.”</p><p>After the <a href="https://theweek.com/business/economy/trump-accounts-a-nest-egg-with-strings-attached"><u>Trump administration’s funding</u></a> cuts at the beginning of the presidential term, 65% of the FDA staff “responsible for coordinating travel and budgets” were culled, requiring investigators to “book their own flights and hotels, obtain diplomatic passports and visas and coordinate with foreign authorities,” said <a href="https://www.propublica.org/article/foreign-food-safety-inspections-historic-low-fda" target="_blank"><u>ProPublica</u></a> in 2025. The FDA has argued that site visits are “just one component of its strategy,” and “border testing, record audits and predictive algorithms” are also used to test food safety, said The Independent. However, “physical testing at the border catches only a sliver of imports.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ What is ferritin face? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>“Forget jade rollers, LED masks and salmon sperm facials,” said Chloe Casey, a lecturer in nutrition and behaviour, on <a href="https://theconversation.com/ferritin-face-is-trending-but-can-your-skin-really-reveal-low-iron-289833" target="_blank">The Conversation</a>. The “latest skincare trend” is… a blood test.</p><p>That’s the way to investigate “Ferritin face”, which is cropping up all over <a href="https://theweek.com/news/media/960639/the-pros-and-cons-of-social-media">social media</a>. Posters are claiming that iron deficiency can be seen on your face via symptoms such as dark under-eyes, pale and dry skin, and hair loss. </p><p>There is a “kernel” of truth in the observation, but self-diagnosis and self-medication could cause more harm than good.</p><h2 id="what-is-ferritin">What is ferritin?</h2><p>Ferritin is a protein that plays a “significant role in the absorption, storage, and release of iron”, said the <a href="https://www.southtees.nhs.uk/services/pathology/tests/ferritin/" target="_blank">NHS</a>. Roughly 25% of iron in the body is stored, and the majority of that is ferritin. It is found in many types of cells in the body, but especially in the “liver, spleen, bone marrow, and in reticuloendothelial cells”.</p><p>A blood test for ferritin allows you to “get a snapshot of the body’s iron reserves”, said <a href="https://www.theguardian.com/science/2026/oct/28/ferritin-face-social-media-claims-iron-deficiency" target="_blank">The Guardian</a>. Because iron levels naturally “fluctuate throughout the day”, testing ferritin levels is a “better indicator” of iron deficiency problems such as <a href="https://theweek.com/health/what-is-sickle-cell-anaemia">anaemia</a>, said <a href="https://www.independent.co.uk/life-style/ferritin-face-low-iron-levels-b3074102.html" target="_blank">The Independent</a>.</p><p>You are more likely to suffer from low ferritin and iron levels if you are pregnant or suffer heavy periods, though this can also occur as a result of gastrointestinal problems, poor absorption or dietary choices.</p><h2 id="is-social-media-trend-harmful">Is social media trend harmful?</h2><p>It’s true that severe iron deficiency can “make someone look pale”, said Casey on The Conversation. But that doesn’t mean that low ferritin levels produce a “distinctive facial appearance. Hormones, bad sleep, stress, dehydration or not eating enough key nutrients can all leave you looking pale and tired.”</p><p>On social media, the “line between medical advice and marketing gets blurry fast”. A message warning of a medical condition is quickly linked to a supplement, “pill or powder” available for purchase. Fundamentally, a “mirror can’t tell you whether your ferritin is low – only a blood test can do that”.</p><h2 id="what-can-you-do-about-it">What can you do about it?</h2><p>A good way to improve iron levels is having a well-balanced diet. Red meat and shellfish contain iron that can be “more readily absorbed”, said <a href="https://graziadaily.co.uk/beauty-hair/skin/ferritin-face-trend/" target="_blank">Grazia</a>. Beans, lentils, chickpeas, tofu, leafy green vegetables and nuts are also rich in iron. </p><p>Those at risk of low ferritin should ask for blood tests including a full blood count, a ferritin level check, and tests for levels of B12 and folate, Toby Richards, a surgeon and iron therapy specialist, told The Guardian. </p><p>“Taking iron supplements without a diagnosis can be harmful,” said the <a href="https://www.bbc.co.uk/news/articles/cmlykvpdx4x0o" target="_blank">BBC</a>, and it could “delay the investigation of an underlying problem”.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/what-is-ferritin-face</link>
                                                                            <description>
                            <![CDATA[ Social media trend claims facial clues could detect iron deficiencies, but professionals are sceptical ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">yBHmTkvsyTv4BwVkFnHKvK</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/KHXpZ5vKbghM4xxJ4LtAR7-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 12 Nov 2026 12:55:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Will Barker, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Will Barker joined The Week team as a staff writer in 2025, covering UK and global news and politics. He previously worked at the Financial Times and The Sun, contributing to the arts and world news desks, respectively. Before that, he achieved a gold-standard NCTJ Diploma at News Associates in Twickenham, with specialisms in media law and data journalism. While studying for his diploma, he also wrote for the South West Londoner, and channelled his passion for sport by reporting for The Cricket Paper.&lt;/p&gt;&lt;p&gt;As an undergraduate of Merton College, University of Oxford, Will read English and French, specialising in early-20th century multilingual poetry, and contributed to the Merton College magazine. His degree also included a year abroad, when he worked for Auditoire, on organisational and translation projects such as the Paris 2024 Olympics opening ceremony. After graduating, he moved to Dublin to study an M.Phil in literary translation at Trinity College Dublin. Alongside his research, he freelanced for a communications company analysing media coverage, which helped him realise that writing was his calling.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/KHXpZ5vKbghM4xxJ4LtAR7-1920-80.jpg">
                                                            <media:credit><![CDATA[Darya Komarova / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Users of social media claims low ferritin symptoms include dark under-eyes, pale and dry skin, and hair loss]]></media:description>                                                            <media:text><![CDATA[Woman looking frustrated and tired due to health concerns]]></media:text>
                                <media:title type="plain"><![CDATA[Woman looking frustrated and tired due to health concerns]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/KHXpZ5vKbghM4xxJ4LtAR7-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>“Forget jade rollers, LED masks and salmon sperm facials,” said Chloe Casey, a lecturer in nutrition and behaviour, on <a href="https://theconversation.com/ferritin-face-is-trending-but-can-your-skin-really-reveal-low-iron-289833" target="_blank">The Conversation</a>. The “latest skincare trend” is… a blood test.</p><p>That’s the way to investigate “Ferritin face”, which is cropping up all over <a href="https://theweek.com/news/media/960639/the-pros-and-cons-of-social-media">social media</a>. Posters are claiming that iron deficiency can be seen on your face via symptoms such as dark under-eyes, pale and dry skin, and hair loss. </p><p>There is a “kernel” of truth in the observation, but self-diagnosis and self-medication could cause more harm than good.</p><h2 id="what-is-ferritin">What is ferritin?</h2><p>Ferritin is a protein that plays a “significant role in the absorption, storage, and release of iron”, said the <a href="https://www.southtees.nhs.uk/services/pathology/tests/ferritin/" target="_blank">NHS</a>. Roughly 25% of iron in the body is stored, and the majority of that is ferritin. It is found in many types of cells in the body, but especially in the “liver, spleen, bone marrow, and in reticuloendothelial cells”.</p><p>A blood test for ferritin allows you to “get a snapshot of the body’s iron reserves”, said <a href="https://www.theguardian.com/science/2026/oct/28/ferritin-face-social-media-claims-iron-deficiency" target="_blank">The Guardian</a>. Because iron levels naturally “fluctuate throughout the day”, testing ferritin levels is a “better indicator” of iron deficiency problems such as <a href="https://theweek.com/health/what-is-sickle-cell-anaemia">anaemia</a>, said <a href="https://www.independent.co.uk/life-style/ferritin-face-low-iron-levels-b3074102.html" target="_blank">The Independent</a>.</p><p>You are more likely to suffer from low ferritin and iron levels if you are pregnant or suffer heavy periods, though this can also occur as a result of gastrointestinal problems, poor absorption or dietary choices.</p><h2 id="is-social-media-trend-harmful">Is social media trend harmful?</h2><p>It’s true that severe iron deficiency can “make someone look pale”, said Casey on The Conversation. But that doesn’t mean that low ferritin levels produce a “distinctive facial appearance. Hormones, bad sleep, stress, dehydration or not eating enough key nutrients can all leave you looking pale and tired.”</p><p>On social media, the “line between medical advice and marketing gets blurry fast”. A message warning of a medical condition is quickly linked to a supplement, “pill or powder” available for purchase. Fundamentally, a “mirror can’t tell you whether your ferritin is low – only a blood test can do that”.</p><h2 id="what-can-you-do-about-it">What can you do about it?</h2><p>A good way to improve iron levels is having a well-balanced diet. Red meat and shellfish contain iron that can be “more readily absorbed”, said <a href="https://graziadaily.co.uk/beauty-hair/skin/ferritin-face-trend/" target="_blank">Grazia</a>. Beans, lentils, chickpeas, tofu, leafy green vegetables and nuts are also rich in iron. </p><p>Those at risk of low ferritin should ask for blood tests including a full blood count, a ferritin level check, and tests for levels of B12 and folate, Toby Richards, a surgeon and iron therapy specialist, told The Guardian. </p><p>“Taking iron supplements without a diagnosis can be harmful,” said the <a href="https://www.bbc.co.uk/news/articles/cmlykvpdx4x0o" target="_blank">BBC</a>, and it could “delay the investigation of an underlying problem”.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Colorectal cancer is more deadly for young people. Scientists may know why. ]]></title>
                                                                                                <dc:content><![CDATA[ <p>For years, scientists have been stumped by the rise of early-onset colorectal cancer, which appears to be more treatment-resistant than in older patients. A new study may have discovered distinct biological traits that prove the cancers are indeed different. </p><h2 id="what-did-the-study-uncover">What did the study uncover?</h2><p>Scientists have long believed that early-onset colorectal <a href="https://www.theweek.com/religion/pope-leos-cancer-diagnosis-and-the-future-of-his-papacy">cancer</a> must be “biologically distinct” from the cancer found in older patients, said <a href="https://www.statnews.com/2026/10/29/early-onset-colorectal-cancer-dana-farber-study-qa-kimmie-ng/" target="_blank">Stat News</a>, since younger patients tend to be more difficult to treat. Patients under the age of 50 are often diagnosed at “later stages” with “tumors with more aggressive features.” Their outlook, especially for those “under the age of 35,” may not be as good as that of someone in their 60s, despite receiving “more aggressive treatment” and “being at baseline healthier,” study co-author Kimmie Ng said to Stat News. </p><p>Researchers from Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute published the study in <a href="https://doi.org/10.1038/s41591-026-04721-y" target="_blank">Nature Medicine</a>. The biggest difference found between the two age groups was a “higher presence of stromal cells” in younger colorectal cancer patients, said <a href="https://www.washingtonpost.com/health/2026/11/01/new-clues-emerge-why-colon-cancer-is-harder-treat-young-people/" target="_blank">The Washington Post.</a> Stromal cells influence a tumor’s growth and can “shield it from immune cells or drugs.” The team also identified dozens of <a href="https://www.theweek.com/science/genes-dna-personality-life-outcomes">genes</a> associated with “cancer’s propensity to metastasize and spread,” perhaps explaining why early-onset colorectal cancer is faster-growing, said the Post.</p><h2 id="what-will-the-findings-change">What will the findings change?</h2><p>Researchers hope the paper will encourage more research into the distinct attributes of early-onset cancer <a href="https://www.theweek.com/health/antarctic-sea-squirt-cancer-melanoma">tumors</a> and how to approach them. Patients are typically treated the same, regardless of age. But following up on these findings could highlight “therapeutic targets” for a more precise treatment approach in the future for young patients, Ng said to the Post. </p><p>While the study doesn’t offer any “immediate new takeaways” for young people concerned about colon cancer, study co-author Ana Anderson suggests following existing guidance to lower your risk, said <a href="https://www.businessinsider.com/new-study-colon-cancer-tumors-different-young-people-2026-10" target="_blank">Business Insider</a>. The recommended <a href="https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html" target="_blank">screening age</a> was lowered from 50 to 45 a few years ago, but you should see a doctor sooner if you experience common colon cancer symptoms. If you’re “extra cautious,” she said, it’s never a bad idea to stay active and cut down on inflammatory <a href="https://www.theweek.com/culture-life/food-drink/superfoods-diet-healthy-food">foods.</a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/colorectal-cancer-is-more-deadly-for-young-people-scientists-may-know-why</link>
                                                                            <description>
                            <![CDATA[ A new study sheds light on aggressive early-onset colorectal cancer ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Exj48jCxgZGHKpHYGJdRJZ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/ZLcdgLE4hXQZeCnyxeTCX8-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 11 Nov 2026 17:40:01 +0000</pubDate>                                                                                                                                <updated>Wed, 11 Nov 2026 22:39:40 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/ZLcdgLE4hXQZeCnyxeTCX8-1920-80.jpg">
                                                            <media:credit><![CDATA[Panuwat Dangsungnoen / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[March is Colorectal Cancer Awareness month, represented by a blue ribbon]]></media:description>                                                            <media:text><![CDATA[Doctor holding a blue ribbon with a human Colon anatomy model]]></media:text>
                                <media:title type="plain"><![CDATA[Doctor holding a blue ribbon with a human Colon anatomy model]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/ZLcdgLE4hXQZeCnyxeTCX8-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>For years, scientists have been stumped by the rise of early-onset colorectal cancer, which appears to be more treatment-resistant than in older patients. A new study may have discovered distinct biological traits that prove the cancers are indeed different. </p><h2 id="what-did-the-study-uncover">What did the study uncover?</h2><p>Scientists have long believed that early-onset colorectal <a href="https://www.theweek.com/religion/pope-leos-cancer-diagnosis-and-the-future-of-his-papacy">cancer</a> must be “biologically distinct” from the cancer found in older patients, said <a href="https://www.statnews.com/2026/10/29/early-onset-colorectal-cancer-dana-farber-study-qa-kimmie-ng/" target="_blank">Stat News</a>, since younger patients tend to be more difficult to treat. Patients under the age of 50 are often diagnosed at “later stages” with “tumors with more aggressive features.” Their outlook, especially for those “under the age of 35,” may not be as good as that of someone in their 60s, despite receiving “more aggressive treatment” and “being at baseline healthier,” study co-author Kimmie Ng said to Stat News. </p><p>Researchers from Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute published the study in <a href="https://doi.org/10.1038/s41591-026-04721-y" target="_blank">Nature Medicine</a>. The biggest difference found between the two age groups was a “higher presence of stromal cells” in younger colorectal cancer patients, said <a href="https://www.washingtonpost.com/health/2026/11/01/new-clues-emerge-why-colon-cancer-is-harder-treat-young-people/" target="_blank">The Washington Post.</a> Stromal cells influence a tumor’s growth and can “shield it from immune cells or drugs.” The team also identified dozens of <a href="https://www.theweek.com/science/genes-dna-personality-life-outcomes">genes</a> associated with “cancer’s propensity to metastasize and spread,” perhaps explaining why early-onset colorectal cancer is faster-growing, said the Post.</p><h2 id="what-will-the-findings-change">What will the findings change?</h2><p>Researchers hope the paper will encourage more research into the distinct attributes of early-onset cancer <a href="https://www.theweek.com/health/antarctic-sea-squirt-cancer-melanoma">tumors</a> and how to approach them. Patients are typically treated the same, regardless of age. But following up on these findings could highlight “therapeutic targets” for a more precise treatment approach in the future for young patients, Ng said to the Post. </p><p>While the study doesn’t offer any “immediate new takeaways” for young people concerned about colon cancer, study co-author Ana Anderson suggests following existing guidance to lower your risk, said <a href="https://www.businessinsider.com/new-study-colon-cancer-tumors-different-young-people-2026-10" target="_blank">Business Insider</a>. The recommended <a href="https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html" target="_blank">screening age</a> was lowered from 50 to 45 a few years ago, but you should see a doctor sooner if you experience common colon cancer symptoms. If you’re “extra cautious,” she said, it’s never a bad idea to stay active and cut down on inflammatory <a href="https://www.theweek.com/culture-life/food-drink/superfoods-diet-healthy-food">foods.</a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A bird flu outbreak at a Utah mink farm could be a public health crisis ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A virulent avian flu strain has made its way to a Utah mink farm, which could potentially open the door for the virus to spread to — and between — humans. Many are concerned about the federal government’s lack of action in preventing the spread. </p><h2 id="bird-to-mink-to-human">Bird to mink to human</h2><p>This strain of bird flu is “so virulent that if a single chicken tests positive, the U.S. government requires farmers to kill the whole flock to protect other farms as well as public health,” said <a href="https://www.propublica.org/article/bird-flu-mink-farm-utah-human-risk" target="_blank"><u>ProPublica</u></a>. The virus, though, has spread uncontrolled through the mink farm for more than two months, and there are “no federal rules for how to deal with sick mink.” In “other countries where such outbreaks have occurred, the government has ordered farms to kill their mink,” said <a href="https://www.theguardian.com/us-news/2026/oct/25/bird-flu-utah-mink-farm-trump-administration" target="_blank"><u>The Guardian</u></a>. No similar plans exist in Utah for now. </p><p>The <a href="https://theweek.com/health/a-sexually-transmitted-stomach-bug-is-spreading-in-the-us"><u>outbreak</u></a> is particularly concerning as “mink have lungs and airways that on a cellular level are remarkably similar to those of people,” said ProPublica. In the past, the animals have contracted <a href="https://theweek.com/health/what-we-learned-from-covid-inquiry-report-on-social-care"><u>Covid-19</u></a> and spread it to humans. Bird flu could emulate the same trajectory. </p><h2 id="fuzzy-instructions">Fuzzy instructions</h2><p>Despite the risk of a major public health issue, “there’s just not a lot of options out there other than kind of sitting and waiting and seeing what happens,” Utah’s State Veterinarian Amanda Price said to ProPublica. Mink are “bred in captivity and raised on farms, occupying a regulatory gray area between wildlife and agriculture,” said <a href="https://www.sltrib.com/news/2026/09/27/animal-advocates-raise-alarm-over/" target="_blank"><u>The Salt Lake Tribune</u></a>. One bird flu vaccine is approved for mammals, but “only USDA Secretary Brooke Rollins can authorize its use.” Because bird flu in mink is new in the U.S., “there’s little research to guide the dosage or determine how well it would work.”</p><p>The good news: A <a href="https://theweek.com/health/hantavirus-are-we-ready-for-another-pandemic"><u>pandemic</u></a> threat is not present just yet. “The risk is greatest among people who have exposure to sick animals,” Brown University epidemiology professor Jennifer Nuzzo said to The Guardian. “If that is not you, I think you can take this off your worry list.” But it still “does not abdicate the government of its responsibility to try to prevent a pandemic.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/a-bird-flu-outbreak-at-a-utah-mink-farm-could-be-a-public-health-crisis</link>
                                                                            <description>
                            <![CDATA[ The animals have lungs similar to humans ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">GaACHrWVT4FYxGtNJSj2XF</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/4oxhnEgzv8rDJe48jDVdQT-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 11 Nov 2026 06:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/4oxhnEgzv8rDJe48jDVdQT-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images ]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The government has very little guidance in dealing with disease outbreak in mink]]></media:description>                                                            <media:text><![CDATA[Photo collage of a caged mink, a micrograph of the bird flu virus, and empty cages on a scrap pile.]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a caged mink, a micrograph of the bird flu virus, and empty cages on a scrap pile.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/4oxhnEgzv8rDJe48jDVdQT-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A virulent avian flu strain has made its way to a Utah mink farm, which could potentially open the door for the virus to spread to — and between — humans. Many are concerned about the federal government’s lack of action in preventing the spread. </p><h2 id="bird-to-mink-to-human">Bird to mink to human</h2><p>This strain of bird flu is “so virulent that if a single chicken tests positive, the U.S. government requires farmers to kill the whole flock to protect other farms as well as public health,” said <a href="https://www.propublica.org/article/bird-flu-mink-farm-utah-human-risk" target="_blank"><u>ProPublica</u></a>. The virus, though, has spread uncontrolled through the mink farm for more than two months, and there are “no federal rules for how to deal with sick mink.” In “other countries where such outbreaks have occurred, the government has ordered farms to kill their mink,” said <a href="https://www.theguardian.com/us-news/2026/oct/25/bird-flu-utah-mink-farm-trump-administration" target="_blank"><u>The Guardian</u></a>. No similar plans exist in Utah for now. </p><p>The <a href="https://theweek.com/health/a-sexually-transmitted-stomach-bug-is-spreading-in-the-us"><u>outbreak</u></a> is particularly concerning as “mink have lungs and airways that on a cellular level are remarkably similar to those of people,” said ProPublica. In the past, the animals have contracted <a href="https://theweek.com/health/what-we-learned-from-covid-inquiry-report-on-social-care"><u>Covid-19</u></a> and spread it to humans. Bird flu could emulate the same trajectory. </p><h2 id="fuzzy-instructions">Fuzzy instructions</h2><p>Despite the risk of a major public health issue, “there’s just not a lot of options out there other than kind of sitting and waiting and seeing what happens,” Utah’s State Veterinarian Amanda Price said to ProPublica. Mink are “bred in captivity and raised on farms, occupying a regulatory gray area between wildlife and agriculture,” said <a href="https://www.sltrib.com/news/2026/09/27/animal-advocates-raise-alarm-over/" target="_blank"><u>The Salt Lake Tribune</u></a>. One bird flu vaccine is approved for mammals, but “only USDA Secretary Brooke Rollins can authorize its use.” Because bird flu in mink is new in the U.S., “there’s little research to guide the dosage or determine how well it would work.”</p><p>The good news: A <a href="https://theweek.com/health/hantavirus-are-we-ready-for-another-pandemic"><u>pandemic</u></a> threat is not present just yet. “The risk is greatest among people who have exposure to sick animals,” Brown University epidemiology professor Jennifer Nuzzo said to The Guardian. “If that is not you, I think you can take this off your worry list.” But it still “does not abdicate the government of its responsibility to try to prevent a pandemic.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Palantir’s controversial NHS contract ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The government is preparing to extend Palantir’s controversial NHS contract despite growing concerns over its software’s performance and widespread reluctance across hospitals to use it.</p><p>MPs, medics and campaigners have urged Health Secretary Yvette Cooper to trigger an early “break clause” in February, said the <a href="https://www.ft.com/content/bd35cc23-9c24-4ac5-8754-76ed8dd0c264?syn-25a6b1a6=1" target="_blank">Financial Times</a>. But ministers reviewing the <a href="https://theweek.com/tech/palantir-influence-in-the-british-state-mod-mandelson">£330 million deal</a> to deploy the US tech giant’s flagship AI system have concluded that removing Palantir would be “too disruptive”.</p><h2 id="what-is-palantir-s-contract-with-the-nhs">What is Palantir’s contract with the NHS?</h2><p>In 2023, NHS England awarded a Palantir-led consortium a contract to link datasets across hospitals and trusts. The result, the Federated Data Platform (FDP), is powered by Palantir’s Foundry software and loaned out to <a href="https://theweek.com/tag/nhs">NHS</a> teams to build applications, coordinate patient records, schedule procedures and reduce waiting lists. </p><p>The deal was controversial from the off due to Palantir’s work with <a href="https://www.theweek.com/tech/palantir-controversy-alex-karp">US immigration enforcement and the Israeli military</a>. Officials privately warned Wes Streeting, then health secretary, last year that Palantir’s reputation would deter NHS trusts from using its software, said <a href="https://www.theguardian.com/society/2026/feb/12/nhs-deal-with-ai-firm-palantir-called-into-question-after-officials-concerns-revealed" target="_blank">The Guardian</a> in February. Accusations that the procurement process was rigged also deepened after it emerged that Palantir had hired <a href="https://www.theweek.com/politics/peter-mandelson-vetting-who-knew-what-and-when">Peter Mandelson’s lobbying firm</a> ahead of the successful bid.</p><p>In June, the Commons Health and Social Care Committee recommended that the contract not be extended. “People don’t trust Palantir, its benefits are contested and other tools could deliver the same or similar advantages,” said committee member and Labour MP Ben Coleman in <a href="https://www.theguardian.com/commentisfree/2026/nov/09/british-people-palantir-nhs-health-data-us-tech-firm" target="_blank">The Guardian</a>.</p><h2 id="has-its-software-helped-the-nhs">Has its software helped the NHS?</h2><p>The NHS and government claims of benefits are fiercely contested. Many doctors say the FDP is less effective than existing technology; some senior NHS leaders called it “slow and clunky”, said Peter Geoghegan and Lucas Amin in the <a href="https://www.lrb.co.uk/the-paper/v48/n13/peter-geoghegan-and-lucas-amin/this-looks-absolutely-rubbish" target="_blank">London Review of Books</a>.</p><p>Active usage is far lower than official claims suggest. NHS England said that, as of June this year, 139 NHS trusts were “live” on Palantir’s software. But 52 of them “did not use a single FDP app”, said the LRB, citing a Department of Health and Social Care official.</p><p>NHS England claims Palantir’s patient discharge tool was responsible for a 15% decrease in delayed discharges. But the Health Foundation think tank reported that hospitals using the tool saw “no noticeable improvement” compared with those that didn’t, said <a href="https://www.bmj.com/content/394/bmj-2026-100485" target="_blank">The BMJ</a>.</p><p>Palantir has claimed it is helping to deliver “99,000 more NHS operations”, but digital rights advocacy group <a href="https://www.foxglove.org.uk/2026/06/16/nhs-trusts-palantir-fdp-tools-fewer-operations/" target="_blank">Foxglove</a> says that nearly a third of NHS trusts using Palantir’s theatre scheduling tool performed fewer procedures after it was deployed.</p><p>In July, the <a href="https://osr.statisticsauthority.gov.uk/news/nhs-england-federated-data-platform-fdp-presentation-and-communication-of-information-and-performance-metrics/" target="_blank">Office for Statistics Regulation</a> said that NHS England lacked sufficient evidence for its claims that the FDP was directly responsible for performance improvements.</p><h2 id="what-might-happen-next">What might happen next?</h2><p>The National Audit Office, the independent public spending watchdog, is reviewing the rollout and costs of the FDP, and will publish a report this winter. NHS England also commissioned Imperial College London to evaluate clinical outcomes, with that final report due in 2029. </p><p>The government’s review of Palantir’s contract is still under way, but Cooper told MPs she wanted to use the NHS “to develop UK sovereign <a href="https://theweek.com/tag/artificial-intelligence">AI</a>”. The government is planning to put the FDP contract out to tender, said <a href="https://www.bmj.com/content/395/bmj-2026-101381" target="_blank">The BMJ</a>. That would force Palantir to “rebid against UK-based competitors”.</p><p>Health officials have been “sounding out a handful of British companies to bid to run the FDP”, said the FT. Rivals “insist they are ready to take over the contract”, but Palantir’s defenders claim switching to “an untested alternative” would be “a significant gamble”.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/palantirs-controversial-nhs-contract</link>
                                                                            <description>
                            <![CDATA[ Ministers plan to extend deal, overruling MPs and medics who dispute value and efficacy of data platform built on US tech giant’s software ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">A7NPb5THvgLYtraojNUB5X</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/4Aqd65oYUfnbSoFsv5XPaW-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 10 Nov 2026 12:25:47 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Harriet Marsden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Harriet Marsden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Harriet Marsden is a senior staff writer and podcast panellist for The Week, mostly covering world news and writing the weekly &lt;a href=&quot;https://theweek.com/globaldigest&quot;&gt;Global Digest&lt;/a&gt; newsletter. Before joining the site in 2023, she was a freelance journalist for seven years, working for The Guardian, The Times and The Independent among others, and regularly appearing on BBC Radio London and Times Radio. She has a particular interest in gender equality and attended the 67th Commission on the Status of Women as a UN Women UK delegate.&lt;/p&gt;&lt;p&gt;In 2021, Harriet was awarded the “journalist-at-large” fellowship by the Local Trust charity, and spent a year travelling independently to some of England’s most deprived areas to write about local culture and community activism. She has a master’s in international journalism from City University, and an undergraduate degree in languages from the University of Cambridge, specialising in Latin American studies. She has also worked as a journalist in Bolivia, Colombia and Spain.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/4Aqd65oYUfnbSoFsv5XPaW-1920-80.jpg">
                                                            <media:credit><![CDATA[Matthew Chattle / Future Publishing / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Officials warned that Palantir’s political reputation would impact uptake of its software in NHS trusts]]></media:description>                                                            <media:text><![CDATA[A placard reading &quot;Get Palantir out of our hospitals&quot; held up during a protest opposite St Thomas&#039;s Hospital]]></media:text>
                                <media:title type="plain"><![CDATA[A placard reading &quot;Get Palantir out of our hospitals&quot; held up during a protest opposite St Thomas&#039;s Hospital]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/4Aqd65oYUfnbSoFsv5XPaW-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The government is preparing to extend Palantir’s controversial NHS contract despite growing concerns over its software’s performance and widespread reluctance across hospitals to use it.</p><p>MPs, medics and campaigners have urged Health Secretary Yvette Cooper to trigger an early “break clause” in February, said the <a href="https://www.ft.com/content/bd35cc23-9c24-4ac5-8754-76ed8dd0c264?syn-25a6b1a6=1" target="_blank">Financial Times</a>. But ministers reviewing the <a href="https://theweek.com/tech/palantir-influence-in-the-british-state-mod-mandelson">£330 million deal</a> to deploy the US tech giant’s flagship AI system have concluded that removing Palantir would be “too disruptive”.</p><h2 id="what-is-palantir-s-contract-with-the-nhs">What is Palantir’s contract with the NHS?</h2><p>In 2023, NHS England awarded a Palantir-led consortium a contract to link datasets across hospitals and trusts. The result, the Federated Data Platform (FDP), is powered by Palantir’s Foundry software and loaned out to <a href="https://theweek.com/tag/nhs">NHS</a> teams to build applications, coordinate patient records, schedule procedures and reduce waiting lists. </p><p>The deal was controversial from the off due to Palantir’s work with <a href="https://www.theweek.com/tech/palantir-controversy-alex-karp">US immigration enforcement and the Israeli military</a>. Officials privately warned Wes Streeting, then health secretary, last year that Palantir’s reputation would deter NHS trusts from using its software, said <a href="https://www.theguardian.com/society/2026/feb/12/nhs-deal-with-ai-firm-palantir-called-into-question-after-officials-concerns-revealed" target="_blank">The Guardian</a> in February. Accusations that the procurement process was rigged also deepened after it emerged that Palantir had hired <a href="https://www.theweek.com/politics/peter-mandelson-vetting-who-knew-what-and-when">Peter Mandelson’s lobbying firm</a> ahead of the successful bid.</p><p>In June, the Commons Health and Social Care Committee recommended that the contract not be extended. “People don’t trust Palantir, its benefits are contested and other tools could deliver the same or similar advantages,” said committee member and Labour MP Ben Coleman in <a href="https://www.theguardian.com/commentisfree/2026/nov/09/british-people-palantir-nhs-health-data-us-tech-firm" target="_blank">The Guardian</a>.</p><h2 id="has-its-software-helped-the-nhs">Has its software helped the NHS?</h2><p>The NHS and government claims of benefits are fiercely contested. Many doctors say the FDP is less effective than existing technology; some senior NHS leaders called it “slow and clunky”, said Peter Geoghegan and Lucas Amin in the <a href="https://www.lrb.co.uk/the-paper/v48/n13/peter-geoghegan-and-lucas-amin/this-looks-absolutely-rubbish" target="_blank">London Review of Books</a>.</p><p>Active usage is far lower than official claims suggest. NHS England said that, as of June this year, 139 NHS trusts were “live” on Palantir’s software. But 52 of them “did not use a single FDP app”, said the LRB, citing a Department of Health and Social Care official.</p><p>NHS England claims Palantir’s patient discharge tool was responsible for a 15% decrease in delayed discharges. But the Health Foundation think tank reported that hospitals using the tool saw “no noticeable improvement” compared with those that didn’t, said <a href="https://www.bmj.com/content/394/bmj-2026-100485" target="_blank">The BMJ</a>.</p><p>Palantir has claimed it is helping to deliver “99,000 more NHS operations”, but digital rights advocacy group <a href="https://www.foxglove.org.uk/2026/06/16/nhs-trusts-palantir-fdp-tools-fewer-operations/" target="_blank">Foxglove</a> says that nearly a third of NHS trusts using Palantir’s theatre scheduling tool performed fewer procedures after it was deployed.</p><p>In July, the <a href="https://osr.statisticsauthority.gov.uk/news/nhs-england-federated-data-platform-fdp-presentation-and-communication-of-information-and-performance-metrics/" target="_blank">Office for Statistics Regulation</a> said that NHS England lacked sufficient evidence for its claims that the FDP was directly responsible for performance improvements.</p><h2 id="what-might-happen-next">What might happen next?</h2><p>The National Audit Office, the independent public spending watchdog, is reviewing the rollout and costs of the FDP, and will publish a report this winter. NHS England also commissioned Imperial College London to evaluate clinical outcomes, with that final report due in 2029. </p><p>The government’s review of Palantir’s contract is still under way, but Cooper told MPs she wanted to use the NHS “to develop UK sovereign <a href="https://theweek.com/tag/artificial-intelligence">AI</a>”. The government is planning to put the FDP contract out to tender, said <a href="https://www.bmj.com/content/395/bmj-2026-101381" target="_blank">The BMJ</a>. That would force Palantir to “rebid against UK-based competitors”.</p><p>Health officials have been “sounding out a handful of British companies to bid to run the FDP”, said the FT. Rivals “insist they are ready to take over the contract”, but Palantir’s defenders claim switching to “an untested alternative” would be “a significant gamble”.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Insurers flee healthcare markets amid open enrollment ]]></title>
                                                                                                <dc:content><![CDATA[ <p>With open enrollment underway, many people face a stark reality when it comes to healthcare. A slew of insurers are vanishing from marketplaces, most notably the Affordable Care Act exchange. This could leave many without coverage options for 2027.</p><h2 id="at-least-11-insurers-fleeing">At least 11 insurers fleeing</h2><p>The ACA, or <a href="https://theweek.com/politics/obamacare-survive-dropping-enrollment">Obamacare</a>, is at the center of the insurer pullouts as the insurers “reassess the profitability of their marketplace participation,” said health policy organization <a href="https://www.kff.org/affordable-care-act/tracking-insurer-participation-changes-in-the-aca-marketplaces-in-2027/" target="_blank">KFF</a>. At least 11 insurers have announced plans to leave the ACA marketplace in 2027, including major companies like UnitedHealth, PacificSource and Cigna. The latter, which has more than 350,000 ACA enrollees, will “exit the 11 states in which it currently participates both on- and off-exchange.”</p><p><a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">The ACA isn</a>’<a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">t the only target</a>. Other insurers believe that “flat Medicare Advantage rates as proposed by the Trump administration” would “likely force them to take a deep look at the benefits they offer,” said industry outlet <a href="https://www.fiercehealthcare.com/regulatory/cms-proposes-flat-ma-rates-risk-adjustment-updates-2027" target="_blank">Fierce Healthcare</a>. The funding changes at a “time of sharply rising medical costs and high utilization of care will impact seniors’ coverage,” Chris Bond, a spokesperson for insurance lobby AHIP, said in a statement per the outlet.</p><h2 id="creating-discontinuities-in-care">Creating ‘discontinuities in care’</h2><p>This insurer exodus could lead to problems for sick people, <a href="https://theweek.com/personal-finance/save-on-rising-health-care-costs">especially lower-income Americans</a>. If someone has a “doctor who doesn’t accept the fewer number of options that are available to you, that can be very disruptive, especially if you’re someone who has a chronic illness,” Miranda Yaver, a professor of health policy and management at the University of Pittsburgh, told <a href="https://www.nbcnews.com/health/health-care/many-aca-coverage-face-new-crisis-2027-insurers-fleeing-market-rcna606211" target="_blank">NBC News</a>. “This is going to create a lot of discontinuities in care and coverage for people.” The changes also mean “constant upheaval, whether it’s the plan pulling out or the subsidies have changed or the doctor network has changed,” insurance broker Jennifer Chumbley Hogue said to the outlet.</p><p>Such withdrawals ultimately “reflect a familiar cycle,” said the industry outlet healthinsurance.org. Insurer participation in various markets has long been “cyclical over time, generally increasing when the individual market was healthier and larger and decreasing when it was sicker and smaller.” Decisions on what plans to offer are primarily “driven by insurers’ assessment of profitability and overall market stability.” </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/insurers-fleeing-healthcare-markets-enrollment-aca</link>
                                                                            <description>
                            <![CDATA[ The moves could leave ACA enrollees vulnerable heading into 2027 ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Fo9LW8X36JHMUiQqWqNrJ7</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/8y5HdoL9UY63K2WwR9uXNA-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 04 Nov 2026 17:26:39 +0000</pubDate>                                                                                                                                <updated>Wed, 04 Nov 2026 21:54:12 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/8y5HdoL9UY63K2WwR9uXNA-1920-80.jpg">
                                                            <media:credit><![CDATA[Michael Nagle / Bloomberg / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[These changes ‘can be very disruptive, especially if you’re someone who has a chronic illness’]]></media:description>                                                            <media:text><![CDATA[A sign advertising health insurance sign-ups in Quakertown, Pennsylvania. ]]></media:text>
                                <media:title type="plain"><![CDATA[A sign advertising health insurance sign-ups in Quakertown, Pennsylvania. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/8y5HdoL9UY63K2WwR9uXNA-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>With open enrollment underway, many people face a stark reality when it comes to healthcare. A slew of insurers are vanishing from marketplaces, most notably the Affordable Care Act exchange. This could leave many without coverage options for 2027.</p><h2 id="at-least-11-insurers-fleeing">At least 11 insurers fleeing</h2><p>The ACA, or <a href="https://theweek.com/politics/obamacare-survive-dropping-enrollment">Obamacare</a>, is at the center of the insurer pullouts as the insurers “reassess the profitability of their marketplace participation,” said health policy organization <a href="https://www.kff.org/affordable-care-act/tracking-insurer-participation-changes-in-the-aca-marketplaces-in-2027/" target="_blank">KFF</a>. At least 11 insurers have announced plans to leave the ACA marketplace in 2027, including major companies like UnitedHealth, PacificSource and Cigna. The latter, which has more than 350,000 ACA enrollees, will “exit the 11 states in which it currently participates both on- and off-exchange.”</p><p><a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">The ACA isn</a>’<a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">t the only target</a>. Other insurers believe that “flat Medicare Advantage rates as proposed by the Trump administration” would “likely force them to take a deep look at the benefits they offer,” said industry outlet <a href="https://www.fiercehealthcare.com/regulatory/cms-proposes-flat-ma-rates-risk-adjustment-updates-2027" target="_blank">Fierce Healthcare</a>. The funding changes at a “time of sharply rising medical costs and high utilization of care will impact seniors’ coverage,” Chris Bond, a spokesperson for insurance lobby AHIP, said in a statement per the outlet.</p><h2 id="creating-discontinuities-in-care">Creating ‘discontinuities in care’</h2><p>This insurer exodus could lead to problems for sick people, <a href="https://theweek.com/personal-finance/save-on-rising-health-care-costs">especially lower-income Americans</a>. If someone has a “doctor who doesn’t accept the fewer number of options that are available to you, that can be very disruptive, especially if you’re someone who has a chronic illness,” Miranda Yaver, a professor of health policy and management at the University of Pittsburgh, told <a href="https://www.nbcnews.com/health/health-care/many-aca-coverage-face-new-crisis-2027-insurers-fleeing-market-rcna606211" target="_blank">NBC News</a>. “This is going to create a lot of discontinuities in care and coverage for people.” The changes also mean “constant upheaval, whether it’s the plan pulling out or the subsidies have changed or the doctor network has changed,” insurance broker Jennifer Chumbley Hogue said to the outlet.</p><p>Such withdrawals ultimately “reflect a familiar cycle,” said the industry outlet healthinsurance.org. Insurer participation in various markets has long been “cyclical over time, generally increasing when the individual market was healthier and larger and decreasing when it was sicker and smaller.” Decisions on what plans to offer are primarily “driven by insurers’ assessment of profitability and overall market stability.” </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A new framework reveals the stages of women’s heart health ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Heart disease poses a significant threat to women, but research into the issue has been lacking for years. Now, for the first time, four medical societies have published a shared framework and clinical guidance to help doctors identify and treat cardiovascular risk throughout a woman’s life. </p><h2 id="what-did-the-group-outline">What did the group outline?</h2><p>The <a href="https://newsroom.heart.org/news/leading-health-groups-redefine-heart-health-for-girls-and-women" target="_blank">American Heart Association</a>, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine have created a system to help redefine <a href="https://www.theweek.com/health/microplastics-cardiovascular-health">heart health</a> for girls and women. The group outlines four “Female Life Stages” where hormones could affect heart health: perimenarche (ages 8-15), regular ovarian cycling (ages 15-44), <a href="https://www.theweek.com/health/women-over-40-perimenopause-postpartum">perimenopause</a> (ages 45-51) and postmenopause (age 51 and older). <a href="https://www.theweek.com/health/zero-trimester-influencers-healthy-pregnancy-pros-cons">Pregnancy</a> at any life stage is also included. Three manuscripts published in the AHA’s flagship journal, <a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001483" target="_blank">Circulation</a>, include guidelines for navigating these stages.</p><p>The coalition asserts that because “female-specific biology” affects girls’ and women’s hearts “throughout their lives,” it requires “connected, holistic care starting in adolescence” to reflect “transitions not found in the male models” that dominate health care: “periods, pregnancy, perimenopause, and menopause,” said <a href="https://www.statnews.com/2026/10/26/heart-health-women-four-life-stages-qa-sadiya-khan/" target="_blank">Stat</a>.</p><p>What happens in adolescence and young adulthood “impacts your life for years and decades to come,” so acting at that point can “really change the course of someone’s cardiovascular health story,” Sadiya Khan, the chair of the group and a professor of cardiovascular epidemiology at Northwestern University Feinberg School of Medicine, said to Stat. Keeping the various aspects of women’s healthcare “all connected and not siloed,” even though that’s “typically how we have approached care,” will require an “integrative approach.”</p><h2 id="why-was-a-new-framework-needed">Why was a new framework needed?</h2><p><a href="https://www.goredforwomen.org/en/about-heart-disease-in-women/facts" target="_blank">Heart disease</a> is already the number one killer of women globally, and both heart disease and stroke are “projected to rise significantly in women over the next two decades,” said <a href="https://www.nbcnews.com/health/heart-health/know-five-phases-womens-girls-heart-health-rcna605069" target="_blank">NBC News</a>. Still, very little is known about how female biology affects heart health. Scientists were “not required to include women in clinical trials on heart disease until 1993,” and today, “fewer women are still included in the trials than men.” Women’s healthcare is also “often uniquely fragmented across different specialties” throughout their lifetime. </p><p>Ultimately, girls and women “represent half the population,” and “every clinician, every specialty and every health system” has a role to play in their well-being, Khan said at <a href="https://time.com/article/2026/10/26/a-new-way-to-think-about-women-heart-health-sadiya-s-khan-essay/" target="_blank">Time</a>. Women can “do much to protect their health,” but they should not have to “connect the dots in their care alone.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/a-new-framework-reveals-the-stages-of-womens-heart-health</link>
                                                                            <description>
                            <![CDATA[ Doctors now have guidance for earlier intervention in girls’ and women’s cardiovascular health ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">koHyKhakfzrSbDvxNVxtPK</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/7BLprdxg8fmEXqgogewUsR-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 30 Oct 2026 17:39:36 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/7BLprdxg8fmEXqgogewUsR-1920-80.jpg">
                                                            <media:credit><![CDATA[KoldoyChris / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Experts say more research is needed in women’s healthcare overall]]></media:description>                                                            <media:text><![CDATA[Smiling female medical doctor forming a heart shape with a stethoscope]]></media:text>
                                <media:title type="plain"><![CDATA[Smiling female medical doctor forming a heart shape with a stethoscope]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/7BLprdxg8fmEXqgogewUsR-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Heart disease poses a significant threat to women, but research into the issue has been lacking for years. Now, for the first time, four medical societies have published a shared framework and clinical guidance to help doctors identify and treat cardiovascular risk throughout a woman’s life. </p><h2 id="what-did-the-group-outline">What did the group outline?</h2><p>The <a href="https://newsroom.heart.org/news/leading-health-groups-redefine-heart-health-for-girls-and-women" target="_blank">American Heart Association</a>, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine have created a system to help redefine <a href="https://www.theweek.com/health/microplastics-cardiovascular-health">heart health</a> for girls and women. The group outlines four “Female Life Stages” where hormones could affect heart health: perimenarche (ages 8-15), regular ovarian cycling (ages 15-44), <a href="https://www.theweek.com/health/women-over-40-perimenopause-postpartum">perimenopause</a> (ages 45-51) and postmenopause (age 51 and older). <a href="https://www.theweek.com/health/zero-trimester-influencers-healthy-pregnancy-pros-cons">Pregnancy</a> at any life stage is also included. Three manuscripts published in the AHA’s flagship journal, <a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001483" target="_blank">Circulation</a>, include guidelines for navigating these stages.</p><p>The coalition asserts that because “female-specific biology” affects girls’ and women’s hearts “throughout their lives,” it requires “connected, holistic care starting in adolescence” to reflect “transitions not found in the male models” that dominate health care: “periods, pregnancy, perimenopause, and menopause,” said <a href="https://www.statnews.com/2026/10/26/heart-health-women-four-life-stages-qa-sadiya-khan/" target="_blank">Stat</a>.</p><p>What happens in adolescence and young adulthood “impacts your life for years and decades to come,” so acting at that point can “really change the course of someone’s cardiovascular health story,” Sadiya Khan, the chair of the group and a professor of cardiovascular epidemiology at Northwestern University Feinberg School of Medicine, said to Stat. Keeping the various aspects of women’s healthcare “all connected and not siloed,” even though that’s “typically how we have approached care,” will require an “integrative approach.”</p><h2 id="why-was-a-new-framework-needed">Why was a new framework needed?</h2><p><a href="https://www.goredforwomen.org/en/about-heart-disease-in-women/facts" target="_blank">Heart disease</a> is already the number one killer of women globally, and both heart disease and stroke are “projected to rise significantly in women over the next two decades,” said <a href="https://www.nbcnews.com/health/heart-health/know-five-phases-womens-girls-heart-health-rcna605069" target="_blank">NBC News</a>. Still, very little is known about how female biology affects heart health. Scientists were “not required to include women in clinical trials on heart disease until 1993,” and today, “fewer women are still included in the trials than men.” Women’s healthcare is also “often uniquely fragmented across different specialties” throughout their lifetime. </p><p>Ultimately, girls and women “represent half the population,” and “every clinician, every specialty and every health system” has a role to play in their well-being, Khan said at <a href="https://time.com/article/2026/10/26/a-new-way-to-think-about-women-heart-health-sadiya-s-khan-essay/" target="_blank">Time</a>. Women can “do much to protect their health,” but they should not have to “connect the dots in their care alone.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Scientists have deployed an AI-designed virus ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A California startup has used AI to create a virus reportedly capable of fighting off a bacterial infection. The method, if effective, could help people combat disease without worsening antibiotic resistance.</p><h2 id="how-it-works">How it works</h2><p>Researchers at Radical Numerics administered the <a href="https://theweek.com/science/first-ai-designed-virus-scientists"><u>AI bacteriophage</u></a>, through an AI model<strong> </strong>called Omnii-1, to a patient “suffering from a deadly bacterial infection,” with the hope the virus would “kill the microbes causing the infection,” said <a href="https://www.nytimes.com/2026/10/20/science/ai-virus-bacteria-radical-numerics.html" target="_blank"><u>The New York Times</u></a>. If successful, the findings could “point to a new way to use AI in medicine.”</p><p>Phage therapy existed long before AI. Phages can “target particular bacteria with remarkable specificity, sparing beneficial bacteria such as those in the gut that support digestion,” said a technical paper by <a href="https://www.radicalnumerics.ai/blog/omnii-phage#from-phage-discovery-to-phage-design" target="_blank"><u>Radical Numerics</u></a>. The process can be time-consuming, though. </p><p>Creating the therapy without AI requires using a “bacterial sample from a patient’s infection” to “screen existing phage collections for effective candidates,” said the Radical Numerics paper. If no known phages are effective, researchers then turn to “additional collections, environmental samples or engineering.”  </p><p>Using <a href="https://theweek.com/tech/will-ai-end-humanity"><u>AI</u></a> instead “can lead to rapid, on-demand generation of phages that meet patient requirements, accelerating the timeline for treatment,” said <a href="https://www.the-independent.com/news/science/ai-virus-humans-injected-phage-startup-b3071922.html" target="_blank"><u>The Independent</u></a>. </p><h2 id="the-future">The future</h2><p>“If it works, that’s incredible,” Michael Baym, a microbiologist at Harvard University, said to the Times. “My impulse is to be skeptical.” Radical Numerics has not revealed the clinical outcomes of the patient who was given the AI virus, and the study has yet to be peer-reviewed. The company aims to “protect patient confidentiality and maintain the trust” of clinical partners, though it intends to publish the results in the future, Eric Nguyen, the CEO of Radical Numerics, said to the Times.</p><p>Widespread phage therapy could help combat <a href="https://theweek.com/health/a-sexually-transmitted-stomach-bug-is-spreading-in-the-us"><u>antibiotic resistance</u></a>. Phages “do not infect human cells, and phage therapy is generally considered safe,” said Radical Numerics. “Unlike broad-spectrum antibiotics, phages can target particular bacteria with remarkable specificity.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/scientists-have-deployed-an-ai-designed-virus</link>
                                                                            <description>
                            <![CDATA[ It could fight off a deadly bacterial infection ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Yrsv2MPDfBKLpafFo396vh</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/qNjpW8rCaXybRmvuudfHA3-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 30 Oct 2026 06:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/qNjpW8rCaXybRmvuudfHA3-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images ]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Phages can target specific bacteria rather than general bacteria like antibiotics]]></media:description>                                                            <media:text><![CDATA[Photo collage of a syringe, a pattern reminiscent of a bacteria micrograph, and a CG image of a bacteriophage virus]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a syringe, a pattern reminiscent of a bacteria micrograph, and a CG image of a bacteriophage virus]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/qNjpW8rCaXybRmvuudfHA3-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A California startup has used AI to create a virus reportedly capable of fighting off a bacterial infection. The method, if effective, could help people combat disease without worsening antibiotic resistance.</p><h2 id="how-it-works">How it works</h2><p>Researchers at Radical Numerics administered the <a href="https://theweek.com/science/first-ai-designed-virus-scientists"><u>AI bacteriophage</u></a>, through an AI model<strong> </strong>called Omnii-1, to a patient “suffering from a deadly bacterial infection,” with the hope the virus would “kill the microbes causing the infection,” said <a href="https://www.nytimes.com/2026/10/20/science/ai-virus-bacteria-radical-numerics.html" target="_blank"><u>The New York Times</u></a>. If successful, the findings could “point to a new way to use AI in medicine.”</p><p>Phage therapy existed long before AI. Phages can “target particular bacteria with remarkable specificity, sparing beneficial bacteria such as those in the gut that support digestion,” said a technical paper by <a href="https://www.radicalnumerics.ai/blog/omnii-phage#from-phage-discovery-to-phage-design" target="_blank"><u>Radical Numerics</u></a>. The process can be time-consuming, though. </p><p>Creating the therapy without AI requires using a “bacterial sample from a patient’s infection” to “screen existing phage collections for effective candidates,” said the Radical Numerics paper. If no known phages are effective, researchers then turn to “additional collections, environmental samples or engineering.”  </p><p>Using <a href="https://theweek.com/tech/will-ai-end-humanity"><u>AI</u></a> instead “can lead to rapid, on-demand generation of phages that meet patient requirements, accelerating the timeline for treatment,” said <a href="https://www.the-independent.com/news/science/ai-virus-humans-injected-phage-startup-b3071922.html" target="_blank"><u>The Independent</u></a>. </p><h2 id="the-future">The future</h2><p>“If it works, that’s incredible,” Michael Baym, a microbiologist at Harvard University, said to the Times. “My impulse is to be skeptical.” Radical Numerics has not revealed the clinical outcomes of the patient who was given the AI virus, and the study has yet to be peer-reviewed. The company aims to “protect patient confidentiality and maintain the trust” of clinical partners, though it intends to publish the results in the future, Eric Nguyen, the CEO of Radical Numerics, said to the Times.</p><p>Widespread phage therapy could help combat <a href="https://theweek.com/health/a-sexually-transmitted-stomach-bug-is-spreading-in-the-us"><u>antibiotic resistance</u></a>. Phages “do not infect human cells, and phage therapy is generally considered safe,” said Radical Numerics. “Unlike broad-spectrum antibiotics, phages can target particular bacteria with remarkable specificity.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Dementia cases to double by 2050 amid aging populations ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The global incidence of dementia is increasing at a much faster rate than previously known, according to new research. Cases could double by the middle of the century, with millions of people potentially at risk as the world’s population ages. </p><h2 id="what-did-the-study-find">What did the study find?  </h2><p>An estimated 11.3 million people were <a href="https://theweek.com/health/dementia-risk-factors-solutions">diagnosed with dementia</a> in 2023. That figure is expected to jump to 24.7 million diagnoses in 2050, according to research published in the journal <a href="https://jamanetwork.com/journals/jamaneurology/article-abstract/2854983" target="_blank">JAMA Neurology</a>. The estimate, a 118.5% increase, is based on “data from 38,418 people across 22 population-based studies spanning 18 countries and territories on six continents,” said the researchers at Australia’s <a href="https://www.unsw.edu.au/newsroom/news/2026/10/new-dementia-cases-to-hit-24-7-million-annually-by-2050--study" target="_blank">University of New South Wales (UNSW)</a>. Overall, the rate of dementia diagnosis is 9.7 new cases per 1,000 people.</p><p>Dementia incidence is “higher among women than men and substantially higher in low- and middle-income countries than in high-income countries,” said UNSW. This marks a change from prior research, as a large part of what’s known about dementia has “historically come from high-income countries, despite some of the greatest future increases being expected in lower-resource settings.”</p><h2 id="what-can-be-done">What can be done? </h2><p>The results of the study “highlight the growing need for dementia prevention, diagnosis and care as populations age,” said <a href="https://www.usatoday.com/story/news/health/2026/10/14/millions-more-dementia-cases-expected-by-2050-study-finds/92253617007/" target="_blank">USA Today</a>, especially as dementia “already affects more than 57 million people worldwide.” Dementia is “not a future problem.” It’s an “accelerating epidemic crisis that demands immediate attention,” said Dr. Liron Sinvani, the director of research and innovation at the Northwell Institute for Healthy Aging, to <a href="https://www.healthday.com/health-news/mental-health/dementia-expected-to-double-worldwide-by-2050" target="_blank">HealthDay</a>.</p><p>There’s some <a href="https://theweek.com/news/science-health/960737/donanemab-and-seven-other-breakthroughs-for-alzheimers-and-dementia-in">good news on the research front</a>. For the “first time, we can compare dementia incidence across a geographically diverse group of populations using the same statistical approach, giving us a clearer picture of where and among whom new cases are occurring,” said lead study author Dr. Ashleigh Vella. <a href="https://theweek.com/health/alzheimers-disease-no-longer-considered-untreatable">Understanding risk factors</a> among different groups will be “critical” in developing a prevention and care response to “populations facing the greatest future risk.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/dementia-cases-double-2050-aging-population</link>
                                                                            <description>
                            <![CDATA[ Researchers analyzed data from 22 studies across the world ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">u84A3BqbJRwgigJfuzmjeK</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/W6QtSWcUZbwSDiMCDisvRH-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 28 Oct 2026 15:40:31 +0000</pubDate>                                                                                                                                <updated>Wed, 28 Oct 2026 19:07:24 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/W6QtSWcUZbwSDiMCDisvRH-1920-80.jpg">
                                                            <media:credit><![CDATA[Véronique Tournier / Hans Lucas / AFP / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The rate of dementia diagnosis is 9.7 new cases per 1,000 people]]></media:description>                                                            <media:text><![CDATA[Residents at an Alzheimer’s facility in Nouvelle-Aquitaine, France.]]></media:text>
                                <media:title type="plain"><![CDATA[Residents at an Alzheimer’s facility in Nouvelle-Aquitaine, France.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/W6QtSWcUZbwSDiMCDisvRH-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The global incidence of dementia is increasing at a much faster rate than previously known, according to new research. Cases could double by the middle of the century, with millions of people potentially at risk as the world’s population ages. </p><h2 id="what-did-the-study-find">What did the study find?  </h2><p>An estimated 11.3 million people were <a href="https://theweek.com/health/dementia-risk-factors-solutions">diagnosed with dementia</a> in 2023. That figure is expected to jump to 24.7 million diagnoses in 2050, according to research published in the journal <a href="https://jamanetwork.com/journals/jamaneurology/article-abstract/2854983" target="_blank">JAMA Neurology</a>. The estimate, a 118.5% increase, is based on “data from 38,418 people across 22 population-based studies spanning 18 countries and territories on six continents,” said the researchers at Australia’s <a href="https://www.unsw.edu.au/newsroom/news/2026/10/new-dementia-cases-to-hit-24-7-million-annually-by-2050--study" target="_blank">University of New South Wales (UNSW)</a>. Overall, the rate of dementia diagnosis is 9.7 new cases per 1,000 people.</p><p>Dementia incidence is “higher among women than men and substantially higher in low- and middle-income countries than in high-income countries,” said UNSW. This marks a change from prior research, as a large part of what’s known about dementia has “historically come from high-income countries, despite some of the greatest future increases being expected in lower-resource settings.”</p><h2 id="what-can-be-done">What can be done? </h2><p>The results of the study “highlight the growing need for dementia prevention, diagnosis and care as populations age,” said <a href="https://www.usatoday.com/story/news/health/2026/10/14/millions-more-dementia-cases-expected-by-2050-study-finds/92253617007/" target="_blank">USA Today</a>, especially as dementia “already affects more than 57 million people worldwide.” Dementia is “not a future problem.” It’s an “accelerating epidemic crisis that demands immediate attention,” said Dr. Liron Sinvani, the director of research and innovation at the Northwell Institute for Healthy Aging, to <a href="https://www.healthday.com/health-news/mental-health/dementia-expected-to-double-worldwide-by-2050" target="_blank">HealthDay</a>.</p><p>There’s some <a href="https://theweek.com/news/science-health/960737/donanemab-and-seven-other-breakthroughs-for-alzheimers-and-dementia-in">good news on the research front</a>. For the “first time, we can compare dementia incidence across a geographically diverse group of populations using the same statistical approach, giving us a clearer picture of where and among whom new cases are occurring,” said lead study author Dr. Ashleigh Vella. <a href="https://theweek.com/health/alzheimers-disease-no-longer-considered-untreatable">Understanding risk factors</a> among different groups will be “critical” in developing a prevention and care response to “populations facing the greatest future risk.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ What is ‘circadian depression’? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The link between depression and disrupted daily rhythms has long been recognised. But research has now suggested there is a whole new subtype of depression – “circadian depression” – caused by “people’s body clocks being out of whack”, said <a href="https://www.newscientist.com/article/2594761-1-in-4-cases-of-depression-may-be-caused-by-off-kilter-body-clocks/" target="_blank">New Scientist</a>. </p><p>It affects an estimated one in four people with severe depression, according to a large-scale population and genetics study published in the <a href="https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/clinical-and-genetic-correlates-of-a-circadian-subtype-of-depression-in-the-australian-genetics-of-depression-study/A3429C15041E6BA0570968117909DDB6" target="_blank">British Journal of Psychiatry</a>. But treatment with standard antidepressants like SSRIs seems to be less effective, and causes more side effects.</p><h2 id="what-is-circadian-depression">What is ‘circadian depression’?</h2><p>It is “characterised by disrupted sleep, low energy and reduced physical activity during the day”, said <a href="https://www.nature.com/articles/d41586-026-03359-7" target="_blank">Nature</a>. It appears to be linked to dysregulation in the body’s internal clock and seems to affect women more than men. Depressive symptoms tend to start at an earlier age than with other forms of depression, and, although seasonality can aggravate them, it doesn’t necessarily trigger them, like <a href="https://www.theweek.com/politics/permanent-daylight-saving-time-complications">seasonal affective disorder</a> does.</p><p>The study researchers asked 11,380 people with severe depression to fill out surveys about changes in their symptoms and sleep patterns. Nearly a quarter (23%) met at least three of the researchers’ six proposed criteria for circadian depression. This was “not a formal diagnosis”, said <a href="https://www.nytimes.com/2026/10/23/well/mind/circadian-depression-subtype.html" target="_blank">The New York Times</a>, but evidence of a “suggested subtype”. The criteria are: waking up feeling “very tired” regardless of sleep duration; identifying as a “night owl”; going to sleep later than most people; sleeping longer when most depressed; sleeping in on non-working days, and experiencing strong seasonal changes in sleep, mood, appetite or energy.</p><p>Moreover, analysis of participants’ saliva indicated that those who fell into the proposed subtype had genetic variants linked to a higher risk of developing ADHD, bipolar disorder, anxiety, a high body-mass index and insulin resistance. This indicates that circadian depression is “not just depression with bad sleep, but actually there is an underlying biology that is quite distinct from other forms of depression”, the study’s lead author, Emiliana Tonini of the University of Sydney’s Brain and Mind Centre, told the press.</p><h2 id="how-might-it-be-treated">How might it be treated?</h2><p>What’s “critical” about this circadian type of depression is “its poor response to the standard therapies”, study co-author Ian Hickie, a psychiatrist at the Brain and Mind Centre told <a href="https://www.theguardian.com/society/2026/oct/21/australian-researchers-identify-new-subtype-of-depression-linked-to-body-clock-disruptions" target="_blank">The Guardian</a>. Those affected could benefit instead from treatments, such as melatonin or light therapy, that specifically target the body’s circadian rhythms . </p><p>The coordination of your body clock “underpins your mood, your metabolism, your concentration, your sleep-wake cycle and many other key factors”, said Hickie. You can help reset your body clock by exposing yourself to daylight in the morning and maintaining the rhythm and regularity of your sleep-wake cycle, while avoiding artificial light, large meals and exercise once it gets dark. </p><p>“Light is the most powerful signal for keeping our circadian rhythms in sync with the outside world,”  Sophie Bostock, founder of The Sleep Scientist, told <a href="https://www.independent.co.uk/health-and-fitness/circadian-rhythm-healthy-sleep-routine-b3071324.html?reloaded=1" target="_blank">The Independent</a>. “It helps us feel alert during the day and supports the timing of sleep at night.” In the autumn, after the clocks go back and mornings are dark, try to find an opportunity to get outside during working hours. “Even on a cloudy winter day, outdoor light is usually much brighter than indoor lighting.”</p><h2 id="what-are-the-caveats-to-the-study">What are the caveats to the study?</h2><p>Circadian depression is “a plausible” condition, said US chronotherapeutics expert Michael Terman. But the study findings don’t establish a new diagnosis, or prove that circadian depression will respond to different types of treatment, he told The New York Times.  </p><p>A “significant limitation” of the study, acknowledged by its authors, was that the participants “self-reported their sleep-wake cycles”. It’s not clear whether “they did so accurately”. They were also mostly of European ancestry, which “may limit generalisability”. Further, more diverse studies are “needed to replicate our findings”, the researchers said.</p><p>The study also didn’t consider the impact of menopause, which is “predominantly one of the things that women describe as causing sleep disturbance”, Australian psychiatry professor Jayashri Kulkarn told The Guardian. But managing to tie “certain types of depression to a specific genetic profile” will be “important for onward treatment”.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/what-is-circadian-depression</link>
                                                                            <description>
                            <![CDATA[ Scientists suggest one in four people with depression could fall into new subtype linked to a disrupted body clock ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">BXNhAsVFJ2oQkTXhvgDx6U</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/rDhAoWmjZvNZN8arTosC7K-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 28 Oct 2026 13:58:50 +0000</pubDate>                                                                                                                                <updated>Thu, 29 Oct 2026 07:33:00 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Harriet Marsden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Harriet Marsden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Harriet Marsden is a senior staff writer and podcast panellist for The Week, mostly covering world news and writing the weekly &lt;a href=&quot;https://theweek.com/globaldigest&quot;&gt;Global Digest&lt;/a&gt; newsletter. Before joining the site in 2023, she was a freelance journalist for seven years, working for The Guardian, The Times and The Independent among others, and regularly appearing on BBC Radio London and Times Radio. She has a particular interest in gender equality and attended the 67th Commission on the Status of Women as a UN Women UK delegate.&lt;/p&gt;&lt;p&gt;In 2021, Harriet was awarded the “journalist-at-large” fellowship by the Local Trust charity, and spent a year travelling independently to some of England’s most deprived areas to write about local culture and community activism. She has a master’s in international journalism from City University, and an undergraduate degree in languages from the University of Cambridge, specialising in Latin American studies. She has also worked as a journalist in Bolivia, Colombia and Spain.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/rDhAoWmjZvNZN8arTosC7K-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Stephen P. Kelly / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Circadian depression seems to affect women more than men]]></media:description>                                                            <media:text><![CDATA[Photo collage illustration of a woman sleeping, a clock face, the Sun and diagram of Earth&#039;s orbit around the Sun]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage illustration of a woman sleeping, a clock face, the Sun and diagram of Earth&#039;s orbit around the Sun]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/rDhAoWmjZvNZN8arTosC7K-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The link between depression and disrupted daily rhythms has long been recognised. But research has now suggested there is a whole new subtype of depression – “circadian depression” – caused by “people’s body clocks being out of whack”, said <a href="https://www.newscientist.com/article/2594761-1-in-4-cases-of-depression-may-be-caused-by-off-kilter-body-clocks/" target="_blank">New Scientist</a>. </p><p>It affects an estimated one in four people with severe depression, according to a large-scale population and genetics study published in the <a href="https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/clinical-and-genetic-correlates-of-a-circadian-subtype-of-depression-in-the-australian-genetics-of-depression-study/A3429C15041E6BA0570968117909DDB6" target="_blank">British Journal of Psychiatry</a>. But treatment with standard antidepressants like SSRIs seems to be less effective, and causes more side effects.</p><h2 id="what-is-circadian-depression">What is ‘circadian depression’?</h2><p>It is “characterised by disrupted sleep, low energy and reduced physical activity during the day”, said <a href="https://www.nature.com/articles/d41586-026-03359-7" target="_blank">Nature</a>. It appears to be linked to dysregulation in the body’s internal clock and seems to affect women more than men. Depressive symptoms tend to start at an earlier age than with other forms of depression, and, although seasonality can aggravate them, it doesn’t necessarily trigger them, like <a href="https://www.theweek.com/politics/permanent-daylight-saving-time-complications">seasonal affective disorder</a> does.</p><p>The study researchers asked 11,380 people with severe depression to fill out surveys about changes in their symptoms and sleep patterns. Nearly a quarter (23%) met at least three of the researchers’ six proposed criteria for circadian depression. This was “not a formal diagnosis”, said <a href="https://www.nytimes.com/2026/10/23/well/mind/circadian-depression-subtype.html" target="_blank">The New York Times</a>, but evidence of a “suggested subtype”. The criteria are: waking up feeling “very tired” regardless of sleep duration; identifying as a “night owl”; going to sleep later than most people; sleeping longer when most depressed; sleeping in on non-working days, and experiencing strong seasonal changes in sleep, mood, appetite or energy.</p><p>Moreover, analysis of participants’ saliva indicated that those who fell into the proposed subtype had genetic variants linked to a higher risk of developing ADHD, bipolar disorder, anxiety, a high body-mass index and insulin resistance. This indicates that circadian depression is “not just depression with bad sleep, but actually there is an underlying biology that is quite distinct from other forms of depression”, the study’s lead author, Emiliana Tonini of the University of Sydney’s Brain and Mind Centre, told the press.</p><h2 id="how-might-it-be-treated">How might it be treated?</h2><p>What’s “critical” about this circadian type of depression is “its poor response to the standard therapies”, study co-author Ian Hickie, a psychiatrist at the Brain and Mind Centre told <a href="https://www.theguardian.com/society/2026/oct/21/australian-researchers-identify-new-subtype-of-depression-linked-to-body-clock-disruptions" target="_blank">The Guardian</a>. Those affected could benefit instead from treatments, such as melatonin or light therapy, that specifically target the body’s circadian rhythms . </p><p>The coordination of your body clock “underpins your mood, your metabolism, your concentration, your sleep-wake cycle and many other key factors”, said Hickie. You can help reset your body clock by exposing yourself to daylight in the morning and maintaining the rhythm and regularity of your sleep-wake cycle, while avoiding artificial light, large meals and exercise once it gets dark. </p><p>“Light is the most powerful signal for keeping our circadian rhythms in sync with the outside world,”  Sophie Bostock, founder of The Sleep Scientist, told <a href="https://www.independent.co.uk/health-and-fitness/circadian-rhythm-healthy-sleep-routine-b3071324.html?reloaded=1" target="_blank">The Independent</a>. “It helps us feel alert during the day and supports the timing of sleep at night.” In the autumn, after the clocks go back and mornings are dark, try to find an opportunity to get outside during working hours. “Even on a cloudy winter day, outdoor light is usually much brighter than indoor lighting.”</p><h2 id="what-are-the-caveats-to-the-study">What are the caveats to the study?</h2><p>Circadian depression is “a plausible” condition, said US chronotherapeutics expert Michael Terman. But the study findings don’t establish a new diagnosis, or prove that circadian depression will respond to different types of treatment, he told The New York Times.  </p><p>A “significant limitation” of the study, acknowledged by its authors, was that the participants “self-reported their sleep-wake cycles”. It’s not clear whether “they did so accurately”. They were also mostly of European ancestry, which “may limit generalisability”. Further, more diverse studies are “needed to replicate our findings”, the researchers said.</p><p>The study also didn’t consider the impact of menopause, which is “predominantly one of the things that women describe as causing sleep disturbance”, Australian psychiatry professor Jayashri Kulkarn told The Guardian. But managing to tie “certain types of depression to a specific genetic profile” will be “important for onward treatment”.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A sexually transmitted stomach bug is spreading ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Antibiotic-resistant shigellosis infections have been spreading in the U.S. Many are sexually transmitted and can affect the most vulnerable communities. </p><h2 id="what-are-the-symptoms-and-transmission-methods">What are the symptoms and transmission methods?</h2><p>Shigellosis is a <a href="https://theweek.com/health/cyclosporiasis-parasite-stomach-infection-united-states">gastrointestinal illness</a> caused by a group of bacteria called Shigella. Associated symptoms include acute diarrhea, vomiting, stomach pain and fever up to seven days.  In most instances, those with shigellosis are able to recover on their own, but patients with more severe cases may require antibiotics and hospitalization.</p><p>The primary way shigellosis spreads is through the fecal-oral route, usually from contaminated food and water. However, another transmission method has become increasingly prevalent: There is a “distinct and intensifying sexual transmission of shigellosis,” said a study published in <a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00227-6/fulltext" target="_blank"><u>The Lancet</u></a>. Traditional preventative measures for the disease, like handwashing and food safety, are “not likely” to help with this type of spread. </p><p>The <a href="https://theweek.com/health/sepsis-treatment-drug-breakthrough-diagnosis">infection</a> is most commonly passed between men who sleep with other men. “Many men who have sex with men are unaware of the serious and increasing risk posed by sexually transmitted Shigella,” senior study author Kate Baker said in a <a href="https://www.cam.ac.uk/research/news/sexually-transmitted-diarrhoea-spreading-rapidly-among-some-networks-of-gay-men-in-the-uk-study" target="_blank"><u>statement</u></a>.</p><h2 id="how-common-is-it">How common is it?</h2><p>While there is public concern about the spread of the illness, there has not yet been a major outbreak. According to the <a href="https://stacks.cdc.gov/view/cdc/262322" target="_blank"><u>most recent CDC data</u></a>, almost 15,000 people have been diagnosed with shigellosis in the U.S. in 2026, and it has been found in 47 states. These numbers are similar to last year’s count. But there has also been a rise in the number of <a href="https://theweek.com/health/nightmare-bacteria-what-are-they"><u>antibiotic-resistant</u></a> cases.</p><p>Among nearly 17,000 Shigella species isolates with resistance data, extensively drug-resistant (XDR) isolates increased between 2011 and 2023, according to an <a href="https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a1.htm" target="_blank"><u>analysis by the CDC</u></a>. Most U.S. outbreaks “involved drug-susceptible strains and primarily affected children,” but “national surveillance data indicate that most XDR cases occurred among adult men.” </p><p>XDR shigellosis is risky for children and disadvantaged populations like the unhoused. The infection has “gone from being relatively treatable with off-the-shelf drugs” to being “close to untreatable over the course of the last decade or so,” said Baker.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/a-sexually-transmitted-stomach-bug-is-spreading-in-the-us</link>
                                                                            <description>
                            <![CDATA[ Shigellosis is also becoming harder to treat ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">5mCyxDauNYjNe8dFKhDNgY</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/JAzzKfShWND2YiSLGpZrsS-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 23 Oct 2026 17:00:15 +0000</pubDate>                                                                                                                                <updated>Fri, 23 Oct 2026 18:39:51 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/JAzzKfShWND2YiSLGpZrsS-1920-80.jpg">
                                                            <media:credit><![CDATA[quantic69 / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[There are many variants of shigella bacteria that can cause shigellosis]]></media:description>                                                            <media:text><![CDATA[Shigella bacteria]]></media:text>
                                <media:title type="plain"><![CDATA[Shigella bacteria]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/JAzzKfShWND2YiSLGpZrsS-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Antibiotic-resistant shigellosis infections have been spreading in the U.S. Many are sexually transmitted and can affect the most vulnerable communities. </p><h2 id="what-are-the-symptoms-and-transmission-methods">What are the symptoms and transmission methods?</h2><p>Shigellosis is a <a href="https://theweek.com/health/cyclosporiasis-parasite-stomach-infection-united-states">gastrointestinal illness</a> caused by a group of bacteria called Shigella. Associated symptoms include acute diarrhea, vomiting, stomach pain and fever up to seven days.  In most instances, those with shigellosis are able to recover on their own, but patients with more severe cases may require antibiotics and hospitalization.</p><p>The primary way shigellosis spreads is through the fecal-oral route, usually from contaminated food and water. However, another transmission method has become increasingly prevalent: There is a “distinct and intensifying sexual transmission of shigellosis,” said a study published in <a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00227-6/fulltext" target="_blank"><u>The Lancet</u></a>. Traditional preventative measures for the disease, like handwashing and food safety, are “not likely” to help with this type of spread. </p><p>The <a href="https://theweek.com/health/sepsis-treatment-drug-breakthrough-diagnosis">infection</a> is most commonly passed between men who sleep with other men. “Many men who have sex with men are unaware of the serious and increasing risk posed by sexually transmitted Shigella,” senior study author Kate Baker said in a <a href="https://www.cam.ac.uk/research/news/sexually-transmitted-diarrhoea-spreading-rapidly-among-some-networks-of-gay-men-in-the-uk-study" target="_blank"><u>statement</u></a>.</p><h2 id="how-common-is-it">How common is it?</h2><p>While there is public concern about the spread of the illness, there has not yet been a major outbreak. According to the <a href="https://stacks.cdc.gov/view/cdc/262322" target="_blank"><u>most recent CDC data</u></a>, almost 15,000 people have been diagnosed with shigellosis in the U.S. in 2026, and it has been found in 47 states. These numbers are similar to last year’s count. But there has also been a rise in the number of <a href="https://theweek.com/health/nightmare-bacteria-what-are-they"><u>antibiotic-resistant</u></a> cases.</p><p>Among nearly 17,000 Shigella species isolates with resistance data, extensively drug-resistant (XDR) isolates increased between 2011 and 2023, according to an <a href="https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a1.htm" target="_blank"><u>analysis by the CDC</u></a>. Most U.S. outbreaks “involved drug-susceptible strains and primarily affected children,” but “national surveillance data indicate that most XDR cases occurred among adult men.” </p><p>XDR shigellosis is risky for children and disadvantaged populations like the unhoused. The infection has “gone from being relatively treatable with off-the-shelf drugs” to being “close to untreatable over the course of the last decade or so,” said Baker.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ What we learned from Covid Inquiry report on social care ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Social care was an “afterthought” during the Covid-19 pandemic, and government failures allowed the virus to “spread like wildfire” through care homes. </p><p>Those are some of the damning findings in the latest report by the <a href="https://covid19.public-inquiry.uk/wp-content/uploads/2026/10/19064857/M6_Report_Accessible.pdf" target="_blank">UK Covid-19 Inquiry</a>, chaired by Baroness Hallett. It focused on the “devastating” impact of the virus on <a href="https://theweek.com/health/burnhams-plan-to-fix-social-care">adult social care in the UK</a>. More than 43,000 people in care homes were recorded to have died with Covid between March 2020 and July 2022. Last year, a senior civil servant told the inquiry it amounted to “generational slaughter”.</p><h2 id="social-care-was-an-afterthought">Social care was an ‘afterthought’</h2><p>All four UK governments initially focused on protecting hospitals. Adult social care “appeared to be something of an afterthought”, said the report. The “mantra of ‘protecting the NHS’ sometimes came at the expense of the users and providers of care”.</p><p>These failures “created environments in care settings in which the virus could spread like wildfire”.</p><h2 id="hancock-s-protective-ring-was-false">Hancock’s ‘protective ring’ was false</h2><p>Matt Hancock, then the health secretary, claimed ministers had “tried to throw a protective ring” around care homes “right from the start” of the pandemic. That claim was “unfounded”, said the <a href="https://covid19.public-inquiry.uk/news/care-sector-something-of-an-afterthought-with-no-so-called-protective-ring-inquiry-finds/" target="_blank">inquiry</a>. “Quite the opposite was true.”</p><p>“Unfounded is an understatement,” said <a href="https://news.sky.com/story/covid-inquiry-latest-investigation-to-reveal-failings-at-care-homes-during-the-pandemic-13599244" target="_blank">Sky News</a>. At the start of the pandemic, about 25,000 patients were discharged from hospitals into care homes – most without being tested for Covid – to “free up beds”. They and care home staff then received insufficient protection and guidance, “with devastating consequences”, said the inquiry.</p><p>The policy was later ruled unlawful by the High Court. Jean Adamson, speaking on behalf of bereaved families, called Hancock’s claim a “cruel lie”, said Sky News. Hancock isn’t commenting on the report.</p><h2 id="visiting-restrictions-did-immense-harm">Visiting restrictions did ‘immense’ harm</h2><p>Elderly residents’ suffering was “compounded by draconian visiting restrictions”, said <a href="https://www.thetimes.com/uk/healthcare/article/covid-inquiry-pandemic-care-homes-tm230m90h" target="_blank"><u>The Times</u></a>. These caused “incalculable harm”, leaving people to die “abandoned and alone”, without “the comfort or support of their loved ones”, the report said. </p><p>Strict visiting limits were necessary at the start of the pandemic to protect people, but the “balance of harms” shifted; they increasingly did more harm than good, Hallett said. </p><p>The “profound isolation and sense of abandonment” caused by keeping them in place resulted in “immense emotional harm” to residents. Many whose loved ones died without them now remain “wracked with guilt that they do not deserve to carry”.</p><h2 id="desperate-measures-for-protective-equipment">‘Desperate measures’ for protective equipment</h2><p>Unsurprisingly, difficulties getting hold of personal protective equipment (PPE) were “a key theme of this report”, said the <a href="https://www.bbc.co.uk/news/live/cmy4xk1d8l53t" target="_blank">BBC</a>. </p><p>Hospitals were “prioritised for supplies”, leaving care workers resorting to “some very desperate measures”. There were cases of workers “using festival waterproof ponchos, painters’ overalls and bin bags as makeshift PPE”. </p><p>Supply problems were a global issue, the report acknowledged, but better planning would have helped. The lack of PPE for care home staff was “wholly unacceptable”.</p><h2 id="social-care-was-already-a-concern">Social care was already ‘a concern’</h2><p>A 2016 simulation exercise testing the UK’s response to a pandemic found the social care sector was a “particular concern”. </p><p>But when Covid-19 emerged, recommendations had “not been completed”, said the inquiry, leaving ministers to make decisions “without the information they needed”. </p><p>Millions of unpaid, “undervalued” carers were “heavily relied upon” without adequate support. The scale of death and suffering they witnessed was “unlike anything they had seen before”, said the report.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/what-we-learned-from-covid-inquiry-report-on-social-care</link>
                                                                            <description>
                            <![CDATA[ Social care was an ‘afterthought’ at start of pandemic, visiting restrictions did ‘immense’ harm, and Matt Hancock’s claim of ‘protective ring’ was unfounded ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">JMm5A5Q4wipbmysLz4gWKo</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/yFdFHKFWnWRX7kQbzXftF9-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 21 Oct 2026 13:03:09 +0000</pubDate>                                                                                                                                <updated>Wed, 21 Oct 2026 14:43:10 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Harriet Marsden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Harriet Marsden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Harriet Marsden is a senior staff writer and podcast panellist for The Week, mostly covering world news and writing the weekly &lt;a href=&quot;https://theweek.com/globaldigest&quot;&gt;Global Digest&lt;/a&gt; newsletter. Before joining the site in 2023, she was a freelance journalist for seven years, working for The Guardian, The Times and The Independent among others, and regularly appearing on BBC Radio London and Times Radio. She has a particular interest in gender equality and attended the 67th Commission on the Status of Women as a UN Women UK delegate.&lt;/p&gt;&lt;p&gt;In 2021, Harriet was awarded the “journalist-at-large” fellowship by the Local Trust charity, and spent a year travelling independently to some of England’s most deprived areas to write about local culture and community activism. She has a master’s in international journalism from City University, and an undergraduate degree in languages from the University of Cambridge, specialising in Latin American studies. She has also worked as a journalist in Bolivia, Colombia and Spain.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/yFdFHKFWnWRX7kQbzXftF9-1920-80.jpg">
                                                            <media:credit><![CDATA[Hugh Hastings / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[More than 43,000 people in care homes were recorded to have died with Covid between March 2020 and July 2022]]></media:description>                                                            <media:text><![CDATA[An old woman has her hand held in a care home during Covid]]></media:text>
                                <media:title type="plain"><![CDATA[An old woman has her hand held in a care home during Covid]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/yFdFHKFWnWRX7kQbzXftF9-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Social care was an “afterthought” during the Covid-19 pandemic, and government failures allowed the virus to “spread like wildfire” through care homes. </p><p>Those are some of the damning findings in the latest report by the <a href="https://covid19.public-inquiry.uk/wp-content/uploads/2026/10/19064857/M6_Report_Accessible.pdf" target="_blank">UK Covid-19 Inquiry</a>, chaired by Baroness Hallett. It focused on the “devastating” impact of the virus on <a href="https://theweek.com/health/burnhams-plan-to-fix-social-care">adult social care in the UK</a>. More than 43,000 people in care homes were recorded to have died with Covid between March 2020 and July 2022. Last year, a senior civil servant told the inquiry it amounted to “generational slaughter”.</p><h2 id="social-care-was-an-afterthought">Social care was an ‘afterthought’</h2><p>All four UK governments initially focused on protecting hospitals. Adult social care “appeared to be something of an afterthought”, said the report. The “mantra of ‘protecting the NHS’ sometimes came at the expense of the users and providers of care”.</p><p>These failures “created environments in care settings in which the virus could spread like wildfire”.</p><h2 id="hancock-s-protective-ring-was-false">Hancock’s ‘protective ring’ was false</h2><p>Matt Hancock, then the health secretary, claimed ministers had “tried to throw a protective ring” around care homes “right from the start” of the pandemic. That claim was “unfounded”, said the <a href="https://covid19.public-inquiry.uk/news/care-sector-something-of-an-afterthought-with-no-so-called-protective-ring-inquiry-finds/" target="_blank">inquiry</a>. “Quite the opposite was true.”</p><p>“Unfounded is an understatement,” said <a href="https://news.sky.com/story/covid-inquiry-latest-investigation-to-reveal-failings-at-care-homes-during-the-pandemic-13599244" target="_blank">Sky News</a>. At the start of the pandemic, about 25,000 patients were discharged from hospitals into care homes – most without being tested for Covid – to “free up beds”. They and care home staff then received insufficient protection and guidance, “with devastating consequences”, said the inquiry.</p><p>The policy was later ruled unlawful by the High Court. Jean Adamson, speaking on behalf of bereaved families, called Hancock’s claim a “cruel lie”, said Sky News. Hancock isn’t commenting on the report.</p><h2 id="visiting-restrictions-did-immense-harm">Visiting restrictions did ‘immense’ harm</h2><p>Elderly residents’ suffering was “compounded by draconian visiting restrictions”, said <a href="https://www.thetimes.com/uk/healthcare/article/covid-inquiry-pandemic-care-homes-tm230m90h" target="_blank"><u>The Times</u></a>. These caused “incalculable harm”, leaving people to die “abandoned and alone”, without “the comfort or support of their loved ones”, the report said. </p><p>Strict visiting limits were necessary at the start of the pandemic to protect people, but the “balance of harms” shifted; they increasingly did more harm than good, Hallett said. </p><p>The “profound isolation and sense of abandonment” caused by keeping them in place resulted in “immense emotional harm” to residents. Many whose loved ones died without them now remain “wracked with guilt that they do not deserve to carry”.</p><h2 id="desperate-measures-for-protective-equipment">‘Desperate measures’ for protective equipment</h2><p>Unsurprisingly, difficulties getting hold of personal protective equipment (PPE) were “a key theme of this report”, said the <a href="https://www.bbc.co.uk/news/live/cmy4xk1d8l53t" target="_blank">BBC</a>. </p><p>Hospitals were “prioritised for supplies”, leaving care workers resorting to “some very desperate measures”. There were cases of workers “using festival waterproof ponchos, painters’ overalls and bin bags as makeshift PPE”. </p><p>Supply problems were a global issue, the report acknowledged, but better planning would have helped. The lack of PPE for care home staff was “wholly unacceptable”.</p><h2 id="social-care-was-already-a-concern">Social care was already ‘a concern’</h2><p>A 2016 simulation exercise testing the UK’s response to a pandemic found the social care sector was a “particular concern”. </p><p>But when Covid-19 emerged, recommendations had “not been completed”, said the inquiry, leaving ministers to make decisions “without the information they needed”. </p><p>Millions of unpaid, “undervalued” carers were “heavily relied upon” without adequate support. The scale of death and suffering they witnessed was “unlike anything they had seen before”, said the report.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ The UN warns about ‘mind-reading’ technology ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A new United Nations report is sounding the alarm on another potential risk of our constantly evolving world: technology that could allow governments to “read minds” via brainwave interfaces. While your inner thoughts are mostly safe for now, the U.N. is worried this may not always be the case.</p><h2 id="introduces-significant-risks">‘Introduces significant risks’</h2><p>The U.N. believes this type of ‘<a href="https://theweek.com/news/science-health/961200/could-new-technology-reveal-what-youre-thinking-about">neurotechnology</a>’ is advancing so quickly that “governments’ ability to access and manipulate people’s brains could one day pose a threat to fundamental human rights,” said <a href="https://www.nytimes.com/2026/10/08/world/europe/united-nations-technology-warning.html" target="_blank">The New York Times</a>, which first published the U.N.’s report. Neurotechnology “raises profound human rights challenges when applied to the administration of justice,” U.N. Secretary-General António Guterres said in the report, and its “expansion beyond clinical settings into investigative, judicial and correctional contexts introduces significant risks.”</p><p>This is not the first time the U.N. has issued warnings about the matter. The organization has been concerned about <a href="https://theweek.com/science/russia-pigeons-brain-control-drones">military applications of neurotechnology</a>, especially “brain-computer interfaces, which translate brain activity into commands that can control devices such as computers or robotic prosthetic limbs,” said <a href="https://www.politico.com/newsletters/future-pulse/2024/12/20/un-warns-of-military-brain-control-00195554" target="_blank">Politico</a>. The U.N. fears that if a “brain-computer interface is used inappropriately by the military, it could lead to human rights abuses.”</p><p>In 2022, UNESCO also published a report on the ethical issues of neurotechnology. Unlike “many other frontier technologies, neurotechnology can directly access, manipulate and emulate the structure of the brain, which is central to notions of human identity, freedom of thought, autonomy, privacy and well-being,” said <a href="https://unesdoc.unesco.org/ark:/48223/pf0000383559" target="_blank">UNESCO’s report</a>. Still, this marks the first time the U.N. as a whole is waving such a large red flag.</p><h2 id="a-number-of-recommendations">A ‘number of recommendations’</h2><p>The U.N. report proposed some solutions to <a href="https://theweek.com/health/growing-a-brain-in-the-lab">safeguard advancing neurotechnologies</a>. It lists a “number of recommendations, including establishing regulations consistent with international law, recognizing thoughts as ‘highly sensitive personal data’ and requiring explicit consent for the use of neurotechnology in criminal justice settings,” said the Times. </p><p>The report also gives “states an opportunity to establish clear rules to regulate the use of neurotechnology, based on human rights,” Jeremy Laurence, a spokesman for the U.N. Human Rights Office, said to the Times. This should be accomplished before the technologies “become routine in investigations, courts and prisons.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/tech/united-nations-neurotechnology-mind-reading</link>
                                                                            <description>
                            <![CDATA[ Neurotechnology creates ‘profound human rights challenges,’ the United Nation’s secretary-general said ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">9eHsj4HRXEkzMjXf9sPY3m</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/yNKHMueNNVJZSsLhMcDjHh-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 15 Oct 2026 17:34:08 +0000</pubDate>                                                                                                                                <updated>Mon, 19 Oct 2026 20:58:08 +0000</updated>
                                                                                                                                            <category><![CDATA[Tech]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/yNKHMueNNVJZSsLhMcDjHh-1920-80.jpg">
                                                            <media:credit><![CDATA[CFOTO / Future Publishing / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A brain interface device on display in Hangzhou, China]]></media:description>                                                            <media:text><![CDATA[A brain interface device on display in Hangzhou, China.]]></media:text>
                                <media:title type="plain"><![CDATA[A brain interface device on display in Hangzhou, China.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/yNKHMueNNVJZSsLhMcDjHh-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A new United Nations report is sounding the alarm on another potential risk of our constantly evolving world: technology that could allow governments to “read minds” via brainwave interfaces. While your inner thoughts are mostly safe for now, the U.N. is worried this may not always be the case.</p><h2 id="introduces-significant-risks">‘Introduces significant risks’</h2><p>The U.N. believes this type of ‘<a href="https://theweek.com/news/science-health/961200/could-new-technology-reveal-what-youre-thinking-about">neurotechnology</a>’ is advancing so quickly that “governments’ ability to access and manipulate people’s brains could one day pose a threat to fundamental human rights,” said <a href="https://www.nytimes.com/2026/10/08/world/europe/united-nations-technology-warning.html" target="_blank">The New York Times</a>, which first published the U.N.’s report. Neurotechnology “raises profound human rights challenges when applied to the administration of justice,” U.N. Secretary-General António Guterres said in the report, and its “expansion beyond clinical settings into investigative, judicial and correctional contexts introduces significant risks.”</p><p>This is not the first time the U.N. has issued warnings about the matter. The organization has been concerned about <a href="https://theweek.com/science/russia-pigeons-brain-control-drones">military applications of neurotechnology</a>, especially “brain-computer interfaces, which translate brain activity into commands that can control devices such as computers or robotic prosthetic limbs,” said <a href="https://www.politico.com/newsletters/future-pulse/2024/12/20/un-warns-of-military-brain-control-00195554" target="_blank">Politico</a>. The U.N. fears that if a “brain-computer interface is used inappropriately by the military, it could lead to human rights abuses.”</p><p>In 2022, UNESCO also published a report on the ethical issues of neurotechnology. Unlike “many other frontier technologies, neurotechnology can directly access, manipulate and emulate the structure of the brain, which is central to notions of human identity, freedom of thought, autonomy, privacy and well-being,” said <a href="https://unesdoc.unesco.org/ark:/48223/pf0000383559" target="_blank">UNESCO’s report</a>. Still, this marks the first time the U.N. as a whole is waving such a large red flag.</p><h2 id="a-number-of-recommendations">A ‘number of recommendations’</h2><p>The U.N. report proposed some solutions to <a href="https://theweek.com/health/growing-a-brain-in-the-lab">safeguard advancing neurotechnologies</a>. It lists a “number of recommendations, including establishing regulations consistent with international law, recognizing thoughts as ‘highly sensitive personal data’ and requiring explicit consent for the use of neurotechnology in criminal justice settings,” said the Times. </p><p>The report also gives “states an opportunity to establish clear rules to regulate the use of neurotechnology, based on human rights,” Jeremy Laurence, a spokesman for the U.N. Human Rights Office, said to the Times. This should be accomplished before the technologies “become routine in investigations, courts and prisons.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ How safe are UK zoos? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The City of Doncaster council has launched a health and safety investigation at Yorkshire Wildlife Park after a fatality in a big cat enclosure. William Chapman was killed by a Siberian <a href="https://theweek.com/science/new-cat-species-discovered-bolivia">tiger</a> after he “allegedly climbed over a barrier into the animal’s enclosure” on Saturday, said <a href="https://www.thetimes.com/life-style/wildlife-nature/article/yorkshire-wildlife-park-tiger-attack-3hwzvdrs7" target="_blank">The Times</a>. Before entering the enclosure, he had been “dancing and wearing headphones” and was heard asking other visitors to take a photo of him.</p><p>Some are calling for tighter security measures at wildlife parks after recent high-profile incidents, but others argue that it is the changing behaviour of human visitors that poses a more serious threat to their existence.</p><h2 id="deeply-tragic">‘Deeply tragic’</h2><p>This is the “second serious incident at a UK zoo in just a few months”, said <a href="https://www.theguardian.com/world/2026/oct/12/two-tragic-incidents-safety-english-zoos-rethink" target="_blank">The Guardian</a>. In June, a three-year-old boy was seriously injured in Cambridgeshire, after allegedly being thrown into a crocodile enclosure by a stranger. Police arrested a man in his 30s, but he was released after he was “assessed as not being fit for interview”. </p><p>Although this death is “deeply tragic”, there are “millions” of visits to wildlife parks every year, and these incidents are “vanishingly rare”, said Amy Dickman, professor of wildlife conservation at the University of Oxford. The “harsh reality”, however, is that it is “virtually impossible for zoos to stop people who are very determined to breach safety measures”.</p><p>“Zoos are actually one of the safest places you can visit,” Jo Judge, chief executive of the British and Irish Association of Zoos and Aquariums, told the <a href="https://www.bbc.co.uk/news/articles/c9146j15gnggo" target="_blank">BBC</a>. They undergo a “huge number” of risk assessments, as well as “full inspections every six years and periodic inspections every three”.</p><p>Modern zoos must find a balance between allowing visitors to be close to animals and keep them safe without being too “heavy-handed”, Dr Campbell Murn, a former member of the government’s zoo expert committee, told the broadcaster. There is already “enormous consideration” for visitor safety. “despite the best security systems and enclosures” sometimes “a determined thief will get into somebody’s house or somebody’s car”.</p><h2 id="props-for-social-media">‘Props’ for social media</h2><p>Safety at zoos is “not always only about keeping animals in, it’s about keeping humans out”, Will Travers of the Born Free Foundation, which campaigns for the abolition of zoos, told the <a href="https://www.express.co.uk/news/uk/2256423/zoo-expert-yorkshire-wildlife-park-tiger-attack-will-travers" target="_blank">Daily Express</a>. Turning animal habitats into public attractions encourages a “very unnatural relationship with dangerous wild animals”.</p><p>Zoo safety has not worsened, nor are animals “somehow more dangerous”: “human behaviour itself has instead become a problem”, said <a href="https://www.telegraph.co.uk/news/2026/10/11/what-do-visitor-tragedies-mean-for-modern-zoos/" target="_blank">The Telegraph</a>. In 2019, a woman “climbed over a concrete barrier” at a zoo in Arizona “in a bid to take a selfie with a jaguar” before bystanders intervened. And in May, two American tourists were arrested in Japan after allegedly scaling a fence to enter the enclosure of <a href="https://theweek.com/photos/the-weeks-best-photos-february-26-2026">Punch</a>, a “nine-month-old macaque who captured global attention” after becoming emotionally attached to a soft toy. In the face of this human-led change, “zoos may now have to reflect not just on how they are run, but what they are even for”.</p><p>It is “unarguable” that phones and social media have altered the relationship between animals and zoo visitors. Where people would once have been “happy to see a photograph” of a famous animal, now they are “desperate to put their own interactions with endangered species” online. Dangerous animals have become “props” for content, and all too often individuals “endanger their lives” for clicks.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/how-safe-are-uk-zoos</link>
                                                                            <description>
                            <![CDATA[ Recent incidents in Yorkshire and Cambridgeshire may force us to rethink our relationship with wildlife parks ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">oeyQrfVgptkVqfY894xBrJ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/H5SGUwQWU9zKqpvZ98FYkY-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 13 Oct 2026 13:31:56 +0000</pubDate>                                                                                                                                <updated>Tue, 13 Oct 2026 13:56:45 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Will Barker, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Will Barker joined The Week team as a staff writer in 2025, covering UK and global news and politics. He previously worked at the Financial Times and The Sun, contributing to the arts and world news desks, respectively. Before that, he achieved a gold-standard NCTJ Diploma at News Associates in Twickenham, with specialisms in media law and data journalism. While studying for his diploma, he also wrote for the South West Londoner, and channelled his passion for sport by reporting for The Cricket Paper.&lt;/p&gt;&lt;p&gt;As an undergraduate of Merton College, University of Oxford, Will read English and French, specialising in early-20th century multilingual poetry, and contributed to the Merton College magazine. His degree also included a year abroad, when he worked for Auditoire, on organisational and translation projects such as the Paris 2024 Olympics opening ceremony. After graduating, he moved to Dublin to study an M.Phil in literary translation at Trinity College Dublin. Alongside his research, he freelanced for a communications company analysing media coverage, which helped him realise that writing was his calling.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/H5SGUwQWU9zKqpvZ98FYkY-1920-80.jpg">
                                                            <media:credit><![CDATA[Oli Scarff / AFP / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A man was killed by a Siberian tiger after he ‘allegedly climbed over a barrier into the animal’s enclosure’ on Saturday]]></media:description>                                                            <media:text><![CDATA[A tiger and cub at Yorkshire Wildlife Park]]></media:text>
                                <media:title type="plain"><![CDATA[A tiger and cub at Yorkshire Wildlife Park]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/H5SGUwQWU9zKqpvZ98FYkY-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The City of Doncaster council has launched a health and safety investigation at Yorkshire Wildlife Park after a fatality in a big cat enclosure. William Chapman was killed by a Siberian <a href="https://theweek.com/science/new-cat-species-discovered-bolivia">tiger</a> after he “allegedly climbed over a barrier into the animal’s enclosure” on Saturday, said <a href="https://www.thetimes.com/life-style/wildlife-nature/article/yorkshire-wildlife-park-tiger-attack-3hwzvdrs7" target="_blank">The Times</a>. Before entering the enclosure, he had been “dancing and wearing headphones” and was heard asking other visitors to take a photo of him.</p><p>Some are calling for tighter security measures at wildlife parks after recent high-profile incidents, but others argue that it is the changing behaviour of human visitors that poses a more serious threat to their existence.</p><h2 id="deeply-tragic">‘Deeply tragic’</h2><p>This is the “second serious incident at a UK zoo in just a few months”, said <a href="https://www.theguardian.com/world/2026/oct/12/two-tragic-incidents-safety-english-zoos-rethink" target="_blank">The Guardian</a>. In June, a three-year-old boy was seriously injured in Cambridgeshire, after allegedly being thrown into a crocodile enclosure by a stranger. Police arrested a man in his 30s, but he was released after he was “assessed as not being fit for interview”. </p><p>Although this death is “deeply tragic”, there are “millions” of visits to wildlife parks every year, and these incidents are “vanishingly rare”, said Amy Dickman, professor of wildlife conservation at the University of Oxford. The “harsh reality”, however, is that it is “virtually impossible for zoos to stop people who are very determined to breach safety measures”.</p><p>“Zoos are actually one of the safest places you can visit,” Jo Judge, chief executive of the British and Irish Association of Zoos and Aquariums, told the <a href="https://www.bbc.co.uk/news/articles/c9146j15gnggo" target="_blank">BBC</a>. They undergo a “huge number” of risk assessments, as well as “full inspections every six years and periodic inspections every three”.</p><p>Modern zoos must find a balance between allowing visitors to be close to animals and keep them safe without being too “heavy-handed”, Dr Campbell Murn, a former member of the government’s zoo expert committee, told the broadcaster. There is already “enormous consideration” for visitor safety. “despite the best security systems and enclosures” sometimes “a determined thief will get into somebody’s house or somebody’s car”.</p><h2 id="props-for-social-media">‘Props’ for social media</h2><p>Safety at zoos is “not always only about keeping animals in, it’s about keeping humans out”, Will Travers of the Born Free Foundation, which campaigns for the abolition of zoos, told the <a href="https://www.express.co.uk/news/uk/2256423/zoo-expert-yorkshire-wildlife-park-tiger-attack-will-travers" target="_blank">Daily Express</a>. Turning animal habitats into public attractions encourages a “very unnatural relationship with dangerous wild animals”.</p><p>Zoo safety has not worsened, nor are animals “somehow more dangerous”: “human behaviour itself has instead become a problem”, said <a href="https://www.telegraph.co.uk/news/2026/10/11/what-do-visitor-tragedies-mean-for-modern-zoos/" target="_blank">The Telegraph</a>. In 2019, a woman “climbed over a concrete barrier” at a zoo in Arizona “in a bid to take a selfie with a jaguar” before bystanders intervened. And in May, two American tourists were arrested in Japan after allegedly scaling a fence to enter the enclosure of <a href="https://theweek.com/photos/the-weeks-best-photos-february-26-2026">Punch</a>, a “nine-month-old macaque who captured global attention” after becoming emotionally attached to a soft toy. In the face of this human-led change, “zoos may now have to reflect not just on how they are run, but what they are even for”.</p><p>It is “unarguable” that phones and social media have altered the relationship between animals and zoo visitors. Where people would once have been “happy to see a photograph” of a famous animal, now they are “desperate to put their own interactions with endangered species” online. Dangerous animals have become “props” for content, and all too often individuals “endanger their lives” for clicks.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ How other nations pay for care ]]></title>
                                                                                                <dc:content><![CDATA[ <p>At present, <a href="https://www.theweek.com/health/burnhams-plan-to-fix-social-care" target="_blank">England’s adult care system</a> is “one of the most threadbare in the developed world”, according to Thea Stein of the Nuffield Trust, which has analysed the arrangements of 11 comparable nations and regions. England is an “outlier” in that eligibility for any public funding at all is strictly means-tested.</p><p>The most generous system is in <strong>Denmark</strong>, where the state pays 100% of care costs, with no means test. Those in residential care do get billed for bed and board, but means-tested housing benefit is available.</p><p><strong>Australia </strong>has a similar system, also funded by general taxation. In most cases, bed and board have to be paid for, but there are a series of daily spending caps on different elements, such as food and hotel costs.</p><p><strong>Japan</strong>, with the oldest population in the world, introduced a tax on all over-40s in 2000, ring-fenced for care. Everyone who needs it is given a monthly care allowance. They contribute 10%-30% of costs, depending on income; total contributions are capped.</p><p>A similar insurance system operates in <strong>Germany</strong>, but with no cap. Individuals usually pay half of costs. Unusually, adult children can (in rare cases) be liable to pay for parents’ care if the parents run out of money.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/how-other-nations-pay-for-care</link>
                                                                            <description>
                            <![CDATA[ Germany and Australia among the nations who could offer inspiration for bolstering England’s ‘threadbare’ care system ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">d4Jmz7cXXH342my4vq3b5A</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/ttwZCx3aG6FPcbq3FGLTC9-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sun, 11 Oct 2026 06:15:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (The Week UK) ]]></author>                    <dc:creator><![CDATA[ The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/ttwZCx3aG6FPcbq3FGLTC9-1920-80.jpg">
                                                            <media:credit><![CDATA[Yusuke Harada / NurPhoto / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Since 2000, over-40s in Japan pay an additional tax towards old-age care]]></media:description>                                                            <media:text><![CDATA[An old woman in a wheelchair stares at cherry blossom in Japan]]></media:text>
                                <media:title type="plain"><![CDATA[An old woman in a wheelchair stares at cherry blossom in Japan]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/ttwZCx3aG6FPcbq3FGLTC9-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>At present, <a href="https://www.theweek.com/health/burnhams-plan-to-fix-social-care" target="_blank">England’s adult care system</a> is “one of the most threadbare in the developed world”, according to Thea Stein of the Nuffield Trust, which has analysed the arrangements of 11 comparable nations and regions. England is an “outlier” in that eligibility for any public funding at all is strictly means-tested.</p><p>The most generous system is in <strong>Denmark</strong>, where the state pays 100% of care costs, with no means test. Those in residential care do get billed for bed and board, but means-tested housing benefit is available.</p><p><strong>Australia </strong>has a similar system, also funded by general taxation. In most cases, bed and board have to be paid for, but there are a series of daily spending caps on different elements, such as food and hotel costs.</p><p><strong>Japan</strong>, with the oldest population in the world, introduced a tax on all over-40s in 2000, ring-fenced for care. Everyone who needs it is given a monthly care allowance. They contribute 10%-30% of costs, depending on income; total contributions are capped.</p><p>A similar insurance system operates in <strong>Germany</strong>, but with no cap. Individuals usually pay half of costs. Unusually, adult children can (in rare cases) be liable to pay for parents’ care if the parents run out of money.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Pneumonic plague: the suspected death and outbreak in Russia ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Concerns are sweeping across Russia and the world after a laboratory technician reportedly died from pneumonic plague in Siberia. Many more people are now being quarantined. But health officials in the United States say there is no reason to worry about a global outbreak, at least for the time being.  </p><h2 id="what-happened-in-russia">What happened in Russia?</h2><p>A 28-year-old researcher at the Irkutsk Antiplague Research Institute of Siberia in the town of Shelekhov died last week after being infected with pneumonia of “unknown” origin, according to Russia’s public health agency, Rospotrebnadzor. The disease is now possibly believed to be pneumonic plague, an <a href="https://theweek.com/76088/what-was-black-death-and-how-did-it-end">illness</a> “caused by bacteria, Yersinia pestis, famous for causing the Black Death, that remains with us today mostly in animals across parts of Asia, Africa and the Americas,” Simon Clarke, a professor of cellular microbiology at the U.K.’s University of Reading, said in a <a href="https://www.reading.ac.uk/news/2026/Expert-Comment/Plague-outbreak-in-Russia-expert-comment" target="_blank">statement</a>.</p><p>The disease is <a href="https://theweek.com/health/kissing-bug-disease-chagas-us">deadly</a> but “generally treatable with antibiotics if identified quickly,” said Clarke. After the researcher’s death, “dozens of people were reported to be in isolation,” even as Russia claimed “no microorganisms associated with the employee’s professional duties were detected in samples taken from the patient,” said <a href="https://www.cnn.com/2026/10/04/europe/russia-laboratory-plague-accident-intl" target="_blank">CNN</a>. The head of Rospotrebnadzor later arrived in Shelekhov to hold an emergency meeting about a “particularly dangerous infection,” said Russian news outlet <a href="https://www.irk.ru/news/20261002/head/" target="_blank">IRK</a>. It was originally reported that the worker who died caught the disease from a broken test tube, which Russia has denied.</p><h2 id="what-next">What next? </h2><p>Given the similarities to the <a href="https://theweek.com/world-news/did-the-covid-virus-leak-from-a-lab">alleged coronavirus lab leak cover-up</a>, some people have “likened the reports coming out of Russia to those that circulated in the early days of the Covid-19 outbreak in early 2020,” said <a href="https://time.com/article/2026/10/05/russia-plague-fears-siberia-quarantine-lab-worker-died/" target="_blank">Time</a>. But for now, experts are saying a similar pandemic is unlikely. It is “important to remember that pneumonic plague is a very different disease,” Clarke said. U.S. officials say they will continue to <a href="https://theweek.com/health/cicada-covid-19-variant-us-virus">watch for updates</a>. </p><p>The State Department has also sent a letter to Moscow warning that its “failure to disclose details about the death of a lab worker from a plague research center in Siberia runs counter to its international health obligations,” said <a href="https://www.wsj.com/world/russia/u-s-escalates-pressure-on-russia-over-siberia-lab-death-6f61225a" target="_blank">The Wall Street Journal</a>. The U.S. is “monitoring it closely,” Secretary of State Marco Rubio <a href="https://x.com/RapidResponse47/status/2107103037970153714" target="_blank">told reporters</a>. “I don't think it's cause for alarm, but it is cause for focus.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/pneumonic-plague-russia-disease-death</link>
                                                                            <description>
                            <![CDATA[ Numerous people have been quarantined as a result of the disease ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">aw3Pi2bXHRs78m7ruZySYQ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/ft52UpABTTCTWLTrRY4zMT-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 07 Oct 2026 17:14:28 +0000</pubDate>                                                                                                                                <updated>Wed, 14 Oct 2026 20:40:42 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/ft52UpABTTCTWLTrRY4zMT-1920-80.jpg">
                                                            <media:credit><![CDATA[Igor Ivanko / AFP / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The entrance to Russian health ministry Rospotrebnadzor, which is monitoring the ‘particularly dangerous infection’]]></media:description>                                                            <media:text><![CDATA[The entrance to Rospotrebnadzor, the Russian health ministry.]]></media:text>
                                <media:title type="plain"><![CDATA[The entrance to Rospotrebnadzor, the Russian health ministry.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/ft52UpABTTCTWLTrRY4zMT-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Concerns are sweeping across Russia and the world after a laboratory technician reportedly died from pneumonic plague in Siberia. Many more people are now being quarantined. But health officials in the United States say there is no reason to worry about a global outbreak, at least for the time being.  </p><h2 id="what-happened-in-russia">What happened in Russia?</h2><p>A 28-year-old researcher at the Irkutsk Antiplague Research Institute of Siberia in the town of Shelekhov died last week after being infected with pneumonia of “unknown” origin, according to Russia’s public health agency, Rospotrebnadzor. The disease is now possibly believed to be pneumonic plague, an <a href="https://theweek.com/76088/what-was-black-death-and-how-did-it-end">illness</a> “caused by bacteria, Yersinia pestis, famous for causing the Black Death, that remains with us today mostly in animals across parts of Asia, Africa and the Americas,” Simon Clarke, a professor of cellular microbiology at the U.K.’s University of Reading, said in a <a href="https://www.reading.ac.uk/news/2026/Expert-Comment/Plague-outbreak-in-Russia-expert-comment" target="_blank">statement</a>.</p><p>The disease is <a href="https://theweek.com/health/kissing-bug-disease-chagas-us">deadly</a> but “generally treatable with antibiotics if identified quickly,” said Clarke. After the researcher’s death, “dozens of people were reported to be in isolation,” even as Russia claimed “no microorganisms associated with the employee’s professional duties were detected in samples taken from the patient,” said <a href="https://www.cnn.com/2026/10/04/europe/russia-laboratory-plague-accident-intl" target="_blank">CNN</a>. The head of Rospotrebnadzor later arrived in Shelekhov to hold an emergency meeting about a “particularly dangerous infection,” said Russian news outlet <a href="https://www.irk.ru/news/20261002/head/" target="_blank">IRK</a>. It was originally reported that the worker who died caught the disease from a broken test tube, which Russia has denied.</p><h2 id="what-next">What next? </h2><p>Given the similarities to the <a href="https://theweek.com/world-news/did-the-covid-virus-leak-from-a-lab">alleged coronavirus lab leak cover-up</a>, some people have “likened the reports coming out of Russia to those that circulated in the early days of the Covid-19 outbreak in early 2020,” said <a href="https://time.com/article/2026/10/05/russia-plague-fears-siberia-quarantine-lab-worker-died/" target="_blank">Time</a>. But for now, experts are saying a similar pandemic is unlikely. It is “important to remember that pneumonic plague is a very different disease,” Clarke said. U.S. officials say they will continue to <a href="https://theweek.com/health/cicada-covid-19-variant-us-virus">watch for updates</a>. </p><p>The State Department has also sent a letter to Moscow warning that its “failure to disclose details about the death of a lab worker from a plague research center in Siberia runs counter to its international health obligations,” said <a href="https://www.wsj.com/world/russia/u-s-escalates-pressure-on-russia-over-siberia-lab-death-6f61225a" target="_blank">The Wall Street Journal</a>. The U.S. is “monitoring it closely,” Secretary of State Marco Rubio <a href="https://x.com/RapidResponse47/status/2107103037970153714" target="_blank">told reporters</a>. “I don't think it's cause for alarm, but it is cause for focus.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Online sports betting leads to more emergency room visits for gambling disorders ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Gambling is putting people in the hospital, according to a new study. The increase in online sports betting has worsened mental health problems in younger men, leading to more hospital visits as a result.</p><h2 id="mind-games">Mind games</h2><p><a href="https://theweek.com/tech/gambling-on-everything"><u>Online gambling</u></a> is “associated with a doubling of the rates of severe cases of gambling disorders, with increases occurring only in young men,” said a study published in the <a href="https://www.ajpmonline.org/article/S0749-3797(26)00294-1/fulltext" target="_blank"><u>American Journal of Preventive Medicine</u></a>. More young men are showing up at emergency rooms with “major depression and suicidality,” as well as “other mental health or substance abuse diagnoses” exacerbated by gambling, said <a href="https://time.com/article/2026/10/05/gambling-emergency-room-visits/" target="_blank"><u>Time</u></a>. </p><p>The uptick in these health issues is “particularly concerning given the rapid growth and promotion of online sports betting, which targets this demographic,” said study author Ryan Forrest, a doctoral student at the University of Toronto, in a <a href="https://www.utoronto.ca/news/emergency-room-visits-gambling-disorders-doubled-following-expansion-online-market-study-finds" target="_blank"><u>news release</u></a>. And the “consequences of rising gambling involve not just harm to people who are gambling but wider effects on families and communities.” </p><h2 id="underscored">Underscored</h2><p>While the study centered on Ontario, Canada, the U.S. has a similar <a href="https://theweek.com/politics/utah-betting-kalshi-polymarket-legal"><u>spike in gambling</u></a>. Since 2018, several states have legalized online <a href="https://theweek.com/sports/biggest-sports-betting-scandals-history"><u>sports betting</u></a>. </p><p>“It’s just not a regulated environment out there,” said Cynthia Grant, the vice president of clinical for Birches Health, the largest U.S. provider specializing in treating gambling disorders, to Time. “People’s lives are being ruined, their relationships are being destroyed,” and “their retirement accounts are gone.”</p><p>This data “likely represents only a small fraction of the overall harms associated with gambling in the population,” said the study. Unfortunately, “most people experiencing gambling problems will never seek care,” said senior study author Daniel Myran in the release. But increased ER visits may be “revealing much larger increases in gambling-related harm.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/sports-betting-gambling-disorders-health</link>
                                                                            <description>
                            <![CDATA[ Money is not the only cost of this ubiquitous practice ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">WNa9mRqzfovpChZEubFJSZ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/fcxrwApYgYzCMi3Ct5qQsn-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 07 Oct 2026 06:00:00 +0000</pubDate>                                                                                                                                <updated>Mon, 26 Oct 2026 21:42:08 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/fcxrwApYgYzCMi3Ct5qQsn-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Stephen P. Kelly / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Gambling can worsen preexisting mental health problems ]]></media:description>                                                            <media:text><![CDATA[Illustration of a poker chip with a Caduceus symbol]]></media:text>
                                <media:title type="plain"><![CDATA[Illustration of a poker chip with a Caduceus symbol]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/fcxrwApYgYzCMi3Ct5qQsn-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Gambling is putting people in the hospital, according to a new study. The increase in online sports betting has worsened mental health problems in younger men, leading to more hospital visits as a result.</p><h2 id="mind-games">Mind games</h2><p><a href="https://theweek.com/tech/gambling-on-everything"><u>Online gambling</u></a> is “associated with a doubling of the rates of severe cases of gambling disorders, with increases occurring only in young men,” said a study published in the <a href="https://www.ajpmonline.org/article/S0749-3797(26)00294-1/fulltext" target="_blank"><u>American Journal of Preventive Medicine</u></a>. More young men are showing up at emergency rooms with “major depression and suicidality,” as well as “other mental health or substance abuse diagnoses” exacerbated by gambling, said <a href="https://time.com/article/2026/10/05/gambling-emergency-room-visits/" target="_blank"><u>Time</u></a>. </p><p>The uptick in these health issues is “particularly concerning given the rapid growth and promotion of online sports betting, which targets this demographic,” said study author Ryan Forrest, a doctoral student at the University of Toronto, in a <a href="https://www.utoronto.ca/news/emergency-room-visits-gambling-disorders-doubled-following-expansion-online-market-study-finds" target="_blank"><u>news release</u></a>. And the “consequences of rising gambling involve not just harm to people who are gambling but wider effects on families and communities.” </p><h2 id="underscored">Underscored</h2><p>While the study centered on Ontario, Canada, the U.S. has a similar <a href="https://theweek.com/politics/utah-betting-kalshi-polymarket-legal"><u>spike in gambling</u></a>. Since 2018, several states have legalized online <a href="https://theweek.com/sports/biggest-sports-betting-scandals-history"><u>sports betting</u></a>. </p><p>“It’s just not a regulated environment out there,” said Cynthia Grant, the vice president of clinical for Birches Health, the largest U.S. provider specializing in treating gambling disorders, to Time. “People’s lives are being ruined, their relationships are being destroyed,” and “their retirement accounts are gone.”</p><p>This data “likely represents only a small fraction of the overall harms associated with gambling in the population,” said the study. Unfortunately, “most people experiencing gambling problems will never seek care,” said senior study author Daniel Myran in the release. But increased ER visits may be “revealing much larger increases in gambling-related harm.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ AI anxiety has entered the therapy chat ]]></title>
                                                                                                <dc:content><![CDATA[ <p>With artificial intelligence permeating nearly every aspect of our lives, therapists are seeing more people expressing anxiety about the technology. And that number is likely to rise exponentially in the coming years.</p><h2 id="techistential-dread">‘Techistential dread’</h2><p>Rapid technological advancement can “induce a sense of overarching anxiety,” said therapist Mark Wilkes at <a href="https://www.deseret.com/opinion/2026/09/27/techistential-dread/" target="_blank">Deseret News</a>. Think of it as “techistential dread,” or the “vertigo of wondering if a new advancement will help or hurt, increase opportunities or threaten human thriving.”</p><p>For <a href="https://www.theweek.com/tech/silicon-valley-worker-activism-makes-comeback">Silicon Valley</a> therapist Candice Thompson, “discussing fears and worries about AI has now become a regular part of her workday,” said <a href="https://www.nytimes.com/2026/10/01/well/mind/ai-anxiety-therapy-artificial-intelligence.html" target="_blank">The New York Times</a>. During her “clinical lifetime,” she has “never seen an existential threat like this,” said Thompson to the outlet. No one is immune, “even my clients who are not working in tech.” </p><p>Fears about <a href="https://www.theweek.com/business/ai-fears-halo-trade-scare-trade-economy-investing">AI </a>are becoming increasingly common among therapy clients, as the technology “reshapes the workplace, gobbles up natural resources” and raises concerns about “privacy and security.” For those who “already have a diagnosed disorder,” such as generalized anxiety, the “distress over AI may feel even more intense.” </p><p>There is a “parallel” between this and “depression over climate change,” sociologist Sherry Turkle, the author of “Artificial Intimacy: Who We Become When We Talk to Machines,” said to the Times. “You feel that things are ‘deeply amiss.’” But action may feel “futile, so the depression becomes diffuse.”</p><h2 id="no-simple-answers">‘No simple answers’ </h2><p>For people anxious about AI, there are “no simple answers,” but experts recommend “doing what you can to move the needle in your own life or in public life,” said the Times. The “existential dread” that some express often stems from a “sense of having lost control and any sense of meaning,” said psychologist Yuxin Sun to the Times. It may help to ask: “What are the things I am not going to outsource to AI?”</p><p>For therapists, one place to begin is to “distinguish between goals and values,” said <a href="https://www.psychologytoday.com/us/blog/philosophy-and-therapy/202609/why-therapists-should-be-concerned-about-ai" target="_blank">Psychology Today</a>. It seems “plausible” that some clients’ “medium-term goals” will be “usurped by machines.” So goals, at least “certain kinds of professional goals,” will arguably “no longer be as central to clients’ self-conceptions as they have traditionally been.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/ai-anxiety-has-entered-the-therapy-chat</link>
                                                                            <description>
                            <![CDATA[ Fear about what a fully integrated AI future could mean has many people on edge ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">gvFvBAXfAKdeioPznYuUZC</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/e4qzeu3ebBzHkYWfoUjDrn-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 06 Oct 2026 06:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 07 Oct 2026 15:26:41 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/e4qzeu3ebBzHkYWfoUjDrn-1920-80.jpg">
                                                            <media:credit><![CDATA[Microgen Images / Science Photo Library / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The technology is getting stronger and more capable by the day]]></media:description>                                                            <media:text><![CDATA[Therapist talking to a patient with anxiety]]></media:text>
                                <media:title type="plain"><![CDATA[Therapist talking to a patient with anxiety]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/e4qzeu3ebBzHkYWfoUjDrn-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>With artificial intelligence permeating nearly every aspect of our lives, therapists are seeing more people expressing anxiety about the technology. And that number is likely to rise exponentially in the coming years.</p><h2 id="techistential-dread">‘Techistential dread’</h2><p>Rapid technological advancement can “induce a sense of overarching anxiety,” said therapist Mark Wilkes at <a href="https://www.deseret.com/opinion/2026/09/27/techistential-dread/" target="_blank">Deseret News</a>. Think of it as “techistential dread,” or the “vertigo of wondering if a new advancement will help or hurt, increase opportunities or threaten human thriving.”</p><p>For <a href="https://www.theweek.com/tech/silicon-valley-worker-activism-makes-comeback">Silicon Valley</a> therapist Candice Thompson, “discussing fears and worries about AI has now become a regular part of her workday,” said <a href="https://www.nytimes.com/2026/10/01/well/mind/ai-anxiety-therapy-artificial-intelligence.html" target="_blank">The New York Times</a>. During her “clinical lifetime,” she has “never seen an existential threat like this,” said Thompson to the outlet. No one is immune, “even my clients who are not working in tech.” </p><p>Fears about <a href="https://www.theweek.com/business/ai-fears-halo-trade-scare-trade-economy-investing">AI </a>are becoming increasingly common among therapy clients, as the technology “reshapes the workplace, gobbles up natural resources” and raises concerns about “privacy and security.” For those who “already have a diagnosed disorder,” such as generalized anxiety, the “distress over AI may feel even more intense.” </p><p>There is a “parallel” between this and “depression over climate change,” sociologist Sherry Turkle, the author of “Artificial Intimacy: Who We Become When We Talk to Machines,” said to the Times. “You feel that things are ‘deeply amiss.’” But action may feel “futile, so the depression becomes diffuse.”</p><h2 id="no-simple-answers">‘No simple answers’ </h2><p>For people anxious about AI, there are “no simple answers,” but experts recommend “doing what you can to move the needle in your own life or in public life,” said the Times. The “existential dread” that some express often stems from a “sense of having lost control and any sense of meaning,” said psychologist Yuxin Sun to the Times. It may help to ask: “What are the things I am not going to outsource to AI?”</p><p>For therapists, one place to begin is to “distinguish between goals and values,” said <a href="https://www.psychologytoday.com/us/blog/philosophy-and-therapy/202609/why-therapists-should-be-concerned-about-ai" target="_blank">Psychology Today</a>. It seems “plausible” that some clients’ “medium-term goals” will be “usurped by machines.” So goals, at least “certain kinds of professional goals,” will arguably “no longer be as central to clients’ self-conceptions as they have traditionally been.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Kratom: a dangerous high  ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-is-kratom">What is kratom?</h2><p>Derived from the leaves of the kratom tree, the legal high is sold in convenience stores, smoke shops, and service stations across the U.S. with the pitch that it can ease pain and boost energy. As use has increased—some 5 million Americans have tried kratom, turning the drug into a billion- dollar industry—so have its harms. More than 5,200 people fatally overdosed on kratom between 2020 and 2024, according to the CDC, and kratom-related hospitalizations and poisonings have rocketed nearly 1,300% over the past decade, with nearly 3,500 people severely sickened last year. Authorities found packages of the drug while investigating the mysterious deaths of two University of Mississippi undergrads, ages 18 and 20, in separate incidents recently. Responding to growing concern, the Drug Enforcement Administration this summer temporarily classified three kratom derivatives as federally illegal Schedule 1 substances, a category that includes heroin and LSD. But the Department of Health and Human Services emphasized the change was “not intended to regulate natural leaf kratom,” only synthetics and concentrates of its psychoactive compounds. Many experts call that insufficient—and suggest ties between Trump Cabinet members and kratom firms could be influencing regulations. “It’s looking like we have a coin-operated drug policy,” said former White House adviser Dr. Kevin Sabet. </p><h2 id="what-effect-does-kratom-have-on-users">What effect does kratom have on users?</h2><p>Low doses have a stimulant effect; people in Southeast Asia, where the tree is native, have for centuries chewed leaves as a pick-me-up.  But in higher doses, kratom acts as a <a href="https://theweek.com/health/pharmacy-benefit-managers-opioid-prescriptions">narcotic</a>, because two psychoactive compounds— mitragynine and 7-hydroxymitragynine  (7-OH)—bind to the same receptors as opioids. “If you take two pills it’s like a cup of coffee,” podcaster Joe  Rogan said in 2019. “I took eight and I  was f---ed up.” Kratom leaves are typically imported from Indonesia and processed stateside into capsules, gummies, and other products. While natural kratom contains only trace amounts of 7-OH, some companies sell concentrated or synthetic forms of the compound under brand names such as  Magic 7OH and 7 O’Heaven for as little as  $4 a pop. Those concentrates can be up to  13 times stronger than morphine, and users risk addiction, liver damage, and seizures— or worse. Weston Walker, a health- conscious  Florida attorney, collapsed and died in 2021  after taking a lethal amount of kratom extract. “You just never imagine your 37-year old, healthy-as-a-horse brother is going to pass away,” said his sister, Whitney Briggs.</p><h2 id="why-do-people-take-the-drug">Why do people take the drug?</h2><p>Many take it purely recreationally, enjoying a mild alcohol-free buzz from the kratom- infused drinks and cocktails served at hundreds of kratom lounges and bars across the U.S. Some long-haul truckers use it to stay awake on the road. But kratom’s most vocal defenders say it helps them manage pain and chronic conditions, and a Johns Hopkins survey last year found that over a quarter of kratom users take it as an opioid replacement. But while some users say it helped wean them off opioids, others find themselves trading one addiction for another. “Anyone who says kratom is not addictive has never tried it,” a former opioid and kratom user named Jack told Aeon. “I probably spent over $120 a day on kratom, way more than I had spent on oxies.” </p><h2 id="how-has-the-government-responded">How has the government responded? </h2><p>A 2016 attempt at banning kratom’s main compounds failed after intense pushback from the American Kratom Association and other lobbying groups. The DEA’s order this summer on three kratom derivatives also bans substances that contain more than 0.05% of 7-OH, a level that excludes raw kratom leaves. But Brandeis University opioid researcher Dr. Andrew Kolodny notes that the majority of patients he has treated for 7-OH addiction started with natural kratom, and that there’s no clear line marking one form as dangerous and the other safe. “The DEA should control kratom in all its forms,” he said. </p><h2 id="why-hasn-t-it">Why hasn’t it? </h2><p>Some experts point to financial links between Trump Cabinet officials and the <a href="https://theweek.com/health/fda-restricting-kratom-related-products">kratom industry.</a> In 2023, the Justice Department sued one of the country’s largest kratom firms, Oklahoma-based Botanic Tonics, alleging its kratom- infused Feel Free drink was an unsafe “new dietary ingredient.” The DOJ dropped the case last December, saying it was not “a prudent use of government resources,” and over the following months, Botanic Tonics donated $1 million to MAHA PAC, which is associated with Health Secretary Robert F. Kennedy Jr., and $443,000 to the Republican National Committee. Asked about the donation, Kennedy said, “I don’t make decisions for the Justice Department.” Markwayne Mullin, the former Oklahoma senator who in March became Homeland Security secretary, has invested up to $1 million in Botanic Tonics. <em>The New York Times</em> reported that Mullin has asked the FDA to soften its warnings on kratom while publicly promoting bans on 7-OH, whose makers compete with Botanic Tonics’ “natural” products. The Department of Homeland Security said Mullin “follows all ethics and conflict-of- interest standards.” </p><h2 id="can-states-take-action">Can states take action? </h2><p>Over a dozen have enacted bans on kratom,  7-OH, or both, though enforcement is spotty.  Not all experts support <a href="https://theweek.com/health/narcan-naloxone-america-drugstores">blanket prohibition</a>:  Johns Hopkins psychiatrist Kirsten Smith warns that a “moral panic freakout” could stifle research into whether kratom can indeed offer an off-ramp from opiates. But most agree kratom companies should not be left to self- regulate. Many in the industry, meanwhile, dismiss health harms from their product. Mac Haddow of the American Kratom Association has applauded the  DEA’s 7-OH ban but has also blamed irresponsible consumers for any deaths caused by natural kratom use. “Can we regulate stupid?” he asked. “I can’t do that—no one can.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/kratom-opiod-trum-administration</link>
                                                                            <description>
                            <![CDATA[ Is an addictive opioid-like drug getting preferential treatment from the Trump administration? ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">iKjEsgBVPuytP9jpyNKZt9</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/sCAUjPKSP2hymavdDRK5BL-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 05 Oct 2026 17:04:06 +0000</pubDate>                                                                                                                                <updated>Mon, 05 Oct 2026 17:21:49 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (The Week US) ]]></author>                    <dc:creator><![CDATA[ The Week US ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/sCAUjPKSP2hymavdDRK5BL-1920-80.jpg">
                                                            <media:credit><![CDATA[Alejandra Villa Loarca / Newsday RM / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[“Anyone who says kratom is not addictive has never tried it”]]></media:description>                                                            <media:text><![CDATA[Huntington, N.Y.: Products containing Kratom on sale at a local tobacco store in Huntington, New York on August 21, 2025. (Photo by Alejandra Villa Loarca/Newsday RM via Getty Images)]]></media:text>
                                <media:title type="plain"><![CDATA[Huntington, N.Y.: Products containing Kratom on sale at a local tobacco store in Huntington, New York on August 21, 2025. (Photo by Alejandra Villa Loarca/Newsday RM via Getty Images)]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/sCAUjPKSP2hymavdDRK5BL-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-is-kratom">What is kratom?</h2><p>Derived from the leaves of the kratom tree, the legal high is sold in convenience stores, smoke shops, and service stations across the U.S. with the pitch that it can ease pain and boost energy. As use has increased—some 5 million Americans have tried kratom, turning the drug into a billion- dollar industry—so have its harms. More than 5,200 people fatally overdosed on kratom between 2020 and 2024, according to the CDC, and kratom-related hospitalizations and poisonings have rocketed nearly 1,300% over the past decade, with nearly 3,500 people severely sickened last year. Authorities found packages of the drug while investigating the mysterious deaths of two University of Mississippi undergrads, ages 18 and 20, in separate incidents recently. Responding to growing concern, the Drug Enforcement Administration this summer temporarily classified three kratom derivatives as federally illegal Schedule 1 substances, a category that includes heroin and LSD. But the Department of Health and Human Services emphasized the change was “not intended to regulate natural leaf kratom,” only synthetics and concentrates of its psychoactive compounds. Many experts call that insufficient—and suggest ties between Trump Cabinet members and kratom firms could be influencing regulations. “It’s looking like we have a coin-operated drug policy,” said former White House adviser Dr. Kevin Sabet. </p><h2 id="what-effect-does-kratom-have-on-users">What effect does kratom have on users?</h2><p>Low doses have a stimulant effect; people in Southeast Asia, where the tree is native, have for centuries chewed leaves as a pick-me-up.  But in higher doses, kratom acts as a <a href="https://theweek.com/health/pharmacy-benefit-managers-opioid-prescriptions">narcotic</a>, because two psychoactive compounds— mitragynine and 7-hydroxymitragynine  (7-OH)—bind to the same receptors as opioids. “If you take two pills it’s like a cup of coffee,” podcaster Joe  Rogan said in 2019. “I took eight and I  was f---ed up.” Kratom leaves are typically imported from Indonesia and processed stateside into capsules, gummies, and other products. While natural kratom contains only trace amounts of 7-OH, some companies sell concentrated or synthetic forms of the compound under brand names such as  Magic 7OH and 7 O’Heaven for as little as  $4 a pop. Those concentrates can be up to  13 times stronger than morphine, and users risk addiction, liver damage, and seizures— or worse. Weston Walker, a health- conscious  Florida attorney, collapsed and died in 2021  after taking a lethal amount of kratom extract. “You just never imagine your 37-year old, healthy-as-a-horse brother is going to pass away,” said his sister, Whitney Briggs.</p><h2 id="why-do-people-take-the-drug">Why do people take the drug?</h2><p>Many take it purely recreationally, enjoying a mild alcohol-free buzz from the kratom- infused drinks and cocktails served at hundreds of kratom lounges and bars across the U.S. Some long-haul truckers use it to stay awake on the road. But kratom’s most vocal defenders say it helps them manage pain and chronic conditions, and a Johns Hopkins survey last year found that over a quarter of kratom users take it as an opioid replacement. But while some users say it helped wean them off opioids, others find themselves trading one addiction for another. “Anyone who says kratom is not addictive has never tried it,” a former opioid and kratom user named Jack told Aeon. “I probably spent over $120 a day on kratom, way more than I had spent on oxies.” </p><h2 id="how-has-the-government-responded">How has the government responded? </h2><p>A 2016 attempt at banning kratom’s main compounds failed after intense pushback from the American Kratom Association and other lobbying groups. The DEA’s order this summer on three kratom derivatives also bans substances that contain more than 0.05% of 7-OH, a level that excludes raw kratom leaves. But Brandeis University opioid researcher Dr. Andrew Kolodny notes that the majority of patients he has treated for 7-OH addiction started with natural kratom, and that there’s no clear line marking one form as dangerous and the other safe. “The DEA should control kratom in all its forms,” he said. </p><h2 id="why-hasn-t-it">Why hasn’t it? </h2><p>Some experts point to financial links between Trump Cabinet officials and the <a href="https://theweek.com/health/fda-restricting-kratom-related-products">kratom industry.</a> In 2023, the Justice Department sued one of the country’s largest kratom firms, Oklahoma-based Botanic Tonics, alleging its kratom- infused Feel Free drink was an unsafe “new dietary ingredient.” The DOJ dropped the case last December, saying it was not “a prudent use of government resources,” and over the following months, Botanic Tonics donated $1 million to MAHA PAC, which is associated with Health Secretary Robert F. Kennedy Jr., and $443,000 to the Republican National Committee. Asked about the donation, Kennedy said, “I don’t make decisions for the Justice Department.” Markwayne Mullin, the former Oklahoma senator who in March became Homeland Security secretary, has invested up to $1 million in Botanic Tonics. <em>The New York Times</em> reported that Mullin has asked the FDA to soften its warnings on kratom while publicly promoting bans on 7-OH, whose makers compete with Botanic Tonics’ “natural” products. The Department of Homeland Security said Mullin “follows all ethics and conflict-of- interest standards.” </p><h2 id="can-states-take-action">Can states take action? </h2><p>Over a dozen have enacted bans on kratom,  7-OH, or both, though enforcement is spotty.  Not all experts support <a href="https://theweek.com/health/narcan-naloxone-america-drugstores">blanket prohibition</a>:  Johns Hopkins psychiatrist Kirsten Smith warns that a “moral panic freakout” could stifle research into whether kratom can indeed offer an off-ramp from opiates. But most agree kratom companies should not be left to self- regulate. Many in the industry, meanwhile, dismiss health harms from their product. Mac Haddow of the American Kratom Association has applauded the  DEA’s 7-OH ban but has also blamed irresponsible consumers for any deaths caused by natural kratom use. “Can we regulate stupid?” he asked. “I can’t do that—no one can.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A surgeon shortage creates challenges in rural communities ]]></title>
                                                                                                <dc:content><![CDATA[ <p>For Americans in rural communities, getting adequate health treatment has often been an uphill battle. Now, new research shows just how dire the state of healthcare is in these areas, particularly because of a dearth of surgeons in places across the United States.</p><h2 id="how-bad-is-the-surgeon-shortage">How bad is the surgeon shortage?  </h2><p>Currently, 1,180 out of 3,144 counties in the United States — more than a third — have <a href="https://theweek.com/health/how-ai-could-change-your-trip-to-the-doctors">no general surgeon</a>, and at least 951 of them “have no surgeon in any of 12 surgical specialties,” said a recent report from the <a href="https://www.facs.org/media-center/press-releases/2026/15-million-americans-live-in-a-county-with-no-general-surgeon/" target="_blank">American College of Surgeons (ACS)</a>. These shortages represent “15.1 million people lacking access to surgical care.” At least 434 rural hospitals are also in counties “with no identified full-time surgeon.”</p><p><a href="https://theweek.com/health/alloclae-zombie-filler-trend-cosmetic-surgery">Surgeon supply</a> across all specialties is significantly varied and “12 times higher in some regions than others,” said the ACS. And the paucity is likely to increase during the coming years. The U.S. is “projected to be short nearly 28,000 surgeons by 2038, with the workforce meeting just 84.3% of national need,” said a <a href="https://www.facs.org/media-center/press-releases/2026/us-will-face-a-shortage-of-nearly-28-000-surgeons-by-2038-first-nationwide-study-finds/" target="_blank">separate ACS study</a>. The greatest gaps are expected to be in “vascular surgery, ophthalmology, thoracic surgery and plastic surgery.”</p><h2 id="what-has-the-shortage-s-effect-been">What has the shortage’s effect been? </h2><p>Rural communities <a href="https://theweek.com/science/tech-ai-surgical-tools-injuring-patients">can be harmed</a> in various ways. While many people “assume that surgeons primarily perform elective procedures, many surgeons in rural communities serve multiple roles,” study co-author Dr. Thomas Tsai, the medical director for health policy research at the ACS, said to <a href="https://time.com/article/2026/09/29/millions-of-americans-live-in-a-county-without-a-surgeon/" target="_blank">Time</a>. “Access to surgeons is the keystone for the broader rural healthcare ecosystem.” Part of the problem is that “training isn’t keeping pace with demand, especially as the country ages and needs more medical procedures.”</p><p>Bringing in more surgeons is crucial because the “average American may undergo as many as 20 diagnostic and therapeutic procedures over the course of their life, factoring in minor procedures such as endoscopies to major operations,” Tsai told the industry outlet <a href="https://www.fiercehealthcare.com/providers/millions-americans-dont-have-surgeon-their-home-county-study" target="_blank">Fierce Healthcare</a>. The “ability to provide innovative surgical care is a feature and not a flaw of the U.S. healthcare system,” and Americans “need the resources to both expand the supply of surgeons in the U.S. and to sustain viable surgical practices” in rural areas. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/a-surgeon-shortage-creates-challenges-in-rural-communities</link>
                                                                            <description>
                            <![CDATA[ Over a third of counties in the U.S. reportedly have no general surgeons ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">i3NrUXMgH4mETfu4GhJhWc</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/fxskuHA87xBhbv2reVyFbm-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 05 Oct 2026 06:00:00 +0000</pubDate>                                                                                                                                <updated>Mon, 05 Oct 2026 21:52:11 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/fxskuHA87xBhbv2reVyFbm-1920-80.jpg">
                                                            <media:credit><![CDATA[Ricky Carioti / The Washington Post / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A surgeon at a hospital in rural Romney, West Virginia]]></media:description>                                                            <media:text><![CDATA[A surgeon at a hospital in rural Romney, West Virginia.]]></media:text>
                                <media:title type="plain"><![CDATA[A surgeon at a hospital in rural Romney, West Virginia.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/fxskuHA87xBhbv2reVyFbm-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>For Americans in rural communities, getting adequate health treatment has often been an uphill battle. Now, new research shows just how dire the state of healthcare is in these areas, particularly because of a dearth of surgeons in places across the United States.</p><h2 id="how-bad-is-the-surgeon-shortage">How bad is the surgeon shortage?  </h2><p>Currently, 1,180 out of 3,144 counties in the United States — more than a third — have <a href="https://theweek.com/health/how-ai-could-change-your-trip-to-the-doctors">no general surgeon</a>, and at least 951 of them “have no surgeon in any of 12 surgical specialties,” said a recent report from the <a href="https://www.facs.org/media-center/press-releases/2026/15-million-americans-live-in-a-county-with-no-general-surgeon/" target="_blank">American College of Surgeons (ACS)</a>. These shortages represent “15.1 million people lacking access to surgical care.” At least 434 rural hospitals are also in counties “with no identified full-time surgeon.”</p><p><a href="https://theweek.com/health/alloclae-zombie-filler-trend-cosmetic-surgery">Surgeon supply</a> across all specialties is significantly varied and “12 times higher in some regions than others,” said the ACS. And the paucity is likely to increase during the coming years. The U.S. is “projected to be short nearly 28,000 surgeons by 2038, with the workforce meeting just 84.3% of national need,” said a <a href="https://www.facs.org/media-center/press-releases/2026/us-will-face-a-shortage-of-nearly-28-000-surgeons-by-2038-first-nationwide-study-finds/" target="_blank">separate ACS study</a>. The greatest gaps are expected to be in “vascular surgery, ophthalmology, thoracic surgery and plastic surgery.”</p><h2 id="what-has-the-shortage-s-effect-been">What has the shortage’s effect been? </h2><p>Rural communities <a href="https://theweek.com/science/tech-ai-surgical-tools-injuring-patients">can be harmed</a> in various ways. While many people “assume that surgeons primarily perform elective procedures, many surgeons in rural communities serve multiple roles,” study co-author Dr. Thomas Tsai, the medical director for health policy research at the ACS, said to <a href="https://time.com/article/2026/09/29/millions-of-americans-live-in-a-county-without-a-surgeon/" target="_blank">Time</a>. “Access to surgeons is the keystone for the broader rural healthcare ecosystem.” Part of the problem is that “training isn’t keeping pace with demand, especially as the country ages and needs more medical procedures.”</p><p>Bringing in more surgeons is crucial because the “average American may undergo as many as 20 diagnostic and therapeutic procedures over the course of their life, factoring in minor procedures such as endoscopies to major operations,” Tsai told the industry outlet <a href="https://www.fiercehealthcare.com/providers/millions-americans-dont-have-surgeon-their-home-county-study" target="_blank">Fierce Healthcare</a>. The “ability to provide innovative surgical care is a feature and not a flaw of the U.S. healthcare system,” and Americans “need the resources to both expand the supply of surgeons in the U.S. and to sustain viable surgical practices” in rural areas. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Cannabis use linked to worsened seizures ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A new study suggests a worrying link between frequent marijuana use and care-intensive seizures in people with ‘hard-to-treat’ epilepsy. While it’s too early to prove causation, researchers believe the connection warrants further study. </p><h2 id="unsettling-trend">‘Unsettling trend’</h2><p>Adults with “hard-to-treat epilepsy” who used <a href="https://www.theweek.com/politics/trump-reclassify-marijuana-legalization">cannabis</a> most days had “more than twice as many convulsive seizures” per year and “more rapidly became resistant to antiseizure medications” compared with nonusers, according to new research from Washington University School of Medicine in St. Louis, published in the journal <a href="https://doi.org/10.1002/epi.70456" target="_blank">Epilepsia</a>, a <a href="https://www.eurekalert.org/news-releases/1144307" target="_blank">press release</a> said. </p><p>The researchers reviewed the medical records of 64 adults with drug-resistant epilepsy who were admitted to an inpatient unit where “doctors monitored their seizures in real time,” said <a href="https://www.usnews.com/news/health-news/articles/2026-09-28/frequent-marijuana-use-tied-to-more-severe-epilepsy" target="_blank">U.S. News &amp; World Report</a>. Twenty-two of them “reported using marijuana at least 20 days a month.” The difference between the two groups “was significant.” In total, “91% of frequent users experienced convulsive seizures compared with 57% of nonusers.” </p><p>An <a href="https://www.theweek.com/health/the-fdas-estrogen-warning-had-a-blind-spot-menopausal-women-dying-from-utis">FDA</a>-approved cannabis-derived epilepsy treatment exists, Epidiolex, but it is “only made from cannabidiol (CBD),” said <a href="https://gizmodo.com/scientists-uncover-worrying-link-between-frequent-cannabis-use-and-seizures-2000817869" target="_blank">Gizmodo</a>. The team suspects THC, the other active compound in cannabis, “could be the primary culprit behind this unsettling trend.”</p><h2 id="next-steps">Next steps</h2><p>The researchers emphasized that the “current data demonstrate an observational association rather than direct causation,” said <a href="https://neurosciencenews.com/daily-cannabis-epilepsy-worse-31268/" target="_blank">Neuroscience News</a>. Moving forward, the team is designing a “prospective, multisite study” incorporating blood tests rather than “self-reported usage.”</p><p>The primary takeaway is to “not ignore cannabis use in epilepsy or to assume it is beneficial,” said senior study author Aaron Struck to Gizmodo. It is worthwhile to “discuss with a treating physician” if “stopping or reducing THC may be beneficial to your care.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/cannabis-use-linked-to-worsened-seizures</link>
                                                                            <description>
                            <![CDATA[ Could regular marijuana use make epilepsy worse? A new study suggests it might. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">5M9w9gioVYxQKRp3EvBT3R</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/bNCuV9zCsnsSTAT7S24gBQ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 01 Oct 2026 06:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/bNCuV9zCsnsSTAT7S24gBQ-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Cannabis compounds are already being used in epilepsy treatments ]]></media:description>                                                            <media:text><![CDATA[Photo collage of a brain scan, ECG printouts, and a hand holding a joint]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a brain scan, ECG printouts, and a hand holding a joint]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/bNCuV9zCsnsSTAT7S24gBQ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A new study suggests a worrying link between frequent marijuana use and care-intensive seizures in people with ‘hard-to-treat’ epilepsy. While it’s too early to prove causation, researchers believe the connection warrants further study. </p><h2 id="unsettling-trend">‘Unsettling trend’</h2><p>Adults with “hard-to-treat epilepsy” who used <a href="https://www.theweek.com/politics/trump-reclassify-marijuana-legalization">cannabis</a> most days had “more than twice as many convulsive seizures” per year and “more rapidly became resistant to antiseizure medications” compared with nonusers, according to new research from Washington University School of Medicine in St. Louis, published in the journal <a href="https://doi.org/10.1002/epi.70456" target="_blank">Epilepsia</a>, a <a href="https://www.eurekalert.org/news-releases/1144307" target="_blank">press release</a> said. </p><p>The researchers reviewed the medical records of 64 adults with drug-resistant epilepsy who were admitted to an inpatient unit where “doctors monitored their seizures in real time,” said <a href="https://www.usnews.com/news/health-news/articles/2026-09-28/frequent-marijuana-use-tied-to-more-severe-epilepsy" target="_blank">U.S. News &amp; World Report</a>. Twenty-two of them “reported using marijuana at least 20 days a month.” The difference between the two groups “was significant.” In total, “91% of frequent users experienced convulsive seizures compared with 57% of nonusers.” </p><p>An <a href="https://www.theweek.com/health/the-fdas-estrogen-warning-had-a-blind-spot-menopausal-women-dying-from-utis">FDA</a>-approved cannabis-derived epilepsy treatment exists, Epidiolex, but it is “only made from cannabidiol (CBD),” said <a href="https://gizmodo.com/scientists-uncover-worrying-link-between-frequent-cannabis-use-and-seizures-2000817869" target="_blank">Gizmodo</a>. The team suspects THC, the other active compound in cannabis, “could be the primary culprit behind this unsettling trend.”</p><h2 id="next-steps">Next steps</h2><p>The researchers emphasized that the “current data demonstrate an observational association rather than direct causation,” said <a href="https://neurosciencenews.com/daily-cannabis-epilepsy-worse-31268/" target="_blank">Neuroscience News</a>. Moving forward, the team is designing a “prospective, multisite study” incorporating blood tests rather than “self-reported usage.”</p><p>The primary takeaway is to “not ignore cannabis use in epilepsy or to assume it is beneficial,” said senior study author Aaron Struck to Gizmodo. It is worthwhile to “discuss with a treating physician” if “stopping or reducing THC may be beneficial to your care.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Alzheimer’s disease no longer considered untreatable ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Dementia research has reached a major milestone: Alzheimer’s disease is no longer untreatable, according to a landmark global report. The growing range of treatment options marks a shift from seeking a cure to focusing on avoiding the disease entirely.</p><h2 id="era-of-unprecedented-activity">‘Era of unprecedented activity’ </h2><p>The <a href="https://www.theweek.com/health/dei-concerns-funding-cuts-alzheimers">Alzheimer’s</a> research field is “witnessing a period of remarkable scientific momentum,” said the 2026 <a href="https://www.alzint.org/resource/world-alzheimer-report-2025/" target="_blank">World Alzheimer Report</a>, which is coauthored by Alzheimer’s Disease International and health journalist Paul Gallagher. The ADI is a global federation of dementia associations affiliated with the World Health Organization.</p><p>After years of being considered an “inevitable consequence of old age and neurodegeneration,” <a href="https://www.theweek.com/health/watching-tv-brain-volume-dementia-alzheimers">dementia</a> research has entered an “era of unprecedented activity.” Experts are hopeful. </p><p>Hundreds of clinical trials are investigating “medicines, diagnostics, lifestyle interventions, digital technologies, rehabilitation programs” and new care models for the disease, said the report. The disease is now seen as a condition for which “earlier diagnosis, better understanding of disease biology, and a wider range of interventions may collectively improve outcomes.”</p><p>During the past five years alone, novel drugs such as <a href="https://www.neurologylive.com/view/donanemab-shows-durable-amyloid-clearance-consistent-safety-early-start-patients" target="_blank">donanemab</a> (brand name Kisunla) and <a href="https://www.ncoa.org/article/alzheimers-medication-leqembi-now-covered-by-medicare-but-access-and-effectiveness-questions-remain/" target="_blank">lecanemab</a> (brand name Leqembi) have been shown to “modestly slow decline in early Alzheimer’s,” while growing evidence suggests “some dementia cases could potentially be delayed or prevented through risk reduction,” said <a href="https://www.sciencealert.com/alzheimers-is-no-longer-an-untreatable-disease-major-report-concludes-heres-why" target="_blank">Science Alert</a>. </p><h2 id="what-s-next">What’s next?</h2><p>There are drugs that “millions of people are taking right now for other reasons” that might also be able to help with Alzheimer’s disease, said <a href="https://www.vox.com/podcasts/503465/alzheimers-research-progress-amyloid-tau-glp1" target="_blank">Vox</a>. <a href="https://www.theweek.com/health/why-glp-1s-dont-work-for-everyone">GLP-1s</a> “in particular are the big ones.” </p><p>It’s still “sort of theoretical,” but the Alzheimer’s Association is “putting $100 million behind some research projects” to investigate this possible link, said Vox. Years from now, when “millions of people are now on these GLP-1 drugs,” we may “start to see Alzheimer’s less often.” This would be “another reason to be optimistic” that the “future for this disease is looking brighter.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/alzheimers-disease-no-longer-considered-untreatable</link>
                                                                            <description>
                            <![CDATA[ Treatment options are expanding, and experts are turning their attention to prevention ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">vaKCrzgmNc2MSHoWUaTajG</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/qf5poAhEPYyjvPm3suRxwg-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 29 Sep 2026 06:00:00 +0000</pubDate>                                                                                                                                <updated>Tue, 29 Sep 2026 15:38:08 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/qf5poAhEPYyjvPm3suRxwg-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A more effective treatment plan is on the horizon]]></media:description>                                                            <media:text><![CDATA[Photo collage of a brain MRI, pills, and a forget-me-not]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a brain MRI, pills, and a forget-me-not]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/qf5poAhEPYyjvPm3suRxwg-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Dementia research has reached a major milestone: Alzheimer’s disease is no longer untreatable, according to a landmark global report. The growing range of treatment options marks a shift from seeking a cure to focusing on avoiding the disease entirely.</p><h2 id="era-of-unprecedented-activity">‘Era of unprecedented activity’ </h2><p>The <a href="https://www.theweek.com/health/dei-concerns-funding-cuts-alzheimers">Alzheimer’s</a> research field is “witnessing a period of remarkable scientific momentum,” said the 2026 <a href="https://www.alzint.org/resource/world-alzheimer-report-2025/" target="_blank">World Alzheimer Report</a>, which is coauthored by Alzheimer’s Disease International and health journalist Paul Gallagher. The ADI is a global federation of dementia associations affiliated with the World Health Organization.</p><p>After years of being considered an “inevitable consequence of old age and neurodegeneration,” <a href="https://www.theweek.com/health/watching-tv-brain-volume-dementia-alzheimers">dementia</a> research has entered an “era of unprecedented activity.” Experts are hopeful. </p><p>Hundreds of clinical trials are investigating “medicines, diagnostics, lifestyle interventions, digital technologies, rehabilitation programs” and new care models for the disease, said the report. The disease is now seen as a condition for which “earlier diagnosis, better understanding of disease biology, and a wider range of interventions may collectively improve outcomes.”</p><p>During the past five years alone, novel drugs such as <a href="https://www.neurologylive.com/view/donanemab-shows-durable-amyloid-clearance-consistent-safety-early-start-patients" target="_blank">donanemab</a> (brand name Kisunla) and <a href="https://www.ncoa.org/article/alzheimers-medication-leqembi-now-covered-by-medicare-but-access-and-effectiveness-questions-remain/" target="_blank">lecanemab</a> (brand name Leqembi) have been shown to “modestly slow decline in early Alzheimer’s,” while growing evidence suggests “some dementia cases could potentially be delayed or prevented through risk reduction,” said <a href="https://www.sciencealert.com/alzheimers-is-no-longer-an-untreatable-disease-major-report-concludes-heres-why" target="_blank">Science Alert</a>. </p><h2 id="what-s-next">What’s next?</h2><p>There are drugs that “millions of people are taking right now for other reasons” that might also be able to help with Alzheimer’s disease, said <a href="https://www.vox.com/podcasts/503465/alzheimers-research-progress-amyloid-tau-glp1" target="_blank">Vox</a>. <a href="https://www.theweek.com/health/why-glp-1s-dont-work-for-everyone">GLP-1s</a> “in particular are the big ones.” </p><p>It’s still “sort of theoretical,” but the Alzheimer’s Association is “putting $100 million behind some research projects” to investigate this possible link, said Vox. Years from now, when “millions of people are now on these GLP-1 drugs,” we may “start to see Alzheimer’s less often.” This would be “another reason to be optimistic” that the “future for this disease is looking brighter.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Six Flags is in hot water over 100 alleged brain injuries ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Six Flags Magic Mountain is one of the most popular amusement parks in the United States, but its flagship attraction and most popular ride, the X2 roller coaster, has come under fire for possibly causing more than eight dozen severe brain injuries in the past two years. Now, a series of lawsuits has put the future of the ride in jeopardy.</p><h2 id="what-are-these-lawsuits-about">What are these lawsuits about?</h2><p>The three lawsuits represent more than 100 clients who reportedly received brain injuries while riding <a href="https://theweek.com/world-news/why-an-infamous-california-rollercoaster-has-closed">Magic Mountain’s X2</a>. The ride, which has been operating since 2002 at the Los Angeles County <a href="https://theweek.com/culture-life/travel/worlds-best-water-parks">amusement park</a>, has “seats that rotate independently as the train travels along the track, spinning riders as much as 360 degrees,” said <a href="https://www.nytimes.com/2026/09/23/us/six-flags-x2-roller-coaster-injuries.html" target="_blank">The New York Times</a>, sending “riders through dives, flips and twists.” The 200-foot-high attraction can reach speeds of up to 76 miles per hour.</p><p>The lawsuits accuse Six Flags and Magic Mountain of knowingly operating a “defectively designed ride and failing to adequately warn passengers about the risk of serious brain injuries,” said the Times. The allegations come less than a month after a <a href="https://www.cnn.com/six-flags-rollercoaster-brain-injuries-invs" target="_blank">CNN investigation</a> documented numerous instances of injuries on the ride. Two of the lawsuits represent people featured in the investigation, including a pair of riders who “both fell unconscious after getting off the roller coaster and underwent emergency brain surgery for severe traumatic brain injuries,” said CNN.</p><p>Attorneys are “actively investigating these incidents and representing individuals who allege they suffered traumatic brain injuries after riding X2,” Dordick Law Corporation, which filed the three lawsuits, said in a <a href="https://www.dordicklaw.com/southern-california-personal-injury/traumatic-brain-injury/magic-mountain-x2-roller-coaster/" target="_blank">statement</a>. The lawsuit also references a 22-year-old man who “died from a traumatic brain injury after riding X2 four years ago,” said CNN, with Six Flags later reaching a settlement with his family. The outlet also claims it heard from people who “had injuries that were not brain-related or did not have proof of medical treatment.”</p><h2 id="what-comes-next">What comes next? </h2><p>X2 has supposedly been closed since July 12, which was “nearly a full day after the latest injury there, and park officials have remained silent about what necessitated the closure,” said CNN. Six Flags’ <a href="https://www.sixflags.com/magicmountain/scheduled-ride-closures" target="_blank">website</a> still lists the ride as closed, with no timeline listed for its reopening. The company has denied that it was negligent; in court filings related to a different X2 case, Six Flags “said testing showed that the ride operated within accepted acceleration limits and argued that the rider’s injury, a brain bleed, was instead caused by a preexisting condition,” said the Times. </p><p>But lawyers for the alleged injured riders are not backing down. “We want transparency. We want the public to know about the dangers of riding these rollercoasters, and in particular, X2,” attorney Gary Dordick said during a press conference. Magic Mountain “seems to think that it’s okay that if people voluntarily choose to ride a roller coaster, then they’ve assumed the risk.” Ultimately, the “fate of X2 remains unknown, as Six Flags officials remain tight-lipped on the attraction’s future,” said <a href="https://ktla.com/news/local-news/lawsuits-filed-alleging-catastrophic-brain-injuries-from-x2-rollercoaster/" target="_blank">KTLA-5</a>.</p><p>Despite the injuries, <a href="https://theweek.com/united-states/1024748/is-it-safe-to-ride-a-roller-coaster">U.S. amusement parks</a> “typically have high safety standards, with many requiring daily inspections of roller coasters and other attractions before they can operate,” said <a href="https://ew.com/six-flags-magic-mountain-x2-roller-coaster-alleged-brain-injury-12136911" target="_blank">Entertainment Weekly</a>. Every ride at a Six Flags park “undergoes extensive inspection and maintenance procedures designed to meet or exceed manufacturer requirements and industry standards,” according to the company’s <a href="https://www.sixflags.com/blog/ride-safety-at-six-flags" target="_blank">safety statement</a>. They are “designed with sophisticated control systems, advanced restraint technologies, redundant safety features and multiple layers of monitoring.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/law/six-flags-is-in-hot-water-over-100-alleged-brain-injuries</link>
                                                                            <description>
                            <![CDATA[ The supposed injuries all happened in the last two years ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">i9yHprRj5idX7DrwNT6HCb</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/GgzKXkEFUzFJS59puddPjC-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 25 Sep 2026 19:09:23 +0000</pubDate>                                                                                                                                <updated>Fri, 25 Sep 2026 22:15:16 +0000</updated>
                                                                                                                                            <category><![CDATA[Law]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/GgzKXkEFUzFJS59puddPjC-1920-80.jpg">
                                                            <media:credit><![CDATA[Justin Sullivan / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A general view of Six Flags Magic Mountain, which may have operated a ‘defectively designed ride’]]></media:description>                                                            <media:text><![CDATA[A general view of Six Flags Magic Mountain in Southern California.]]></media:text>
                                <media:title type="plain"><![CDATA[A general view of Six Flags Magic Mountain in Southern California.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/GgzKXkEFUzFJS59puddPjC-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Six Flags Magic Mountain is one of the most popular amusement parks in the United States, but its flagship attraction and most popular ride, the X2 roller coaster, has come under fire for possibly causing more than eight dozen severe brain injuries in the past two years. Now, a series of lawsuits has put the future of the ride in jeopardy.</p><h2 id="what-are-these-lawsuits-about">What are these lawsuits about?</h2><p>The three lawsuits represent more than 100 clients who reportedly received brain injuries while riding <a href="https://theweek.com/world-news/why-an-infamous-california-rollercoaster-has-closed">Magic Mountain’s X2</a>. The ride, which has been operating since 2002 at the Los Angeles County <a href="https://theweek.com/culture-life/travel/worlds-best-water-parks">amusement park</a>, has “seats that rotate independently as the train travels along the track, spinning riders as much as 360 degrees,” said <a href="https://www.nytimes.com/2026/09/23/us/six-flags-x2-roller-coaster-injuries.html" target="_blank">The New York Times</a>, sending “riders through dives, flips and twists.” The 200-foot-high attraction can reach speeds of up to 76 miles per hour.</p><p>The lawsuits accuse Six Flags and Magic Mountain of knowingly operating a “defectively designed ride and failing to adequately warn passengers about the risk of serious brain injuries,” said the Times. The allegations come less than a month after a <a href="https://www.cnn.com/six-flags-rollercoaster-brain-injuries-invs" target="_blank">CNN investigation</a> documented numerous instances of injuries on the ride. Two of the lawsuits represent people featured in the investigation, including a pair of riders who “both fell unconscious after getting off the roller coaster and underwent emergency brain surgery for severe traumatic brain injuries,” said CNN.</p><p>Attorneys are “actively investigating these incidents and representing individuals who allege they suffered traumatic brain injuries after riding X2,” Dordick Law Corporation, which filed the three lawsuits, said in a <a href="https://www.dordicklaw.com/southern-california-personal-injury/traumatic-brain-injury/magic-mountain-x2-roller-coaster/" target="_blank">statement</a>. The lawsuit also references a 22-year-old man who “died from a traumatic brain injury after riding X2 four years ago,” said CNN, with Six Flags later reaching a settlement with his family. The outlet also claims it heard from people who “had injuries that were not brain-related or did not have proof of medical treatment.”</p><h2 id="what-comes-next">What comes next? </h2><p>X2 has supposedly been closed since July 12, which was “nearly a full day after the latest injury there, and park officials have remained silent about what necessitated the closure,” said CNN. Six Flags’ <a href="https://www.sixflags.com/magicmountain/scheduled-ride-closures" target="_blank">website</a> still lists the ride as closed, with no timeline listed for its reopening. The company has denied that it was negligent; in court filings related to a different X2 case, Six Flags “said testing showed that the ride operated within accepted acceleration limits and argued that the rider’s injury, a brain bleed, was instead caused by a preexisting condition,” said the Times. </p><p>But lawyers for the alleged injured riders are not backing down. “We want transparency. We want the public to know about the dangers of riding these rollercoasters, and in particular, X2,” attorney Gary Dordick said during a press conference. Magic Mountain “seems to think that it’s okay that if people voluntarily choose to ride a roller coaster, then they’ve assumed the risk.” Ultimately, the “fate of X2 remains unknown, as Six Flags officials remain tight-lipped on the attraction’s future,” said <a href="https://ktla.com/news/local-news/lawsuits-filed-alleging-catastrophic-brain-injuries-from-x2-rollercoaster/" target="_blank">KTLA-5</a>.</p><p>Despite the injuries, <a href="https://theweek.com/united-states/1024748/is-it-safe-to-ride-a-roller-coaster">U.S. amusement parks</a> “typically have high safety standards, with many requiring daily inspections of roller coasters and other attractions before they can operate,” said <a href="https://ew.com/six-flags-magic-mountain-x2-roller-coaster-alleged-brain-injury-12136911" target="_blank">Entertainment Weekly</a>. Every ride at a Six Flags park “undergoes extensive inspection and maintenance procedures designed to meet or exceed manufacturer requirements and industry standards,” according to the company’s <a href="https://www.sixflags.com/blog/ride-safety-at-six-flags" target="_blank">safety statement</a>. They are “designed with sophisticated control systems, advanced restraint technologies, redundant safety features and multiple layers of monitoring.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ‘Other so-called improvements might even backfire’ ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="advice-for-parents-who-want-to-prevent-cte-in-youth-athletes">‘Advice for parents who want to prevent CTE in youth athletes’</h2><p><strong>Leana S. Wen at The Washington Post</strong></p><p>Nobody “disputed that CTE is a serious issue, but many seemed to think that young athletes today are at lower risk than previous generations because of better safety precautions,” says Leana S. Wen. The “majority of head impacts that can cause brain damage do not result in a concussion diagnosis but can still contribute to CTE.” Most “important is taking repetitive head impacts out of the game for kids, including no bodychecking in ice hockey and no tackling in football.”</p><p><a href="https://www.washingtonpost.com/opinions/2026/09/24/how-protect-youth-athletes-cte-here-some-advice/" target="_blank"><em>Read more</em></a></p><h2 id="what-peacemaking-loses-when-women-are-left-out">‘What peacemaking loses when women are left out’</h2><p><strong>Cristal Downing at Time</strong></p><p>Wars “exact a heavy toll on women and yet, too often their voices and concerns are pushed to the margins of global peacemaking,” says Cristal Downing. The United Nations “has made halting but real progress in bringing women into peace negotiations and postwar reconstruction from Guatemala to Bangsamoro,” but “now that progress is being reversed.” Finding “space for gender diversity could do more than ensure that women are heard; it could also give peace efforts a better chance of success.”</p><p><a href="https://time.com/article/2026/09/25/peacemaking-united-nations-sudan-syria-gaza-women/" target="_blank"><em>Read more</em></a></p><h2 id="how-private-equity-is-killing-public-access-to-hospitals-and-emergency-care">‘How private equity is killing public access to hospitals and emergency care’</h2><p><strong>Heather Prendergast at The Hill</strong></p><p>Safety-net hospitals “serve a patient population that is disproportionately low-income, publicly insured and racially and ethnically diverse,” says Heather Prendergast. The “corporatization of the healthcare system by private equity has come with significant costs.” While “private equity’s ownership of hospitals may earn millions for their investors, they have put patients, communities and providers at risk.” It is “worth asking what happens to the remaining safety-net hospitals once their primary funding source shrinks even further.”</p><p><a href="https://thehill.com/opinion/healthcare/6109266-private-equity-hospital-closures/" target="_blank"><em>Read more</em></a></p><h2 id="trump-abuses-his-pardon-power-getting-rid-of-it-would-be-a-mistake">‘Trump abuses his pardon power. Getting rid of it would be a mistake.’</h2><p><strong>Abdallah Fayyad at The Boston Globe</strong></p><p>Donald Trump’s “liberal use of his pardon power — particularly his penchant for pardoning wealthy white-collar fraudsters — has created a lucrative industry of so-called pardon brokers,” says Abdallah Fayyad. But “even though the pardon power has undeniably been misused, we shouldn’t dramatically curtail it or get rid of it.” Pardons are a “crucial component of a well-functioning criminal justice system, allowing presidents to undo wrongs when sentences are unjust or punishments are too harsh.”</p><p><a href="https://www.bostonglobe.com/2026/09/25/opinion/donald-trump-pardon-biden-carter/?event=event12" target="_blank"><em>Read more</em></a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/instant-opinion-football-cte-health-peacemaking-doctors-trump</link>
                                                                            <description>
                            <![CDATA[ Opinion, comment and editorials of the day ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">XrNif5hn5jrQoKRWsrtMiH</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/QUVMaCAtnG4nvYXawCb4pg-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 25 Sep 2026 17:45:21 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/QUVMaCAtnG4nvYXawCb4pg-1920-80.jpg">
                                                            <media:credit><![CDATA[Steve Nurenberg / Fort Worth Star-Telegram / Tribune News Service / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Most ‘important is taking repetitive head impacts out of the game’]]></media:description>                                                            <media:text><![CDATA[Kids play football in Texas. ]]></media:text>
                                <media:title type="plain"><![CDATA[Kids play football in Texas. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/QUVMaCAtnG4nvYXawCb4pg-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="advice-for-parents-who-want-to-prevent-cte-in-youth-athletes">‘Advice for parents who want to prevent CTE in youth athletes’</h2><p><strong>Leana S. Wen at The Washington Post</strong></p><p>Nobody “disputed that CTE is a serious issue, but many seemed to think that young athletes today are at lower risk than previous generations because of better safety precautions,” says Leana S. Wen. The “majority of head impacts that can cause brain damage do not result in a concussion diagnosis but can still contribute to CTE.” Most “important is taking repetitive head impacts out of the game for kids, including no bodychecking in ice hockey and no tackling in football.”</p><p><a href="https://www.washingtonpost.com/opinions/2026/09/24/how-protect-youth-athletes-cte-here-some-advice/" target="_blank"><em>Read more</em></a></p><h2 id="what-peacemaking-loses-when-women-are-left-out">‘What peacemaking loses when women are left out’</h2><p><strong>Cristal Downing at Time</strong></p><p>Wars “exact a heavy toll on women and yet, too often their voices and concerns are pushed to the margins of global peacemaking,” says Cristal Downing. The United Nations “has made halting but real progress in bringing women into peace negotiations and postwar reconstruction from Guatemala to Bangsamoro,” but “now that progress is being reversed.” Finding “space for gender diversity could do more than ensure that women are heard; it could also give peace efforts a better chance of success.”</p><p><a href="https://time.com/article/2026/09/25/peacemaking-united-nations-sudan-syria-gaza-women/" target="_blank"><em>Read more</em></a></p><h2 id="how-private-equity-is-killing-public-access-to-hospitals-and-emergency-care">‘How private equity is killing public access to hospitals and emergency care’</h2><p><strong>Heather Prendergast at The Hill</strong></p><p>Safety-net hospitals “serve a patient population that is disproportionately low-income, publicly insured and racially and ethnically diverse,” says Heather Prendergast. The “corporatization of the healthcare system by private equity has come with significant costs.” While “private equity’s ownership of hospitals may earn millions for their investors, they have put patients, communities and providers at risk.” It is “worth asking what happens to the remaining safety-net hospitals once their primary funding source shrinks even further.”</p><p><a href="https://thehill.com/opinion/healthcare/6109266-private-equity-hospital-closures/" target="_blank"><em>Read more</em></a></p><h2 id="trump-abuses-his-pardon-power-getting-rid-of-it-would-be-a-mistake">‘Trump abuses his pardon power. Getting rid of it would be a mistake.’</h2><p><strong>Abdallah Fayyad at The Boston Globe</strong></p><p>Donald Trump’s “liberal use of his pardon power — particularly his penchant for pardoning wealthy white-collar fraudsters — has created a lucrative industry of so-called pardon brokers,” says Abdallah Fayyad. But “even though the pardon power has undeniably been misused, we shouldn’t dramatically curtail it or get rid of it.” Pardons are a “crucial component of a well-functioning criminal justice system, allowing presidents to undo wrongs when sentences are unjust or punishments are too harsh.”</p><p><a href="https://www.bostonglobe.com/2026/09/25/opinion/donald-trump-pardon-biden-carter/?event=event12" target="_blank"><em>Read more</em></a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ GLP-1 use is on the rise in obese children under 12 ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Off-label prescriptions for GLP-1 drugs are on the rise among children under 12, despite a lack of FDA approval in this age group. While most of the kids given the treatment had severe obesity and comorbidities, doctors and parents also seem to be considering weight-loss drugs much earlier. Whether or not it is safe to do so remains unclear.</p><h2 id="how-common-is-glp-1-use-among-young-children">How common is GLP-1 use among young children?</h2><p>The <a href="https://www.aap.org/en/news-room/news-releases/aap/2023/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/#:~:text=Comprehensive%20obesity%20treatment%20may%20include%20nutrition%20support%2C%20physical%20activity%20treatment%2C%20behavioral%20therapy%2C%20pharmacotherapy%2C%20and%20metabolic%20and%20bariatric%20surgery.">American Academy of Pediatrics</a> began recommending GLP-1 therapy for childhood obesity in 2023. Although the number of children under age 12 with obesity being prescribed weight loss drugs like Wegovy and Zepbound remains low compared to the rest of the population, the rise in incidences is striking. </p><p>Prescriptions for GLP-1 receptor agonists among children ages 8 to 11 with obesity increased dramatically between 2019 and 2026, according to a study published in the journal <a href="https://publications.aap.org/pediatrics/article-abstract/doi/10.1542/peds.2026-077048/208779/Trends-in-GLP-1-Receptor-Agonist-Prescriptions-for?redirectedFrom=fulltext?autologincheck=redirected" target="_blank">Pediatrics</a>. Annual prescriptions rose from 0.03% in 2019 to 9.3% in 2026, a “310-fold increase,” said <a href="https://www.forbes.com/sites/victoriaforster/2026/09/21/glp-1-prescriptions-are-rising-among-young-children-what-parents-should-know/" target="_blank">Forbes</a>. </p><p>The study offers the “first national overview in young children” showing “absolute numbers” of children under the age of 12 “receiving GLP-1 treatment,” lead investigator and obesity medicine specialist Babak Orandi said in a statement to <a href="https://nyulangone.org/news/glp-1-use-among-young-children-obesity-us-remains-rare-rising-rapidly" target="_blank">NYU Langone</a>. The “careful use of GLP-1s” remains a “valuable tool in confronting the obesity epidemic among young Americans.” </p><p>Young children with obesity who lived in upper-income communities were 55% more likely to be prescribed GLP-1 medications than those who did not. Physicians and policymakers have a responsibility to ensure that “all young children with obesity who need these drugs have access to them,” study co-author Allan Massie said.</p><h2 id="is-it-dangerous-for-kids-to-take-glp-1s">Is it dangerous for kids to take GLP-1s?</h2><p>It is important to note that “GLP-1 medications aren’t entirely untested in younger children,” with some encouraging evidence available for some drugs, said Forbes. There is “strong data” that daily <a href="https://www.nejm.org/doi/10.1056/NEJMoa2407379" target="_blank">liraglutide</a> is “safe and effective for children aged 6 to 11 with obesity,” Sarah Armstrong, co-director of the Duke University Center for Childhood Obesity Research, said to Forbes. </p><p>Still, the growing trend of <a href="https://www.theweek.com/culture-life/books/fun-absorbing-childrens-books-for-summer">children</a> using <a href="https://www.theweek.com/environment/glp-1s-environment-pollution">GLP-1</a> medications isn’t “completely without its risks,” said <a href="https://gizmodo.com/nearly-1-in-6-kids-on-glp-1s-developed-this-problem-within-a-year-2000815568" target="_blank">Gizmodo</a>. Nearly one in six children and teens who go on a GLP-1 become diagnosed with a nutritional deficiency, according to a recent study published last week in the journal <a href="https://journals.sagepub.com/doi/10.1177/21532176261486979'" target="_blank">Childhood Obesity.</a> This is only an observational study, meaning that the “researchers can’t conclusively prove that the children’s GLP-1 use contributed to their later deficiencies,” Gizmodo said. </p><p>The results suggest doctors should be keeping a closer eye on the nutritional health of kids prescribed these treatments, the researchers said. Nutritional deficiencies are a “meaningful and underrecognized risk among pediatric patients" receiving GLP-1 therapy, the authors said in their paper.</p><p>Hopefully the findings bring “much-needed recognition” to the importance of “proactive nutritional management when GLP-1s are prescribed to children,” as opposed to “waiting until a nutritional deficiency is diagnosed,” said Justin Ryder, a study co-author and a surgeon at Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, in a <a href="https://medicalxpress.com/news/2026-09-glp-1s-linked-nutritional-deficiencies.html" target="_blank">statement</a> from the hospital. Knowing the risks, “we are in a much better position” to prevent harm to “children treated with GLP-1s during a pivotal period.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/glp-1-use-is-on-the-rise-in-obese-children-under-12</link>
                                                                            <description>
                            <![CDATA[ The FDA hasn’t approved the weight loss drugs for that age range, but the numbers are climbing quickly ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">4SDPgTzhFk8prruR5vFD2f</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Ya7nJZbfAYmxPBxkWfpEsK-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 24 Sep 2026 19:43:20 +0000</pubDate>                                                                                                                                <updated>Wed, 30 Sep 2026 20:37:50 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Ya7nJZbfAYmxPBxkWfpEsK-1920-80.jpg">
                                                            <media:credit><![CDATA[Peter Dazeley / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Doctors are dabbling in weight loss shots for extreme cases of childhood obesity]]></media:description>                                                            <media:text><![CDATA[Obese child measuring herself]]></media:text>
                                <media:title type="plain"><![CDATA[Obese child measuring herself]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Ya7nJZbfAYmxPBxkWfpEsK-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Off-label prescriptions for GLP-1 drugs are on the rise among children under 12, despite a lack of FDA approval in this age group. While most of the kids given the treatment had severe obesity and comorbidities, doctors and parents also seem to be considering weight-loss drugs much earlier. Whether or not it is safe to do so remains unclear.</p><h2 id="how-common-is-glp-1-use-among-young-children">How common is GLP-1 use among young children?</h2><p>The <a href="https://www.aap.org/en/news-room/news-releases/aap/2023/american-academy-of-pediatrics-issues-its-first-comprehensive-guideline-on-evaluating-treating-children-and-adolescents-with-obesity/#:~:text=Comprehensive%20obesity%20treatment%20may%20include%20nutrition%20support%2C%20physical%20activity%20treatment%2C%20behavioral%20therapy%2C%20pharmacotherapy%2C%20and%20metabolic%20and%20bariatric%20surgery.">American Academy of Pediatrics</a> began recommending GLP-1 therapy for childhood obesity in 2023. Although the number of children under age 12 with obesity being prescribed weight loss drugs like Wegovy and Zepbound remains low compared to the rest of the population, the rise in incidences is striking. </p><p>Prescriptions for GLP-1 receptor agonists among children ages 8 to 11 with obesity increased dramatically between 2019 and 2026, according to a study published in the journal <a href="https://publications.aap.org/pediatrics/article-abstract/doi/10.1542/peds.2026-077048/208779/Trends-in-GLP-1-Receptor-Agonist-Prescriptions-for?redirectedFrom=fulltext?autologincheck=redirected" target="_blank">Pediatrics</a>. Annual prescriptions rose from 0.03% in 2019 to 9.3% in 2026, a “310-fold increase,” said <a href="https://www.forbes.com/sites/victoriaforster/2026/09/21/glp-1-prescriptions-are-rising-among-young-children-what-parents-should-know/" target="_blank">Forbes</a>. </p><p>The study offers the “first national overview in young children” showing “absolute numbers” of children under the age of 12 “receiving GLP-1 treatment,” lead investigator and obesity medicine specialist Babak Orandi said in a statement to <a href="https://nyulangone.org/news/glp-1-use-among-young-children-obesity-us-remains-rare-rising-rapidly" target="_blank">NYU Langone</a>. The “careful use of GLP-1s” remains a “valuable tool in confronting the obesity epidemic among young Americans.” </p><p>Young children with obesity who lived in upper-income communities were 55% more likely to be prescribed GLP-1 medications than those who did not. Physicians and policymakers have a responsibility to ensure that “all young children with obesity who need these drugs have access to them,” study co-author Allan Massie said.</p><h2 id="is-it-dangerous-for-kids-to-take-glp-1s">Is it dangerous for kids to take GLP-1s?</h2><p>It is important to note that “GLP-1 medications aren’t entirely untested in younger children,” with some encouraging evidence available for some drugs, said Forbes. There is “strong data” that daily <a href="https://www.nejm.org/doi/10.1056/NEJMoa2407379" target="_blank">liraglutide</a> is “safe and effective for children aged 6 to 11 with obesity,” Sarah Armstrong, co-director of the Duke University Center for Childhood Obesity Research, said to Forbes. </p><p>Still, the growing trend of <a href="https://www.theweek.com/culture-life/books/fun-absorbing-childrens-books-for-summer">children</a> using <a href="https://www.theweek.com/environment/glp-1s-environment-pollution">GLP-1</a> medications isn’t “completely without its risks,” said <a href="https://gizmodo.com/nearly-1-in-6-kids-on-glp-1s-developed-this-problem-within-a-year-2000815568" target="_blank">Gizmodo</a>. Nearly one in six children and teens who go on a GLP-1 become diagnosed with a nutritional deficiency, according to a recent study published last week in the journal <a href="https://journals.sagepub.com/doi/10.1177/21532176261486979'" target="_blank">Childhood Obesity.</a> This is only an observational study, meaning that the “researchers can’t conclusively prove that the children’s GLP-1 use contributed to their later deficiencies,” Gizmodo said. </p><p>The results suggest doctors should be keeping a closer eye on the nutritional health of kids prescribed these treatments, the researchers said. Nutritional deficiencies are a “meaningful and underrecognized risk among pediatric patients" receiving GLP-1 therapy, the authors said in their paper.</p><p>Hopefully the findings bring “much-needed recognition” to the importance of “proactive nutritional management when GLP-1s are prescribed to children,” as opposed to “waiting until a nutritional deficiency is diagnosed,” said Justin Ryder, a study co-author and a surgeon at Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, in a <a href="https://medicalxpress.com/news/2026-09-glp-1s-linked-nutritional-deficiencies.html" target="_blank">statement</a> from the hospital. Knowing the risks, “we are in a much better position” to prevent harm to “children treated with GLP-1s during a pivotal period.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ FDA estrogen warning’s impact on menopausal UTI deaths ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Menopausal women spent years unable to get relief from the potentially deadly but often preventable effects of recurrent urinary tract infections, due to the FDA’s black box warning for estrogen products. Despite growing evidence supporting safety and efficacy, and the lifting of the warning, a lingering stigma is keeping women from life-saving care.</p><h2 id="grave-misinterpretation">Grave ‘misinterpretation’</h2><p><a href="https://www.theweek.com/health/the-menopause-gold-rush">Menopause</a> increases the risk of UTIs because “declining estrogen changes the tissue and bacteria of the vagina and urinary tract,” making it “easier for harmful bacteria to grow,” said <a href="https://www.usatoday.com/story/life/health-wellness/2026/09/22/menopause-uti-vaginal-estrogen-sepsis/91680008007/" target="_blank">USA Today</a>. For menopausal women, those infections are also “more likely to spread to the bloodstream,” causing “sepsis, organ failure and death.” </p><p>For years, major medical groups have recommended a low dose of vaginal <a href="https://www.theweek.com/health/women-hormonal-health-allergy-drugs-antacids-tiktok-trend">estrogen</a> to help “prevent recurrent infections” in menopausal women, said USA Today. The cream, tablet or ring can “cost as little as a few dollars a month.” Unfortunately, for nearly two decades, access was limited by the government.</p><p>A set of Women’s Health Initiative (WHI) trials, launched in 1991, suggested that some forms of hormone therapy that included estrogen and progesterone could “increase the risks of cardiovascular problems, breast cancer, endometrial cancer and possibly dementia,” said <a href="https://www.health.harvard.edu/womens-health/fda-removes-menopause-hormone-therapy-black-box-warnings" target="_blank">Harvard Medical School</a>. A “misinterpretation” in 2002 of that landmark research study prompted the FDA to “slap its strongest warning” on all estrogen products, including “low-dose vaginal estrogen” that was never studied in the associated trial, said USA Today. Shortly after, the FDA implemented a black-box warning, its “strongest available measure short of removing a drug from the market,” on all menopause treatments containing estrogen.</p><p>The stringent label “scared doctors” from prescribing medications their “patients desperately needed,” pushed women off treatment and “contributed to decades of missed opportunities” to prevent “serious menopause-related health problems for two generations of women,” said USA Today. Even when groups like the Menopause Society suggested in 2004 that “hormone replacement therapy, including vaginal estrogen, could be used for serious menopause symptoms,” the FDA black-box warning “kept most women from using it.” Many years later, researchers would say the study “overstated the risk of cancer for younger menopausal women,” leading to the FDA removing the black box warning in November 2025. </p><h2 id="deadly-uti-s-still-plague-menopausal-women">Deadly UTI’s still plague menopausal women</h2><p>Nearly a year has passed since the warning was removed from vaginal estrogen and other estrogen products. But the treatment’s “use still isn’t widespread,” likely due to ongoing stigma, said USA Today. </p><p>The first <a href="https://www.theweek.com/culture-life/personal-technology/are-boomers-the-real-phone-addicts">Baby Boomers</a> “turned 54 in 2000,” and estrogen use plummeted from “27% of menopausal women in 1999 to 5% in 2020,” according to the National Institutes of Health, said USA Today. During a similar period, between 1999 and 2023, women’s deaths from “sepsis stemming from UTIs” nearly tripled for women 45 to 64, according to a USA Today analysis of CDC data included in the June 2026 edition of the<a href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71110?utm_medium=article&amp;utm_source=researchgate.net" target="_blank"> International Journal of Gynecology and Obstetrics</a>. </p><p>This was more than “women simply suffering from hot flashes because they weren’t prescribed estrogen,” said Rachel Rubin, a urologist and menopause specialist, to USA Today. “They were dying.” </p><p>Vaginal estrogen has been shown to be an effective treatment for menopausal women with frequent UTIs. In a recent study published in the Urology Journal of nearly 2 million women with recurrent UTIs, “women 55 and older who were prescribed vaginal estrogen were about half as likely to be hospitalized with a UTI as those who were not,” said USA Today. Their recorded rates of sepsis and death were “roughly one-fifth as high.” </p><p>Despite that evidence, “only about 1 in 10 menopausal women covered by Medicare use vaginal estrogen,” according to records reviewed by USA Today. Unlike menopause hormone therapy, which is “widely prescribed,” vaginal estrogen suffers from a “public relations problem,” said <a href="https://www.cidrap.umn.edu/antimicrobial-stewardship/women-don-t-have-live-pain-vaginal-estrogen-menopause-could-reduce-utis" target="_blank">The Center for Infectious Disease Research and Policy</a>, with “few women knowing what it is.” </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/the-fdas-estrogen-warning-had-a-blind-spot-menopausal-women-dying-from-utis</link>
                                                                            <description>
                            <![CDATA[ The black-label warning may be gone, but the stigma still endangers older women ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">9HZStc5VevvpHXoZCGvYe7</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/VwT7V8tRZ5YLMZ6cnBvWyA-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 24 Sep 2026 06:00:00 +0000</pubDate>                                                                                                                                <updated>Tue, 06 Oct 2026 21:42:14 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/VwT7V8tRZ5YLMZ6cnBvWyA-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[While recurrent UTIs can be deadly for older women, hormone therapy is an easy fix]]></media:description>                                                            <media:text><![CDATA[Photo collage of an x-ray image of the urinary system, a hand holding a month&#039;s worth of HRT pills, and mourners attending a funeral]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of an x-ray image of the urinary system, a hand holding a month&#039;s worth of HRT pills, and mourners attending a funeral]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/VwT7V8tRZ5YLMZ6cnBvWyA-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Menopausal women spent years unable to get relief from the potentially deadly but often preventable effects of recurrent urinary tract infections, due to the FDA’s black box warning for estrogen products. Despite growing evidence supporting safety and efficacy, and the lifting of the warning, a lingering stigma is keeping women from life-saving care.</p><h2 id="grave-misinterpretation">Grave ‘misinterpretation’</h2><p><a href="https://www.theweek.com/health/the-menopause-gold-rush">Menopause</a> increases the risk of UTIs because “declining estrogen changes the tissue and bacteria of the vagina and urinary tract,” making it “easier for harmful bacteria to grow,” said <a href="https://www.usatoday.com/story/life/health-wellness/2026/09/22/menopause-uti-vaginal-estrogen-sepsis/91680008007/" target="_blank">USA Today</a>. For menopausal women, those infections are also “more likely to spread to the bloodstream,” causing “sepsis, organ failure and death.” </p><p>For years, major medical groups have recommended a low dose of vaginal <a href="https://www.theweek.com/health/women-hormonal-health-allergy-drugs-antacids-tiktok-trend">estrogen</a> to help “prevent recurrent infections” in menopausal women, said USA Today. The cream, tablet or ring can “cost as little as a few dollars a month.” Unfortunately, for nearly two decades, access was limited by the government.</p><p>A set of Women’s Health Initiative (WHI) trials, launched in 1991, suggested that some forms of hormone therapy that included estrogen and progesterone could “increase the risks of cardiovascular problems, breast cancer, endometrial cancer and possibly dementia,” said <a href="https://www.health.harvard.edu/womens-health/fda-removes-menopause-hormone-therapy-black-box-warnings" target="_blank">Harvard Medical School</a>. A “misinterpretation” in 2002 of that landmark research study prompted the FDA to “slap its strongest warning” on all estrogen products, including “low-dose vaginal estrogen” that was never studied in the associated trial, said USA Today. Shortly after, the FDA implemented a black-box warning, its “strongest available measure short of removing a drug from the market,” on all menopause treatments containing estrogen.</p><p>The stringent label “scared doctors” from prescribing medications their “patients desperately needed,” pushed women off treatment and “contributed to decades of missed opportunities” to prevent “serious menopause-related health problems for two generations of women,” said USA Today. Even when groups like the Menopause Society suggested in 2004 that “hormone replacement therapy, including vaginal estrogen, could be used for serious menopause symptoms,” the FDA black-box warning “kept most women from using it.” Many years later, researchers would say the study “overstated the risk of cancer for younger menopausal women,” leading to the FDA removing the black box warning in November 2025. </p><h2 id="deadly-uti-s-still-plague-menopausal-women">Deadly UTI’s still plague menopausal women</h2><p>Nearly a year has passed since the warning was removed from vaginal estrogen and other estrogen products. But the treatment’s “use still isn’t widespread,” likely due to ongoing stigma, said USA Today. </p><p>The first <a href="https://www.theweek.com/culture-life/personal-technology/are-boomers-the-real-phone-addicts">Baby Boomers</a> “turned 54 in 2000,” and estrogen use plummeted from “27% of menopausal women in 1999 to 5% in 2020,” according to the National Institutes of Health, said USA Today. During a similar period, between 1999 and 2023, women’s deaths from “sepsis stemming from UTIs” nearly tripled for women 45 to 64, according to a USA Today analysis of CDC data included in the June 2026 edition of the<a href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.71110?utm_medium=article&amp;utm_source=researchgate.net" target="_blank"> International Journal of Gynecology and Obstetrics</a>. </p><p>This was more than “women simply suffering from hot flashes because they weren’t prescribed estrogen,” said Rachel Rubin, a urologist and menopause specialist, to USA Today. “They were dying.” </p><p>Vaginal estrogen has been shown to be an effective treatment for menopausal women with frequent UTIs. In a recent study published in the Urology Journal of nearly 2 million women with recurrent UTIs, “women 55 and older who were prescribed vaginal estrogen were about half as likely to be hospitalized with a UTI as those who were not,” said USA Today. Their recorded rates of sepsis and death were “roughly one-fifth as high.” </p><p>Despite that evidence, “only about 1 in 10 menopausal women covered by Medicare use vaginal estrogen,” according to records reviewed by USA Today. Unlike menopause hormone therapy, which is “widely prescribed,” vaginal estrogen suffers from a “public relations problem,” said <a href="https://www.cidrap.umn.edu/antimicrobial-stewardship/women-don-t-have-live-pain-vaginal-estrogen-menopause-could-reduce-utis" target="_blank">The Center for Infectious Disease Research and Policy</a>, with “few women knowing what it is.” </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ White House ousts 760K from ACA, claiming fraud ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened">What happened</h2><p>The Trump administration on Tuesday said it had kicked 760,000 enrollees off the Affordable Care Act insurance marketplace. Vice President JD Vance told a <a href="https://www.youtube.com/watch?v=sl9NSZTvRSU" target="_blank">press conference</a> that the canceled enrollees were a mix of “phantom people” and “real people who just don’t meet the eligibility requirements,” didn’t submit the proper documents or <a href="https://theweek.com/politics/obamacare-survive-dropping-enrollment">weren’t even aware they were enrolled</a> in an ACA health plan. </p><h2 id="who-said-what">Who said what</h2><p>Tuesday’s announcement by the Vance-led anti-fraud task force “represents one of the largest administrative purges targeting individual insurance exchanges” since the administration’s “crackdown on fraud began last year,” <a href="https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7" target="_blank">The Wall Street Journal</a> said. There’s “widespread agreement that unauthorized enrollments should be canceled,” ACA expert Cynthia Cox at KFF said to <a href="https://www.nytimes.com/2026/09/22/health/aca-obamacare-vance-fraud.html" target="_blank">The New York Times</a>, but it’s not clear that “these were all indeed unauthorized enrollments,” and Vance’s panel didn’t appear to use the “appropriate process” to <a href="https://theweek.com/politics/house-approves-aca-credits-gop">determine which to cancel</a>. </p><h2 id="what-next-2">What next? </h2><p>Vance said his anti-fraud effort, including further scrutiny of up to 450,000 more enrollees and bans on about 600 ACA brokers, would <a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">save $2.2 billion</a>. The “price of ACA insurance has skyrocketed” during Trump’s second term, prompting “millions to downgrade their plans or exit the program entirely,” <a href="https://www.npr.org/2026/09/23/g-s1-144623/trump-affordable-care-act" target="_blank">The Associated Press</a> said. “Early filings from insurers suggest that prices will increase substantially again next year,” the Times said.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/white-house-ousts-760k-aca-fraud</link>
                                                                            <description>
                            <![CDATA[ Vice President JD Vance said those removed were “phantom people” and “real people who just don’t meet the eligibility requirements” ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Ujyo5s2QzdouERdMw95EyJ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/7fZz68zKXAuHTPjAhqdcHM-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 23 Sep 2026 14:51:52 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Rafi Schwartz, The Week US) ]]></author>                    <dc:creator><![CDATA[ Rafi Schwartz, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/GMjxXiVgZLL2zyycd6jVxU-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion&#039;s news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi&#039;s work has appeared in Rolling Stone, GOOD and The Forward, among others. He is a graduate of the University of Wisconsin, Madison, with a major in religious studies, and a minor in integrated liberal studies.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Rafi lives in the Twin Cities, where he does not bike, run or take part in any team sports. He does, however, have a variety of interests, hobbies and passions.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/7fZz68zKXAuHTPjAhqdcHM-1920-80.jpg">
                                                            <media:credit><![CDATA[Andrew Harnik / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Vice President JD Vance holds news conference on fraud]]></media:description>                                                            <media:text><![CDATA[Vice President JD Vance Holds News Conference On FraudWASHINGTON, DC - SEPTEMBER 22: Vice President J.D. Vance (C), accompanied by Administrator for the Centers for Medicare &amp; Medicaid Services Dr. Mehmet Oz (L), and Federal Trade Commission (FTC) Chair Andrew Ferguson (R), smiles during a news conference on fraud at the Eisenhower Executive Office Building on the White House Campus on September 22, 2026 in Washington, DC. Vance announced a federal crackdown on Affordable Care Act fraud, removing over 750,000 allegedly ineligible enrollments and banning hundreds of suspect brokers to save taxpayers an estimated $2.2 billion. (Photo by Andrew Harnik/Getty Images)]]></media:text>
                                <media:title type="plain"><![CDATA[Vice President JD Vance Holds News Conference On FraudWASHINGTON, DC - SEPTEMBER 22: Vice President J.D. Vance (C), accompanied by Administrator for the Centers for Medicare &amp; Medicaid Services Dr. Mehmet Oz (L), and Federal Trade Commission (FTC) Chair Andrew Ferguson (R), smiles during a news conference on fraud at the Eisenhower Executive Office Building on the White House Campus on September 22, 2026 in Washington, DC. Vance announced a federal crackdown on Affordable Care Act fraud, removing over 750,000 allegedly ineligible enrollments and banning hundreds of suspect brokers to save taxpayers an estimated $2.2 billion. (Photo by Andrew Harnik/Getty Images)]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/7fZz68zKXAuHTPjAhqdcHM-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened">What happened</h2><p>The Trump administration on Tuesday said it had kicked 760,000 enrollees off the Affordable Care Act insurance marketplace. Vice President JD Vance told a <a href="https://www.youtube.com/watch?v=sl9NSZTvRSU" target="_blank">press conference</a> that the canceled enrollees were a mix of “phantom people” and “real people who just don’t meet the eligibility requirements,” didn’t submit the proper documents or <a href="https://theweek.com/politics/obamacare-survive-dropping-enrollment">weren’t even aware they were enrolled</a> in an ACA health plan. </p><h2 id="who-said-what">Who said what</h2><p>Tuesday’s announcement by the Vance-led anti-fraud task force “represents one of the largest administrative purges targeting individual insurance exchanges” since the administration’s “crackdown on fraud began last year,” <a href="https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7" target="_blank">The Wall Street Journal</a> said. There’s “widespread agreement that unauthorized enrollments should be canceled,” ACA expert Cynthia Cox at KFF said to <a href="https://www.nytimes.com/2026/09/22/health/aca-obamacare-vance-fraud.html" target="_blank">The New York Times</a>, but it’s not clear that “these were all indeed unauthorized enrollments,” and Vance’s panel didn’t appear to use the “appropriate process” to <a href="https://theweek.com/politics/house-approves-aca-credits-gop">determine which to cancel</a>. </p><h2 id="what-next-2">What next? </h2><p>Vance said his anti-fraud effort, including further scrutiny of up to 450,000 more enrollees and bans on about 600 ACA brokers, would <a href="https://theweek.com/business/health-insurance-premiums-soar-aca-subsidies-end">save $2.2 billion</a>. The “price of ACA insurance has skyrocketed” during Trump’s second term, prompting “millions to downgrade their plans or exit the program entirely,” <a href="https://www.npr.org/2026/09/23/g-s1-144623/trump-affordable-care-act" target="_blank">The Associated Press</a> said. “Early filings from insurers suggest that prices will increase substantially again next year,” the Times said.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ‘This power is entirely inward-facing’ ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="in-the-land-of-billionaire-barbarians">‘In the land of billionaire barbarians’</h2><p><strong>Arielle Pardes at The New York Times</strong></p><p>Silicon Valley is “home to four of the most powerful companies in the world,” yet “by looking at it, you’d hardly know this place had any influence,” says Arielle Pardes. Tech billionaires have “donated generously to scientific research and global health initiatives, but little of their money goes to improving their own backyard.” The “lack of investment in the cities where our tech lords work and live reveals a stark reality about how this wealth benefits a select few.”</p><p><a href="https://www.nytimes.com/2026/09/21/opinion/silicon-valley-culture-wasteland.html" target="_blank"><em>Read more</em></a></p><h2 id="should-the-classroom-be-more-like-the-gym">‘Should the classroom be more like the gym?’</h2><p><strong>Dan Rockmore at The New Yorker</strong></p><p>The “body offers something that the mind — at least in a traditional classroom — rarely does: clear, immediate loops linking effort and result,” says Dan Rockmore. In the “gym, we can steadily feel ourselves getting stronger,” but in the “classroom, progress can be difficult to see.” This “clarifies our real responsibilities: drawing out the quiet student, asking the question nobody thought to ask, forging a community of mind and friendship from the struggles of a classroom.”</p><p><a href="https://www.newyorker.com/culture/the-weekend-essay/should-the-classroom-be-more-like-the-gym" target="_blank"><em>Read more</em></a></p><h2 id="the-people-ok-the-men-who-still-love-bitcoin">‘The people — OK, the men — who still love Bitcoin’</h2><p><strong>Nathaniel Moore at Slate</strong></p><p>Among a “predominantly male crowd,” Bitcoin and “other cryptocurrencies offer an appealing alternative because they are not issued or managed by a central bank,” says Nathaniel Moore. The “concept of financial freedom — not having to trust anyone else — is the logical endpoint of the belief that the systems of American life cannot be mended, only circumvented.” Investors are “following the example set by those at the top: looking out for themselves and trying to swell their own stash.”</p><p><a href="https://slate.com/business/2026/09/bitcoin-cryptocurrency-masculinity-economy-emotional-tether.html" target="_blank"><em>Read more</em></a></p><h2 id="the-first-mrna-flu-vaccine-may-be-just-the-beginning">‘The first mRNA flu vaccine may be just the beginning’</h2><p><strong>Sally C. Pipes at the Chicago Tribune</strong></p><p>“Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it,” says Sally C. Pipes. Since “mRNA vaccines can be produced faster than conventional shots, manufacturers may eventually be able to wait longer before deciding which strains to target — and respond faster if circulating strains change.” During the “pandemic, mRNA became almost synonymous with Covid-19 vaccines,” but “anger over government coercion shouldn’t become hostility toward a promising medical technology.”</p><p><a href="https://www.chicagotribune.com/2026/09/20/opinion-mrna-flu-vaccine-mflusiva/" target="_blank"><em>Read more</em></a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/instant-opinion-silicon-valley-tech-education-bitcoin-vaccines</link>
                                                                            <description>
                            <![CDATA[ Opinion, comment and editorials of the day ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">aVQMTs5patvjCXAmDB8acY</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/UsGiqaQA9r2gXmPmMjAbzh-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 21 Sep 2026 17:35:05 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/UsGiqaQA9r2gXmPmMjAbzh-1920-80.jpg">
                                                            <media:credit><![CDATA[Kirby Lee / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The ‘lack of investment in the cities where our tech lords work and live reveals a stark reality’]]></media:description>                                                            <media:text><![CDATA[A general view of the Silicon Valley region of California.]]></media:text>
                                <media:title type="plain"><![CDATA[A general view of the Silicon Valley region of California.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/UsGiqaQA9r2gXmPmMjAbzh-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="in-the-land-of-billionaire-barbarians">‘In the land of billionaire barbarians’</h2><p><strong>Arielle Pardes at The New York Times</strong></p><p>Silicon Valley is “home to four of the most powerful companies in the world,” yet “by looking at it, you’d hardly know this place had any influence,” says Arielle Pardes. Tech billionaires have “donated generously to scientific research and global health initiatives, but little of their money goes to improving their own backyard.” The “lack of investment in the cities where our tech lords work and live reveals a stark reality about how this wealth benefits a select few.”</p><p><a href="https://www.nytimes.com/2026/09/21/opinion/silicon-valley-culture-wasteland.html" target="_blank"><em>Read more</em></a></p><h2 id="should-the-classroom-be-more-like-the-gym">‘Should the classroom be more like the gym?’</h2><p><strong>Dan Rockmore at The New Yorker</strong></p><p>The “body offers something that the mind — at least in a traditional classroom — rarely does: clear, immediate loops linking effort and result,” says Dan Rockmore. In the “gym, we can steadily feel ourselves getting stronger,” but in the “classroom, progress can be difficult to see.” This “clarifies our real responsibilities: drawing out the quiet student, asking the question nobody thought to ask, forging a community of mind and friendship from the struggles of a classroom.”</p><p><a href="https://www.newyorker.com/culture/the-weekend-essay/should-the-classroom-be-more-like-the-gym" target="_blank"><em>Read more</em></a></p><h2 id="the-people-ok-the-men-who-still-love-bitcoin">‘The people — OK, the men — who still love Bitcoin’</h2><p><strong>Nathaniel Moore at Slate</strong></p><p>Among a “predominantly male crowd,” Bitcoin and “other cryptocurrencies offer an appealing alternative because they are not issued or managed by a central bank,” says Nathaniel Moore. The “concept of financial freedom — not having to trust anyone else — is the logical endpoint of the belief that the systems of American life cannot be mended, only circumvented.” Investors are “following the example set by those at the top: looking out for themselves and trying to swell their own stash.”</p><p><a href="https://slate.com/business/2026/09/bitcoin-cryptocurrency-masculinity-economy-emotional-tether.html" target="_blank"><em>Read more</em></a></p><h2 id="the-first-mrna-flu-vaccine-may-be-just-the-beginning">‘The first mRNA flu vaccine may be just the beginning’</h2><p><strong>Sally C. Pipes at the Chicago Tribune</strong></p><p>“Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it,” says Sally C. Pipes. Since “mRNA vaccines can be produced faster than conventional shots, manufacturers may eventually be able to wait longer before deciding which strains to target — and respond faster if circulating strains change.” During the “pandemic, mRNA became almost synonymous with Covid-19 vaccines,” but “anger over government coercion shouldn’t become hostility toward a promising medical technology.”</p><p><a href="https://www.chicagotribune.com/2026/09/20/opinion-mrna-flu-vaccine-mflusiva/" target="_blank"><em>Read more</em></a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Fiji declares national emergency as drugs and stigma fuel HIV outbreak ]]></title>
                                                                                                <dc:content><![CDATA[ <p>New cases of HIV are surging at an unprecedented rate in Fiji, and the South Pacific island nation has declared a national emergency as a result. The government is doubling down on preventative measures with the help of the Joint United Nations Programme on HIV/AIDS (UNAIDS), as drug use and taboos around the disease contribute to the outbreak.</p><h2 id="why-is-there-a-crisis">Why is there a crisis?</h2><p>Over the last 15 years, new <a href="https://www.theweek.com/health/the-twists-and-turns-in-the-fight-against-hiv-and-aids">HIV </a>infections have “increased 12-fold” in <a href="https://www.theweek.com/defence/australia-fiji-defence-pact-treaty-alliance-pacific-security">Fiji</a>, according to recent <a href="https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2026/september/20260916_Fiji_national_crisis" target="_blank">UNAIDS</a> data, said <a href="https://apnews.com/article/fiji-hiv-national-emergency-aids-7b780358acde9ec537a09a199f2b0976" target="_blank">The Associated Press</a>. As of 2025, about 9,000 people live with HIV in a country that has “less than a million people.” This means that about one in every 60 adults there has the virus, “compared with one in 167 five years ago.”</p><p>HIV is now a “national crisis,” and the government is “treating it like one,” said Fiji Health Minister Atonio Lalabalavu in a video statement on <a href="https://www.facebook.com/watch/?v=1386991873016868" target="_blank">Facebook</a>. “No more business as usual.” More people in Fiji are living with HIV than “ever before.”</p><p>Officials warn that the outbreak is not “limited to particular areas or populations,” said <a href="https://www.nytimes.com/2026/09/16/world/asia/fiji-hiv-national-emergency.html" target="_blank">The New York Times</a>. And because Fiji “serves as a regional hub for business, tourism and transport,” the surge could also affect nearby countries in the South Pacific if “left unchecked.” </p><p>Such interconnectedness may have contributed to a spike in infections, said Eamonn Murphy, the director of regional support teams in the Asia Pacific region, Central Asia and Eastern Europe for UNAIDS, to the Times. An influx of drugs like methamphetamine and <a href="https://www.theweek.com/environment/sharks-cocaine-drug-testing-bahamas">cocaine</a> during the <a href="https://www.theweek.com/health/cicada-covid-19-variant-us-virus">Covid-19</a> pandemic added “fuel on the flame” of a longstanding HIV presence. Fiji is also one of “several global hot spots” in which a dangerous trend called <a href="https://www.theweek.com/health/bluetoothing-the-phenomenon-driving-hiv-spike-in-fiji">bluetoothing</a>, in which people “inject themselves with the blood of other drug users to get a cheap high,” is contributing to spikes in disease rates, said the Times.</p><h2 id="what-s-the-plan-to-solve-the-crisis">What’s the plan to solve the crisis?</h2><p>These alarming statistics don’t capture the full scale of the problem, said Renata Ram, the Fiji adviser for UNAIDS, to <a href="https://www.cnn.com/2026/09/16/asia/fiji-hiv-emergency-methamphetamine-intl-hnk" target="_blank">CNN</a>. Most concerning is the “speed of the epidemic” and the “number of people who may be living with HIV without knowing it.” Only about 39% of Fijians living with HIV know their status, and less than a quarter (22%) are on treatment.</p><p>HIV is “not only a health issue,” said Joeli Colati, the executive director of Fiji Network Plus, an advocacy organization for HIV-positive people, to CNN. It’s also connected to “stigma, poverty, confidentiality and fear.” </p><p>Limited testing, low condom use, and shame are often cited as factors contributing to infection. And there are many reasons why people might be hesitant to seek treatment, including a “fear of being recognized at the HIV clinic,” said Colati. Fiji is a “deeply religious society” in which “premarital or casual sex is generally considered taboo,” said CNN.</p><p>Fiji’s government has “ramped up testing and treatment efforts” since January 2025, when the nation first “declared an HIV outbreak,” said the Times. However, an “outbreak-level response is no longer sufficient,” said Lalabalavu in his video statement. Moving forward, Fiji has pledged a “whole-of-government response,” including “expanded access to free testing, prevention services and treatment,” as well as harm-reduction measures such as programs that “allow people who inject drugs to exchange used needles for clean ones,” said the Times. </p><p>Fiji has “recognized the urgency of the moment and is stepping up its response,” said UNAIDS Executive Director Winnie Byanyima in a <a href="https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2026/september/20260916_Fiji_national_crisis" target="_blank">press release</a>. It’s also a “stark reminder to the world that AIDS is not over.” HIV epidemics can “change quickly,” and countries need “health and community systems that are ready to respond urgently.” </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/fiji-national-emergency-hiv-outbreak</link>
                                                                            <description>
                            <![CDATA[ As new HIV diagnoses skyrocket, the government is focusing on community advocacy ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">ZWnEveB6AxypQQfoPomCR8</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/aPvx4LGqm3D9M5mRnXM5eZ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 18 Sep 2026 17:50:20 +0000</pubDate>                                                                                                                                <updated>Fri, 18 Sep 2026 21:23:42 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/aPvx4LGqm3D9M5mRnXM5eZ-1920-80.jpg">
                                                            <media:credit><![CDATA[STR / Contributor / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Fiji&amp;#39;s government is spreading the message with an HIV prevention campaign]]></media:description>                                                            <media:text><![CDATA[An HIV awareness poster displayed along a main road in Fiji]]></media:text>
                                <media:title type="plain"><![CDATA[An HIV awareness poster displayed along a main road in Fiji]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/aPvx4LGqm3D9M5mRnXM5eZ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>New cases of HIV are surging at an unprecedented rate in Fiji, and the South Pacific island nation has declared a national emergency as a result. The government is doubling down on preventative measures with the help of the Joint United Nations Programme on HIV/AIDS (UNAIDS), as drug use and taboos around the disease contribute to the outbreak.</p><h2 id="why-is-there-a-crisis">Why is there a crisis?</h2><p>Over the last 15 years, new <a href="https://www.theweek.com/health/the-twists-and-turns-in-the-fight-against-hiv-and-aids">HIV </a>infections have “increased 12-fold” in <a href="https://www.theweek.com/defence/australia-fiji-defence-pact-treaty-alliance-pacific-security">Fiji</a>, according to recent <a href="https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2026/september/20260916_Fiji_national_crisis" target="_blank">UNAIDS</a> data, said <a href="https://apnews.com/article/fiji-hiv-national-emergency-aids-7b780358acde9ec537a09a199f2b0976" target="_blank">The Associated Press</a>. As of 2025, about 9,000 people live with HIV in a country that has “less than a million people.” This means that about one in every 60 adults there has the virus, “compared with one in 167 five years ago.”</p><p>HIV is now a “national crisis,” and the government is “treating it like one,” said Fiji Health Minister Atonio Lalabalavu in a video statement on <a href="https://www.facebook.com/watch/?v=1386991873016868" target="_blank">Facebook</a>. “No more business as usual.” More people in Fiji are living with HIV than “ever before.”</p><p>Officials warn that the outbreak is not “limited to particular areas or populations,” said <a href="https://www.nytimes.com/2026/09/16/world/asia/fiji-hiv-national-emergency.html" target="_blank">The New York Times</a>. And because Fiji “serves as a regional hub for business, tourism and transport,” the surge could also affect nearby countries in the South Pacific if “left unchecked.” </p><p>Such interconnectedness may have contributed to a spike in infections, said Eamonn Murphy, the director of regional support teams in the Asia Pacific region, Central Asia and Eastern Europe for UNAIDS, to the Times. An influx of drugs like methamphetamine and <a href="https://www.theweek.com/environment/sharks-cocaine-drug-testing-bahamas">cocaine</a> during the <a href="https://www.theweek.com/health/cicada-covid-19-variant-us-virus">Covid-19</a> pandemic added “fuel on the flame” of a longstanding HIV presence. Fiji is also one of “several global hot spots” in which a dangerous trend called <a href="https://www.theweek.com/health/bluetoothing-the-phenomenon-driving-hiv-spike-in-fiji">bluetoothing</a>, in which people “inject themselves with the blood of other drug users to get a cheap high,” is contributing to spikes in disease rates, said the Times.</p><h2 id="what-s-the-plan-to-solve-the-crisis">What’s the plan to solve the crisis?</h2><p>These alarming statistics don’t capture the full scale of the problem, said Renata Ram, the Fiji adviser for UNAIDS, to <a href="https://www.cnn.com/2026/09/16/asia/fiji-hiv-emergency-methamphetamine-intl-hnk" target="_blank">CNN</a>. Most concerning is the “speed of the epidemic” and the “number of people who may be living with HIV without knowing it.” Only about 39% of Fijians living with HIV know their status, and less than a quarter (22%) are on treatment.</p><p>HIV is “not only a health issue,” said Joeli Colati, the executive director of Fiji Network Plus, an advocacy organization for HIV-positive people, to CNN. It’s also connected to “stigma, poverty, confidentiality and fear.” </p><p>Limited testing, low condom use, and shame are often cited as factors contributing to infection. And there are many reasons why people might be hesitant to seek treatment, including a “fear of being recognized at the HIV clinic,” said Colati. Fiji is a “deeply religious society” in which “premarital or casual sex is generally considered taboo,” said CNN.</p><p>Fiji’s government has “ramped up testing and treatment efforts” since January 2025, when the nation first “declared an HIV outbreak,” said the Times. However, an “outbreak-level response is no longer sufficient,” said Lalabalavu in his video statement. Moving forward, Fiji has pledged a “whole-of-government response,” including “expanded access to free testing, prevention services and treatment,” as well as harm-reduction measures such as programs that “allow people who inject drugs to exchange used needles for clean ones,” said the Times. </p><p>Fiji has “recognized the urgency of the moment and is stepping up its response,” said UNAIDS Executive Director Winnie Byanyima in a <a href="https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2026/september/20260916_Fiji_national_crisis" target="_blank">press release</a>. It’s also a “stark reminder to the world that AIDS is not over.” HIV epidemics can “change quickly,” and countries need “health and community systems that are ready to respond urgently.” </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ RFK Jr. assures anti-vaccine group as measles spreads ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-2">What happened</h2><p>Health Secretary Robert F. Kennedy Jr. Thursday addressed the anti-vaccine advocacy group he founded, telling the hundreds of attendees they “have a strong and steadfast friend in the White House.” Kennedy’s keynote speech at the Children’s Health Defense annual conference was slotted between MAHA Institute chief Mark Gorton, who called himself the “boldest anti-vaxxer at an anti-vax conference,” and Andrew Wakefield, whose discredited and retracted 1998 study linking the measles shot to autism helped fuel the anti-vaccine movement. <br /><br />This “would’ve been an unthinkable appearance for past health secretaries,” <a href="https://www.cnn.com/2026/09/17/health/kennedy-antivaccine-group-speech" target="_blank">CNN</a> said, even if the U.S. weren’t experiencing its worst measles outbreak since 1991, “driven largely by unvaccinated people.” About 3,300 cases have been confirmed this year, and the “seven reported measles-associated deaths in the last two years” are “more than the combined total” over the “previous three decades,” <a href="https://apnews.com/article/measles-deaths-pennsylvania-5267e2deff65b12941e6a1c279976f13" target="_blank">The Associated Press</a> said.</p><h2 id="who-said-what-2">Who said what</h2><p>After dedicating the first part of his speech to “far more politically popular topics” like <a href="https://theweek.com/health/food-additives-banned-united-states-european-union">food safety</a> and fringier topics like “so-called chemtrails,” Kennedy “plunged headlong into vaccines,” <a href="https://www.nytimes.com/2026/09/17/health/kennedy-vaccines-childrens-health-defense.html" target="_blank">The New York Times</a> said. That “signaled a notable shift from earlier this year when White House officials” pushed Kennedy to “sidestep the vaccine issue, given widespread support among voters for <a href="https://theweek.com/health/trump-administration-aims-to-limit-childhood-vaccines">protecting children</a> against deadly diseases.” <br /><br />Pennsylvania Gov. Josh Shapiro (D), whose state this week reported its fourth recent <a href="https://theweek.com/health/measles-elimination-status-us-cases">measles-related death</a>, criticized Kennedy for spending his time “addressing the premier vaccine-denial conference in America.” Kennedy’s refusal to acknowledge the deaths as measles-related “ignited a public feud” with Shapiro, the AP said. Kennedy “suggested the deaths may have been ‘fabricated,’” the Times said, and the Centers for Disease Control and Prevention, “which he oversees,” is “currently reporting no measles deaths for 2026.”</p><h2 id="what-next-3">What next?</h2><p>Pennsylvania’s health department late Wednesday requested emergency CDC support for its ballooning measles outbreak, “on condition that the federal agency recognize” the four deaths, <a href="https://www.reuters.com/world/pennsylvania-asks-cdc-help-measles-outbreak-demands-agency-recognize-measles-2026-09-17/" target="_blank">Reuters</a> said.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/kennedy-anti-vaccine-speech-measles</link>
                                                                            <description>
                            <![CDATA[ The measles surge has been driven largely by unvaccinated people ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">a6ZhMkgixKgDSnqJ3eKhW6</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Ch5kJ4QUhYTi2xupwWjjof-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 18 Sep 2026 16:42:42 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Peter Weber, The Week US) ]]></author>                    <dc:creator><![CDATA[ Peter Weber, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/468oRmsak796WaimXBHwL9-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Peter has worked as a news and culture writer and editor at The Week since the site&#039;s launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University. He graduated from Northwestern University with degrees in international studies and performance studies and served in the Peace Corps in Honduras.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Peter has lived in Italy and all major quadrants of the continental U.S. and currently resides in Austin, Texas, where he plays bass and rhythm cello in a garage band.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Ch5kJ4QUhYTi2xupwWjjof-1920-80.jpg">
                                                            <media:credit><![CDATA[Smiley N. Pool / The Dallas Morning News via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Health Secretary Robert F. Kennedy Jr. addressed the &amp;#39;premier vaccine-denial conference in America&amp;#39;]]></media:description>                                                            <media:text><![CDATA[Health Secretary Robert F. Kennedy Jr. speaks at the Republican convention in Dallas.]]></media:text>
                                <media:title type="plain"><![CDATA[Health Secretary Robert F. Kennedy Jr. speaks at the Republican convention in Dallas.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Ch5kJ4QUhYTi2xupwWjjof-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-2">What happened</h2><p>Health Secretary Robert F. Kennedy Jr. Thursday addressed the anti-vaccine advocacy group he founded, telling the hundreds of attendees they “have a strong and steadfast friend in the White House.” Kennedy’s keynote speech at the Children’s Health Defense annual conference was slotted between MAHA Institute chief Mark Gorton, who called himself the “boldest anti-vaxxer at an anti-vax conference,” and Andrew Wakefield, whose discredited and retracted 1998 study linking the measles shot to autism helped fuel the anti-vaccine movement. <br /><br />This “would’ve been an unthinkable appearance for past health secretaries,” <a href="https://www.cnn.com/2026/09/17/health/kennedy-antivaccine-group-speech" target="_blank">CNN</a> said, even if the U.S. weren’t experiencing its worst measles outbreak since 1991, “driven largely by unvaccinated people.” About 3,300 cases have been confirmed this year, and the “seven reported measles-associated deaths in the last two years” are “more than the combined total” over the “previous three decades,” <a href="https://apnews.com/article/measles-deaths-pennsylvania-5267e2deff65b12941e6a1c279976f13" target="_blank">The Associated Press</a> said.</p><h2 id="who-said-what-2">Who said what</h2><p>After dedicating the first part of his speech to “far more politically popular topics” like <a href="https://theweek.com/health/food-additives-banned-united-states-european-union">food safety</a> and fringier topics like “so-called chemtrails,” Kennedy “plunged headlong into vaccines,” <a href="https://www.nytimes.com/2026/09/17/health/kennedy-vaccines-childrens-health-defense.html" target="_blank">The New York Times</a> said. That “signaled a notable shift from earlier this year when White House officials” pushed Kennedy to “sidestep the vaccine issue, given widespread support among voters for <a href="https://theweek.com/health/trump-administration-aims-to-limit-childhood-vaccines">protecting children</a> against deadly diseases.” <br /><br />Pennsylvania Gov. Josh Shapiro (D), whose state this week reported its fourth recent <a href="https://theweek.com/health/measles-elimination-status-us-cases">measles-related death</a>, criticized Kennedy for spending his time “addressing the premier vaccine-denial conference in America.” Kennedy’s refusal to acknowledge the deaths as measles-related “ignited a public feud” with Shapiro, the AP said. Kennedy “suggested the deaths may have been ‘fabricated,’” the Times said, and the Centers for Disease Control and Prevention, “which he oversees,” is “currently reporting no measles deaths for 2026.”</p><h2 id="what-next-3">What next?</h2><p>Pennsylvania’s health department late Wednesday requested emergency CDC support for its ballooning measles outbreak, “on condition that the federal agency recognize” the four deaths, <a href="https://www.reuters.com/world/pennsylvania-asks-cdc-help-measles-outbreak-demands-agency-recognize-measles-2026-09-17/" target="_blank">Reuters</a> said.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ICE’s treatment of detained pregnant women  ]]></title>
                                                                                                <dc:content><![CDATA[ <p>U.S. Immigration and Customs Enforcement has arrested a record number of pregnant people and placed them in detention centers where they receive subpar prenatal and postnatal care. And the agency has lost count of how many have suffered miscarriages.</p><h2 id="what-s-happening-to-women-who-miscarry-in-ice-custody">What’s happening to women who miscarry in ICE custody?</h2><p>The Trump administration “placed more pregnant immigrants in detention” last fall and winter than at “any time over the previous year,” said <a href="https://www.theguardian.com/us-news/ng-interactive/2026/sep/15/ice-detention-miscarriages-pregnancy" target="_blank">The Guardian</a>. In October, there were at least 87 pregnant women and teens in detention, and by November, there were 101, according to government documents obtained by the outlet. ICE reported 18 miscarriages during the first nine months of the Trump administration, but the agency stopped recording miscarriages after Oct. 3. There is no updated data on miscarriages because ICE ended its contract with the Veterans Affairs Financial Services Center, which had been handling medical billing for the agency, according to internal documents. </p><p>Detained pregnant women report they are “struggling to access routine and emergency medical care,” said The Guardian. Women who miscarried or were hospitalized for pregnancy complications told the outlet they “did not receive follow-up care, despite experiencing ongoing pain and symptoms.” While it is difficult to attribute the miscarriages to the detention conditions, it is clear these “incarcerated women” are not “getting the prenatal visits that they’re supposed to get,” Deborah Ottenheimer, an obstetrician-gynecologist and medical expert with Physicians for Human Rights, said to The Guardian. They’re not getting “high-risk prenatal visits if they need them.” And if they do miscarry, the “medical care they receive is minimal to none.” </p><p>Center for Reproductive Rights <a href="https://reproductiverights.org/news/pregnant-postpartum-nursing-women-ice-custody/#:~:text=They're%20being%20put%20in,Separation%20from%20families" target="_blank">reports</a> from earlier this year also indicate high numbers of miscarriages in detention centers and, in severe cases, “allegations of coerced or unnecessary gynecological surgeries and hysterectomies without proper informed consent,” said <a href="https://www.forbes.com/sites/maiahoskin/2026/02/24/why-the-treatment-of-women-in-immigration-detention-should-concern-every-woman-in-america/" target="_blank">Forbes</a>. These reports “raise concerns about compliance with established maternal health standards.” </p><h2 id="is-anything-being-done-to-improve-the-problem">Is anything being done to improve the problem?</h2><p>Initially, a spokesperson for the Department of Homeland Security (DHS), which oversees ICE, said the agency was tracking miscarriages in monthly reports in response to The Guardian’s follow-up questions about the missing data. Later, the spokesperson confirmed it “does not have data on miscarriages from October 2025 through June 2026,” said The Guardian. DHS has “never before acknowledged” that it lost count of miscarriages, “not even when U.S. senators asked the agency for the data.” It is convenient for the Trump administration that ICE cannot report how many miscarriages happened in its custody, because when “you don’t track something of that magnitude,” you don’t have to be “confronted with the reality of what your policies have yielded,” said Faisal Al-Juburi, the co-chief executive of Texas-based immigration services nonprofit Raíces, to The Guardian. “</p><p>In May, Democratic senators Richard Blumenthal (Conn.), Mazie Hirono (Hawaii) and Jon Ossoff (Ga.) demanded answers from DHS regarding the “appalling and horrific treatment” of pregnant, postpartum and nursing women in immigration detention, in a letter sent to Homeland Security Secretary Markwayne Mullin and private contractors operating an ICE detention facility in Texas. The trio cited “cases of miscarriages, medical neglect and the use of shackles during pregnancy,” said <a href="https://www.latintimes.com/pregnant-women-describe-appalling-treatment-ice-custody-including-shackling-during-miscarriages-597276" target="_blank"><u>The Latin Times</u></a>. They also urged the Trump administration to “restore a policy presuming the release of pregnant women from immigration custody except in extraordinary circumstances.”</p><p>This letter came right after new <a href="https://kamlager-dove.house.gov/media/press-releases/kamlager-dove-introduces-updated-pregnant-women-custody-act-after-reports"><u>legislation</u></a> was introduced by Rep. Sydney Kamlager-Dove (D-Calif.) that “would establish care standards for federally incarcerated pregnant people,” including those in ICE and Customs and Border Protection facilities, said <a href="https://www.motherjones.com/politics/2026/05/pregnant-mothers-appalling-horrific-treatment-ice-detention-cbp-shackles/" target="_blank"><u>Mother Jones</u></a>. The bill builds on one that the “House already passed in 2022,” which only applied to those in the Federal Bureau of Prisons’ custody. </p><p>Immigration detention is known to foster “medical neglect, abusive conditions” and “utter disregard for the dignity of people,” Eunice Cho, a senior staff attorney at the ACLU’s National Prison Project and the co-author of a <a href="https://www.aclu.org/documents/aclu-partners-demand-ice-release-pregnant-and-postpartum-people-from-ice-detention" target="_blank"><u>letter</u></a> to ICE documenting these conditions, said in an <a href="https://www.aclu.org/news/immigrants-rights/pregnant-and-postpartum-women-face-neglect-and-abuse-in-ice-detention" target="_blank"><u>ACLU</u></a> report. “What we heard from the pregnant women we interviewed” are some of the “most horrifying stories I’ve heard about detention.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/ice-detention-miscarriages-pregnancy-immigration</link>
                                                                            <description>
                            <![CDATA[ The agency has lost count of miscarriages amid record-high pregnant detainees and reports of denial of medical care ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">zUiriuyGG4pKKvW4tvMXwC</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/gUEcJUj7sGGt5iYh8KVgQQ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 17 Sep 2026 18:51:15 +0000</pubDate>                                                                                                                                <updated>Wed, 23 Sep 2026 21:20:58 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/gUEcJUj7sGGt5iYh8KVgQQ-1920-80.jpg">
                                                            <media:credit><![CDATA[Anadolu / Contributor / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Delaney Hall, an ICE detention facility in Newark, New Jersey]]></media:description>                                                            <media:text><![CDATA[Delaney Hall ICE detention facility in Newark, New Jersey]]></media:text>
                                <media:title type="plain"><![CDATA[Delaney Hall ICE detention facility in Newark, New Jersey]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/gUEcJUj7sGGt5iYh8KVgQQ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>U.S. Immigration and Customs Enforcement has arrested a record number of pregnant people and placed them in detention centers where they receive subpar prenatal and postnatal care. And the agency has lost count of how many have suffered miscarriages.</p><h2 id="what-s-happening-to-women-who-miscarry-in-ice-custody">What’s happening to women who miscarry in ICE custody?</h2><p>The Trump administration “placed more pregnant immigrants in detention” last fall and winter than at “any time over the previous year,” said <a href="https://www.theguardian.com/us-news/ng-interactive/2026/sep/15/ice-detention-miscarriages-pregnancy" target="_blank">The Guardian</a>. In October, there were at least 87 pregnant women and teens in detention, and by November, there were 101, according to government documents obtained by the outlet. ICE reported 18 miscarriages during the first nine months of the Trump administration, but the agency stopped recording miscarriages after Oct. 3. There is no updated data on miscarriages because ICE ended its contract with the Veterans Affairs Financial Services Center, which had been handling medical billing for the agency, according to internal documents. </p><p>Detained pregnant women report they are “struggling to access routine and emergency medical care,” said The Guardian. Women who miscarried or were hospitalized for pregnancy complications told the outlet they “did not receive follow-up care, despite experiencing ongoing pain and symptoms.” While it is difficult to attribute the miscarriages to the detention conditions, it is clear these “incarcerated women” are not “getting the prenatal visits that they’re supposed to get,” Deborah Ottenheimer, an obstetrician-gynecologist and medical expert with Physicians for Human Rights, said to The Guardian. They’re not getting “high-risk prenatal visits if they need them.” And if they do miscarry, the “medical care they receive is minimal to none.” </p><p>Center for Reproductive Rights <a href="https://reproductiverights.org/news/pregnant-postpartum-nursing-women-ice-custody/#:~:text=They're%20being%20put%20in,Separation%20from%20families" target="_blank">reports</a> from earlier this year also indicate high numbers of miscarriages in detention centers and, in severe cases, “allegations of coerced or unnecessary gynecological surgeries and hysterectomies without proper informed consent,” said <a href="https://www.forbes.com/sites/maiahoskin/2026/02/24/why-the-treatment-of-women-in-immigration-detention-should-concern-every-woman-in-america/" target="_blank">Forbes</a>. These reports “raise concerns about compliance with established maternal health standards.” </p><h2 id="is-anything-being-done-to-improve-the-problem">Is anything being done to improve the problem?</h2><p>Initially, a spokesperson for the Department of Homeland Security (DHS), which oversees ICE, said the agency was tracking miscarriages in monthly reports in response to The Guardian’s follow-up questions about the missing data. Later, the spokesperson confirmed it “does not have data on miscarriages from October 2025 through June 2026,” said The Guardian. DHS has “never before acknowledged” that it lost count of miscarriages, “not even when U.S. senators asked the agency for the data.” It is convenient for the Trump administration that ICE cannot report how many miscarriages happened in its custody, because when “you don’t track something of that magnitude,” you don’t have to be “confronted with the reality of what your policies have yielded,” said Faisal Al-Juburi, the co-chief executive of Texas-based immigration services nonprofit Raíces, to The Guardian. “</p><p>In May, Democratic senators Richard Blumenthal (Conn.), Mazie Hirono (Hawaii) and Jon Ossoff (Ga.) demanded answers from DHS regarding the “appalling and horrific treatment” of pregnant, postpartum and nursing women in immigration detention, in a letter sent to Homeland Security Secretary Markwayne Mullin and private contractors operating an ICE detention facility in Texas. The trio cited “cases of miscarriages, medical neglect and the use of shackles during pregnancy,” said <a href="https://www.latintimes.com/pregnant-women-describe-appalling-treatment-ice-custody-including-shackling-during-miscarriages-597276" target="_blank"><u>The Latin Times</u></a>. They also urged the Trump administration to “restore a policy presuming the release of pregnant women from immigration custody except in extraordinary circumstances.”</p><p>This letter came right after new <a href="https://kamlager-dove.house.gov/media/press-releases/kamlager-dove-introduces-updated-pregnant-women-custody-act-after-reports"><u>legislation</u></a> was introduced by Rep. Sydney Kamlager-Dove (D-Calif.) that “would establish care standards for federally incarcerated pregnant people,” including those in ICE and Customs and Border Protection facilities, said <a href="https://www.motherjones.com/politics/2026/05/pregnant-mothers-appalling-horrific-treatment-ice-detention-cbp-shackles/" target="_blank"><u>Mother Jones</u></a>. The bill builds on one that the “House already passed in 2022,” which only applied to those in the Federal Bureau of Prisons’ custody. </p><p>Immigration detention is known to foster “medical neglect, abusive conditions” and “utter disregard for the dignity of people,” Eunice Cho, a senior staff attorney at the ACLU’s National Prison Project and the co-author of a <a href="https://www.aclu.org/documents/aclu-partners-demand-ice-release-pregnant-and-postpartum-people-from-ice-detention" target="_blank"><u>letter</u></a> to ICE documenting these conditions, said in an <a href="https://www.aclu.org/news/immigrants-rights/pregnant-and-postpartum-women-face-neglect-and-abuse-in-ice-detention" target="_blank"><u>ACLU</u></a> report. “What we heard from the pregnant women we interviewed” are some of the “most horrifying stories I’ve heard about detention.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ AI may have cracked the antiaging code  ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A pharmaceutical company claims to have used artificial intelligence to discover a drug that reverses the impacts of aging. Whether or not the medication is truly effective for antiaging purposes remains to be seen, but the finding highlights how the burgeoning technology could make the drug discovery process easier, or at least faster.</p><h2 id="beating-the-aging-clocks">Beating the ‘aging clocks’</h2><p>Last year, Insilico Medicine, a company that “aims to accelerate drug discovery” using <a href="https://www.theweek.com/personal-finance/can-you-trust-artificial-intelligence-to-help-manage-your-money">artificial intelligence</a>, announced that a clinical trial of one of its drug candidates suggested it could help treat a chronic lung disease, said <a href="https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html" target="_blank">The New York Times</a>. The disease in question, idiopathic pulmonary fibrosis, or IPF, is sometimes referred to as “<a href="https://www.theweek.com/health/trial-copper-drug-restores-memory-clears-alzheimers-proteins">Alzheimer’s</a> of the lungs.” Now, new data from the same clinical trial shows an even “more intriguing possibility”: The drug, called rentosertib, could “also slow the aging process.” The company used AI to assist in generating the drug’s molecular structure.</p><p>Rentosertib reduces the biological markers of age as measured by six separate “aging clocks,” or AI technology “designed to predict a person’s morbidity and mortality,” according to a new study published in the journal <a href="https://www.nature.com/articles/s41587-026-03286-y" target="_blank">Nature Biotechnology</a>. This “elaborate clinical trial” is a milestone in the “widespread effort to improve healthcare” using the same technology that underpins “popular chatbots like ChatGPT and image generators like Midjourney.” Insilico is just “one of many startups, tech giants and academic labs” working to “accelerate drug discovery” and “hone other medical tasks with help from these methods.”</p><p>If your biological age is lower, “you are likely to die later,” the AI drug discovery startup’s CEO, Alex Zhavoronkov, said in an interview, per <a href="https://www.bloomberg.com/news/articles/2026-09-07/ai-discovered-drug-reverses-aging-markers-in-study-biotech-says" target="_blank">Bloomberg</a>. But these are early results, and the drug’s potential long-term health effects in larger groups of people are unknown. </p><p>The clinical trial included just 42 patients who had a chronic lung disease. While longevity enthusiasts have “long embraced the repurposing of existing medications” to delay aging, efforts to develop “novel antiaging drugs” have often “ended in failure,” said Bloomberg. With the advent of <a href="https://theweek.com/health/why-glp-1s-dont-work-for-everyone">GLP-1 treatments</a>, however, whose benefits appear to extend well beyond weight loss and diabetes, “major pharmaceutical players are increasingly showing interest in the field.”</p><h2 id="not-replacing-scientific-intuition">‘Not replacing scientific intuition’</h2><p>The results of this study are the first to show “very clearly” that “predicted biological age can be reduced,” Vadim Gladyshev, a Harvard Medical School professor who helped build one of the aging clocks, said to the Times. Still, the study is far from conclusive, Gladyshev acknowledges, citing the small sample size and the unreliability of aging clocks. Most notably, Insilico’s drug has “not yet been tested in healthy patients,” said the Times. Because the company conducted its clinical trial solely with IPF patients, the results may be specific to this condition.</p><p>The idea of “reducing aging certainly sounds good” and has become the “obsession of some tech bro-types,” but the “actual utility of aging clocks is up for debate,” said <a href="https://gizmodo.com/study-suggests-ai-generated-drug-could-slow-aging-2000808265" target="_blank">Gizmodo</a>. More recent models focus on proteomics, or “measuring blood proteins,” which a 2024 <a href="https://www.nature.com/articles/s41591-024-03164-7" target="_blank">study</a> found could be used to determine if a person had a higher risk of age-related diseases. While some <a href="https://www.nature.com/articles/s41514-025-00312-2" target="_blank">researchers</a> believe that these “catch-all measurements” could be useful, there’s still a “long way to go before they become truly meaningful markers.” There isn’t yet a measurement that “serves as a universally accepted ‘age’ indicator,” and some doctors have warned that “leaning on these metrics could lead to pursuing the wrong interventions.”</p><p>AI is not “replacing scientific intuition,” and it is “unlikely to do so anytime soon,” said <a href="https://www.forbes.com/sites/timbajarin/2026/08/24/why-ai-driven-drug-discovery-is-becoming-pharmas-next-big-bet/" target="_blank">Forbes</a>. What it can do is “make the costly, time-consuming R&amp;D work” of preparing for clinical trials “more efficient.” For the drug discovery field, that means the “computer screen is becoming nearly as essential as the lab bench.” That shift is “familiar across industries” as “digital tools increasingly become part of the craft rather than merely an add-on.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/ai-anti-aging-drug-insilico-rentosertib</link>
                                                                            <description>
                            <![CDATA[ An AI-discovered drug could help slow the aging process ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">iDnGuuHSyeqU8S4SjtBkp9</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/jkX8UbhZY4kA2cRCEdQUWQ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 15 Sep 2026 18:22:05 +0000</pubDate>                                                                                                                                <updated>Tue, 15 Sep 2026 19:31:07 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/jkX8UbhZY4kA2cRCEdQUWQ-1920-80.jpg">
                                                            <media:credit><![CDATA[asbe / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The rapidly evolving technology is making its way into medical research]]></media:description>                                                            <media:text><![CDATA[Futuristic Medical Technology with Robotic Hand and Digital Pills. 3D Render]]></media:text>
                                <media:title type="plain"><![CDATA[Futuristic Medical Technology with Robotic Hand and Digital Pills. 3D Render]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/jkX8UbhZY4kA2cRCEdQUWQ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A pharmaceutical company claims to have used artificial intelligence to discover a drug that reverses the impacts of aging. Whether or not the medication is truly effective for antiaging purposes remains to be seen, but the finding highlights how the burgeoning technology could make the drug discovery process easier, or at least faster.</p><h2 id="beating-the-aging-clocks">Beating the ‘aging clocks’</h2><p>Last year, Insilico Medicine, a company that “aims to accelerate drug discovery” using <a href="https://www.theweek.com/personal-finance/can-you-trust-artificial-intelligence-to-help-manage-your-money">artificial intelligence</a>, announced that a clinical trial of one of its drug candidates suggested it could help treat a chronic lung disease, said <a href="https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html" target="_blank">The New York Times</a>. The disease in question, idiopathic pulmonary fibrosis, or IPF, is sometimes referred to as “<a href="https://www.theweek.com/health/trial-copper-drug-restores-memory-clears-alzheimers-proteins">Alzheimer’s</a> of the lungs.” Now, new data from the same clinical trial shows an even “more intriguing possibility”: The drug, called rentosertib, could “also slow the aging process.” The company used AI to assist in generating the drug’s molecular structure.</p><p>Rentosertib reduces the biological markers of age as measured by six separate “aging clocks,” or AI technology “designed to predict a person’s morbidity and mortality,” according to a new study published in the journal <a href="https://www.nature.com/articles/s41587-026-03286-y" target="_blank">Nature Biotechnology</a>. This “elaborate clinical trial” is a milestone in the “widespread effort to improve healthcare” using the same technology that underpins “popular chatbots like ChatGPT and image generators like Midjourney.” Insilico is just “one of many startups, tech giants and academic labs” working to “accelerate drug discovery” and “hone other medical tasks with help from these methods.”</p><p>If your biological age is lower, “you are likely to die later,” the AI drug discovery startup’s CEO, Alex Zhavoronkov, said in an interview, per <a href="https://www.bloomberg.com/news/articles/2026-09-07/ai-discovered-drug-reverses-aging-markers-in-study-biotech-says" target="_blank">Bloomberg</a>. But these are early results, and the drug’s potential long-term health effects in larger groups of people are unknown. </p><p>The clinical trial included just 42 patients who had a chronic lung disease. While longevity enthusiasts have “long embraced the repurposing of existing medications” to delay aging, efforts to develop “novel antiaging drugs” have often “ended in failure,” said Bloomberg. With the advent of <a href="https://theweek.com/health/why-glp-1s-dont-work-for-everyone">GLP-1 treatments</a>, however, whose benefits appear to extend well beyond weight loss and diabetes, “major pharmaceutical players are increasingly showing interest in the field.”</p><h2 id="not-replacing-scientific-intuition">‘Not replacing scientific intuition’</h2><p>The results of this study are the first to show “very clearly” that “predicted biological age can be reduced,” Vadim Gladyshev, a Harvard Medical School professor who helped build one of the aging clocks, said to the Times. Still, the study is far from conclusive, Gladyshev acknowledges, citing the small sample size and the unreliability of aging clocks. Most notably, Insilico’s drug has “not yet been tested in healthy patients,” said the Times. Because the company conducted its clinical trial solely with IPF patients, the results may be specific to this condition.</p><p>The idea of “reducing aging certainly sounds good” and has become the “obsession of some tech bro-types,” but the “actual utility of aging clocks is up for debate,” said <a href="https://gizmodo.com/study-suggests-ai-generated-drug-could-slow-aging-2000808265" target="_blank">Gizmodo</a>. More recent models focus on proteomics, or “measuring blood proteins,” which a 2024 <a href="https://www.nature.com/articles/s41591-024-03164-7" target="_blank">study</a> found could be used to determine if a person had a higher risk of age-related diseases. While some <a href="https://www.nature.com/articles/s41514-025-00312-2" target="_blank">researchers</a> believe that these “catch-all measurements” could be useful, there’s still a “long way to go before they become truly meaningful markers.” There isn’t yet a measurement that “serves as a universally accepted ‘age’ indicator,” and some doctors have warned that “leaning on these metrics could lead to pursuing the wrong interventions.”</p><p>AI is not “replacing scientific intuition,” and it is “unlikely to do so anytime soon,” said <a href="https://www.forbes.com/sites/timbajarin/2026/08/24/why-ai-driven-drug-discovery-is-becoming-pharmas-next-big-bet/" target="_blank">Forbes</a>. What it can do is “make the costly, time-consuming R&amp;D work” of preparing for clinical trials “more efficient.” For the drug discovery field, that means the “computer screen is becoming nearly as essential as the lab bench.” That shift is “familiar across industries” as “digital tools increasingly become part of the craft rather than merely an add-on.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Why GLP-1s don’t work for everyone ]]></title>
                                                                                                <dc:content><![CDATA[ <p>While glucagon-like peptide-1s have been widely celebrated for transforming weight loss, some who attempt to use the medications find themselves in a less-studied patient category called nonresponders. This minority of people haven’t experienced any significant change in weight even after adjusting their dose or switching brands.</p><h2 id="what-are-the-influencing-factors">What are the influencing factors?</h2><p>Between “9% and a third of participants” in <a href="https://bmjopen.bmj.com/content/15/1/e089477" target="_blank">clinical trials</a> for GLP-1 <a href="https://www.theweek.com/business/economy/the-glp-1-economy-how-weight-loss-drugs-are-impacting-major-industries">weight-loss drugs</a> lose less than 5% of their body weight after months of use, which is the threshold associated with health improvements, said <a href="https://www.theguardian.com/science/2026/sep/07/glp1s-weight-loss-drugs-cravings-non-responders" target="_blank">The Guardian</a>. Now, researchers are “trying to work out why” the drugs are ineffective for nonresponders — a discovery that could help doctors “tailor the use of the drugs, maximize cost-effectiveness and reduce side effects.” </p><p>The drug’s lack of efficacy cannot be blamed on patients, said Alexander Miras, an obesity expert at Ulster University, to The Guardian. If the drug does not “reduce hunger and food intake for someone,” it is “just not going to work.”</p><p>For now, the “short answer” to why some people don’t respond is that “we don’t really know,” said Miras. Research suggests that factors such as “motivation, intelligence, education and socioeconomics” are not predictors of how patients would “respond to GLP-1 medications.” </p><p>Other characteristics such as age, sex and whether or not someone has <a href="https://www.theweek.com/science/church-services-dull-pain-and-a-new-diabetes-drug-science-stories-of-the-week">Type 2 diabetes</a> do appear to have an effect. Studies have also suggested “ancestry might have an impact,” with the medications “most effective in people of European ancestry and least effective in people of African American ancestry,” said The Guardian.</p><p>Some may be jumping the gun, however. Many people labeled as nonresponders simply “do not take the medication correctly” or “discontinue treatment before adequate therapeutic effect can be achieved,” said Kingston University biologists Nadine Wehida and Ahmed Elbediwy at <a href="https://theconversation.com/why-weight-loss-drugs-dont-work-for-some-people-284513" target="_blank">The Conversation</a>. Studies show up to <a href="https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16364" target="_blank">20% to 60%</a> of people “stop treatment within the first year” amid “widespread use of the drug in doses below the recommended amounts.”</p><h2 id="is-there-hope-for-nonresponders">Is there hope for nonresponders?</h2><p>There is “no reliable way” to predict what group one will fall into when trying GLP-1s, said <a href="https://med.stanford.edu/news/insights/2026/06/glp1s-101-weight-loss-wegovy-ozempic-zepbound-side-effects-safe-use.html" target="_blank">Stanford Medicine News Center</a>. The good news is “you don’t have to wait long to find out.” In general, higher doses produce better results, so doctors “typically start patients low and increase gradually, watching for side effects.” </p><p>If the dose is not associated with any weight loss, “waiting three months on the same dose is not going to give you more answers,” said Stanford Medicine endocrinologist Sun Kim to the department’s News Center. You should “increase the dose and reassess.” Whether or not it’s working tends to become clear within the first few weeks.</p><p>Certain medical factors such as “thyroid disorders” can “disrupt metabolism,” said <a href="https://www.yalemedicine.org/news/are-you-a-glp-1-nonresponder" target="_blank">Yale Medicine</a>. People with “impaired glucose regulation,” including those with diabetes, therefore tend to “lose less weight on these medications.” A less common underlying condition could also be playing a role. </p><p>Sometimes, “despite doing everything right,” a patient “just doesn’t respond the way we would hope,” said Avlin Imaeda, a Yale Medicine gastroenterologist. And this phenomenon isn’t “unique to weight-loss medications,” said Yale Medicine. Some patients may not react to “certain blood-pressure drugs, antidepressants or cancer therapies.” Biology is complex, and treatment responses can vary widely. </p><p>For those hoping for something to look forward to, a “series of promising new drugs are in development,” said The Guardian. In the meantime, for nonresponders still struggling to lose weight, “weight-loss surgery may be the only option left.” </p><p>GLP-1-based drugs not working does not “predict a lack of response to [bariatric] surgery,” said Miras. In the end, it’s “not your fault,” and it’s not the drug’s fault either. “This is purely luck.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/why-glp-1s-dont-work-for-everyone</link>
                                                                            <description>
                            <![CDATA[ Some people aren’t responding to the drugs at all, no matter if they try Wegovy or Zepbound ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">xtJfUWBRwt86nnDhYEaZhV</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/39bVdEnN3jG6e8yjYY7aQ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 09 Sep 2026 17:18:04 +0000</pubDate>                                                                                                                                <updated>Mon, 14 Sep 2026 21:02:09 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Theara Coleman, The Week US) ]]></author>                    <dc:creator><![CDATA[ Theara Coleman, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/dAioMdXVU5b4AGPkvvymec-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and the cannabis industry. Theara is also a former high school teacher. She earned a bachelor&#039;s in English literature from Howard University in 2013 and a master&#039;s in the same from New York University in 2022.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;A lifelong book lover, Theara is based in New York, where she spends her spare time reading and playing video games.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/39bVdEnN3jG6e8yjYY7aQ-1920-80.jpg">
                                                            <media:credit><![CDATA[THOM LEACH / SCIENCE PHOTO LIBRARY / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The so-called miracle drug is not as effective for some patients ]]></media:description>                                                            <media:text><![CDATA[Semaglutide weight loss drug, conceptual illustration]]></media:text>
                                <media:title type="plain"><![CDATA[Semaglutide weight loss drug, conceptual illustration]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/39bVdEnN3jG6e8yjYY7aQ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>While glucagon-like peptide-1s have been widely celebrated for transforming weight loss, some who attempt to use the medications find themselves in a less-studied patient category called nonresponders. This minority of people haven’t experienced any significant change in weight even after adjusting their dose or switching brands.</p><h2 id="what-are-the-influencing-factors">What are the influencing factors?</h2><p>Between “9% and a third of participants” in <a href="https://bmjopen.bmj.com/content/15/1/e089477" target="_blank">clinical trials</a> for GLP-1 <a href="https://www.theweek.com/business/economy/the-glp-1-economy-how-weight-loss-drugs-are-impacting-major-industries">weight-loss drugs</a> lose less than 5% of their body weight after months of use, which is the threshold associated with health improvements, said <a href="https://www.theguardian.com/science/2026/sep/07/glp1s-weight-loss-drugs-cravings-non-responders" target="_blank">The Guardian</a>. Now, researchers are “trying to work out why” the drugs are ineffective for nonresponders — a discovery that could help doctors “tailor the use of the drugs, maximize cost-effectiveness and reduce side effects.” </p><p>The drug’s lack of efficacy cannot be blamed on patients, said Alexander Miras, an obesity expert at Ulster University, to The Guardian. If the drug does not “reduce hunger and food intake for someone,” it is “just not going to work.”</p><p>For now, the “short answer” to why some people don’t respond is that “we don’t really know,” said Miras. Research suggests that factors such as “motivation, intelligence, education and socioeconomics” are not predictors of how patients would “respond to GLP-1 medications.” </p><p>Other characteristics such as age, sex and whether or not someone has <a href="https://www.theweek.com/science/church-services-dull-pain-and-a-new-diabetes-drug-science-stories-of-the-week">Type 2 diabetes</a> do appear to have an effect. Studies have also suggested “ancestry might have an impact,” with the medications “most effective in people of European ancestry and least effective in people of African American ancestry,” said The Guardian.</p><p>Some may be jumping the gun, however. Many people labeled as nonresponders simply “do not take the medication correctly” or “discontinue treatment before adequate therapeutic effect can be achieved,” said Kingston University biologists Nadine Wehida and Ahmed Elbediwy at <a href="https://theconversation.com/why-weight-loss-drugs-dont-work-for-some-people-284513" target="_blank">The Conversation</a>. Studies show up to <a href="https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.16364" target="_blank">20% to 60%</a> of people “stop treatment within the first year” amid “widespread use of the drug in doses below the recommended amounts.”</p><h2 id="is-there-hope-for-nonresponders">Is there hope for nonresponders?</h2><p>There is “no reliable way” to predict what group one will fall into when trying GLP-1s, said <a href="https://med.stanford.edu/news/insights/2026/06/glp1s-101-weight-loss-wegovy-ozempic-zepbound-side-effects-safe-use.html" target="_blank">Stanford Medicine News Center</a>. The good news is “you don’t have to wait long to find out.” In general, higher doses produce better results, so doctors “typically start patients low and increase gradually, watching for side effects.” </p><p>If the dose is not associated with any weight loss, “waiting three months on the same dose is not going to give you more answers,” said Stanford Medicine endocrinologist Sun Kim to the department’s News Center. You should “increase the dose and reassess.” Whether or not it’s working tends to become clear within the first few weeks.</p><p>Certain medical factors such as “thyroid disorders” can “disrupt metabolism,” said <a href="https://www.yalemedicine.org/news/are-you-a-glp-1-nonresponder" target="_blank">Yale Medicine</a>. People with “impaired glucose regulation,” including those with diabetes, therefore tend to “lose less weight on these medications.” A less common underlying condition could also be playing a role. </p><p>Sometimes, “despite doing everything right,” a patient “just doesn’t respond the way we would hope,” said Avlin Imaeda, a Yale Medicine gastroenterologist. And this phenomenon isn’t “unique to weight-loss medications,” said Yale Medicine. Some patients may not react to “certain blood-pressure drugs, antidepressants or cancer therapies.” Biology is complex, and treatment responses can vary widely. </p><p>For those hoping for something to look forward to, a “series of promising new drugs are in development,” said The Guardian. In the meantime, for nonresponders still struggling to lose weight, “weight-loss surgery may be the only option left.” </p><p>GLP-1-based drugs not working does not “predict a lack of response to [bariatric] surgery,” said Miras. In the end, it’s “not your fault,” and it’s not the drug’s fault either. “This is purely luck.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ‘There are several reasons why we’re in this precarious situation’ ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="healthcare-is-more-badly-broken-than-political-leaders-admit">‘Healthcare is more badly broken than political leaders admit’</h2><p><strong>Marj Halperin at the Chicago Tribune</strong></p><p>While “rising costs are a barrier for too many, even those who can afford comprehensive health insurance are finding money can’t buy you a timely appointment,” says Marj Halperin. Americans in cities are “now in much the same bind as patients in rural areas who have long found limited doctors available for routine care, with specialists often a few hours’ drive away.” It is “time for political leaders to spell out a strategy to speed in the opposite direction.”</p><p><a href="https://www.chicagotribune.com/2026/08/28/opinion-us-healthcare-badly-broken/" target="_blank"><em>Read more</em></a></p><h2 id="a-wildly-popular-movie-meets-the-film-world-s-most-revered-label">‘A wildly popular movie meets the film world’s most revered label’</h2><p><strong>Sophia Nguyen at The Atlantic</strong></p><p>“‘KPop Demon Hunters’ seems to have completely overtaken culture,” says Sophia Nguyen. But “even the most ardent fans likely did not anticipate the mega-hit’s next big merch drop: a disc release from the Criterion Collection, home to some of cinema’s most distinguished titles.” Some of the “label’s longtime devotees greeted the addition of ‘KPop Demon Hunters’<em> </em>with an eye roll,” but “Criterion has good reason to widen the net: Netflix, Apple and Amazon make and distribute a significant share of films.”</p><p><a href="https://www.theatlantic.com/culture/2026/08/kpop-demon-hunters-criterion-collection-movies/688444/" target="_blank"><em>Read more</em></a></p><h2 id="trump-s-tariffs-prove-even-canada-can-t-afford-to-be-nice-to-the-united-states-anymore">‘Trump’s tariffs prove even Canada can’t afford to be nice to the United States anymore’</h2><p><strong>The Philadelphia Inquirer editorial board</strong></p><p>It “fell to Canada, a country famous for friendliness, to demonstrate the limits of an age-old friendship with the United States,” says The Philadelphia Inquirer editorial board. After a “decade of dealing politely with President Donald Trump’s manic ricocheting between trade agreements and trade warfare, supplies of northern niceness are sorely depleted, and rightly so.” Prime Minister Mark Carney’s “defiance in the face of his neighbor’s unprovoked bullying should inspire other traditional American allies to abandon appeasement.”</p><p><a href="https://www.inquirer.com/opinion/editorials/canada-trade-war-trump-bully-cost-prices-tariffs-20260827.html" target="_blank"><em>Read more</em></a></p><h2 id="meta-s-18-billion-settlement-could-reshape-social-media-for-young-people">‘Meta’s $18 billion settlement could reshape social media for young people’</h2><p><strong>Tom Jones at the Poynter Institute</strong></p><p>Meta “reached a landmark settlement and agreed to pay up to $18 billion to 47 states” to settle claims it “endangered children through addictive features,” says Tom Jones. Meta’s promised changes are “meant to curb endless scrolling, which can interrupt sleep and have other negative effects on young people’s health and well-being.” The “smart move for Meta was to settle,” as a “major challenge for all social media companies is verifying the ages of their users.” </p><p><a href="https://www.poynter.org/commentary/2026/meta-settlement-social-media-addiction-children-teens/" target="_blank"><em>Read more</em></a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/instant-opinion-healthcare-doctors-film-donald-trump-meta</link>
                                                                            <description>
                            <![CDATA[ Opinion, comment and editorials of the day ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">wddrK9GXVk4ERK3Rgb6mDM</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/eWkE6xwDskKVLEHRNQoiLd-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 28 Aug 2026 18:43:47 +0000</pubDate>                                                                                                                                <updated>Fri, 28 Aug 2026 18:43:58 +0000</updated>
                                                                                                                                            <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/eWkE6xwDskKVLEHRNQoiLd-1920-80.jpg">
                                                            <media:credit><![CDATA[Deb Cohn-Orbach / UCG / Universal Images Group / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[It is ‘time for political leaders to spell out a strategy’ for healthcare]]></media:description>                                                            <media:text><![CDATA[An empty doctor’s office with a computer on the wall. ]]></media:text>
                                <media:title type="plain"><![CDATA[An empty doctor’s office with a computer on the wall. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/eWkE6xwDskKVLEHRNQoiLd-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="healthcare-is-more-badly-broken-than-political-leaders-admit">‘Healthcare is more badly broken than political leaders admit’</h2><p><strong>Marj Halperin at the Chicago Tribune</strong></p><p>While “rising costs are a barrier for too many, even those who can afford comprehensive health insurance are finding money can’t buy you a timely appointment,” says Marj Halperin. Americans in cities are “now in much the same bind as patients in rural areas who have long found limited doctors available for routine care, with specialists often a few hours’ drive away.” It is “time for political leaders to spell out a strategy to speed in the opposite direction.”</p><p><a href="https://www.chicagotribune.com/2026/08/28/opinion-us-healthcare-badly-broken/" target="_blank"><em>Read more</em></a></p><h2 id="a-wildly-popular-movie-meets-the-film-world-s-most-revered-label">‘A wildly popular movie meets the film world’s most revered label’</h2><p><strong>Sophia Nguyen at The Atlantic</strong></p><p>“‘KPop Demon Hunters’ seems to have completely overtaken culture,” says Sophia Nguyen. But “even the most ardent fans likely did not anticipate the mega-hit’s next big merch drop: a disc release from the Criterion Collection, home to some of cinema’s most distinguished titles.” Some of the “label’s longtime devotees greeted the addition of ‘KPop Demon Hunters’<em> </em>with an eye roll,” but “Criterion has good reason to widen the net: Netflix, Apple and Amazon make and distribute a significant share of films.”</p><p><a href="https://www.theatlantic.com/culture/2026/08/kpop-demon-hunters-criterion-collection-movies/688444/" target="_blank"><em>Read more</em></a></p><h2 id="trump-s-tariffs-prove-even-canada-can-t-afford-to-be-nice-to-the-united-states-anymore">‘Trump’s tariffs prove even Canada can’t afford to be nice to the United States anymore’</h2><p><strong>The Philadelphia Inquirer editorial board</strong></p><p>It “fell to Canada, a country famous for friendliness, to demonstrate the limits of an age-old friendship with the United States,” says The Philadelphia Inquirer editorial board. After a “decade of dealing politely with President Donald Trump’s manic ricocheting between trade agreements and trade warfare, supplies of northern niceness are sorely depleted, and rightly so.” Prime Minister Mark Carney’s “defiance in the face of his neighbor’s unprovoked bullying should inspire other traditional American allies to abandon appeasement.”</p><p><a href="https://www.inquirer.com/opinion/editorials/canada-trade-war-trump-bully-cost-prices-tariffs-20260827.html" target="_blank"><em>Read more</em></a></p><h2 id="meta-s-18-billion-settlement-could-reshape-social-media-for-young-people">‘Meta’s $18 billion settlement could reshape social media for young people’</h2><p><strong>Tom Jones at the Poynter Institute</strong></p><p>Meta “reached a landmark settlement and agreed to pay up to $18 billion to 47 states” to settle claims it “endangered children through addictive features,” says Tom Jones. Meta’s promised changes are “meant to curb endless scrolling, which can interrupt sleep and have other negative effects on young people’s health and well-being.” The “smart move for Meta was to settle,” as a “major challenge for all social media companies is verifying the ages of their users.” </p><p><a href="https://www.poynter.org/commentary/2026/meta-settlement-social-media-addiction-children-teens/" target="_blank"><em>Read more</em></a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Letters ‘refute’ RFK Jr’s Samoa vaccine testimony ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-3">What happened</h2><p>Health Secretary <a href="https://theweek.com/1025265/rfk-jr-controversies">Robert F. Kennedy Jr.</a> repeatedly testified in his Senate confirmation hearing last year that a 2019 trip to Samoa had “nothing to do with vaccines,” but new documents obtained through freedom of information requests “refute that testimony,” <a href="https://apnews.com/article/rfk-jr-kennedy-samoa-vaccines-mmr-ba6ad3ffadca48599b1c178a392fb37b" target="_blank">The Associated Press</a> said Thursday. Kennedy was a “prominent anti-vaccine activist" at the time, and "critics said the visit fueled anti-vaccine sentiment" before a <a href="https://theweek.com/health/measles-elimination-status-us-cases">measles outbreak</a> that killed 83 Samoans. In one letter, Kennedy “explicitly told the Samoan prime minister he wanted to study” the measles, mumps and rubella vaccine there and “used the words ‘vaccine’ or ‘vaccination’ eight times,” said <a href="https://www.theguardian.com/us-news/2026/aug/27/rfk-jr-confirmation-hearing-investigation" target="_blank">The Guardian</a>.</p><h2 id="who-said-what-3">Who said what</h2><p>“RFK’s platform is built on lies” that “leave a trail of dead children,” said Sen. Ron Wyden (Ore.), the top Democrat on the Senate Finance Committee. “There are consequences for lying to Congress.” Watchdog group American Oversight on Thursday <a href="https://www.documentcloud.org/documents/28585103-letter-to-ag-todd-blanche-and-us-attorney-jeanine-pirro-regarding-apparent-false-statements-by-rfk-jr/" target="_blank">asked the Justice Department</a> to investigate Kennedy’s testimony for false statements. The Health and Human Services Department told the AP that “any claim or insinuation” Kennedy “lied under oath or to Congress” based on these letters is “not only false but outright defamatory.” </p><h2 id="what-next-4">What next? </h2><p>“Lying to Congress is a crime, whether or not the witness is under oath,” Georgetown law professor Josh Chafetz told The Guardian. But this Justice Department is “unlikely” to prosecute Kennedy.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/letters-refute-rfk-jr-samoa-vaccines</link>
                                                                            <description>
                            <![CDATA[ The HHS secretary once said his trip to Samoa was unrelated to vaccines ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">iXAWMxPuaCgmMwsbv6jfXY</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/gNxARJ6oQjFRxedwAajA3i-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 28 Aug 2026 15:05:40 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Peter Weber, The Week US) ]]></author>                    <dc:creator><![CDATA[ Peter Weber, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/468oRmsak796WaimXBHwL9-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Peter has worked as a news and culture writer and editor at The Week since the site&#039;s launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University. He graduated from Northwestern University with degrees in international studies and performance studies and served in the Peace Corps in Honduras.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Peter has lived in Italy and all major quadrants of the continental U.S. and currently resides in Austin, Texas, where he plays bass and rhythm cello in a garage band.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/gNxARJ6oQjFRxedwAajA3i-1920-80.jpg">
                                                            <media:credit><![CDATA[Eric Lee / Bloomberg via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Health Secretary Robert F. Kennedy testifies before the Senate]]></media:description>                                                            <media:text><![CDATA[Health Secretary Robert F. Kennedy testifies before the Senate]]></media:text>
                                <media:title type="plain"><![CDATA[Health Secretary Robert F. Kennedy testifies before the Senate]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/gNxARJ6oQjFRxedwAajA3i-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-3">What happened</h2><p>Health Secretary <a href="https://theweek.com/1025265/rfk-jr-controversies">Robert F. Kennedy Jr.</a> repeatedly testified in his Senate confirmation hearing last year that a 2019 trip to Samoa had “nothing to do with vaccines,” but new documents obtained through freedom of information requests “refute that testimony,” <a href="https://apnews.com/article/rfk-jr-kennedy-samoa-vaccines-mmr-ba6ad3ffadca48599b1c178a392fb37b" target="_blank">The Associated Press</a> said Thursday. Kennedy was a “prominent anti-vaccine activist" at the time, and "critics said the visit fueled anti-vaccine sentiment" before a <a href="https://theweek.com/health/measles-elimination-status-us-cases">measles outbreak</a> that killed 83 Samoans. In one letter, Kennedy “explicitly told the Samoan prime minister he wanted to study” the measles, mumps and rubella vaccine there and “used the words ‘vaccine’ or ‘vaccination’ eight times,” said <a href="https://www.theguardian.com/us-news/2026/aug/27/rfk-jr-confirmation-hearing-investigation" target="_blank">The Guardian</a>.</p><h2 id="who-said-what-3">Who said what</h2><p>“RFK’s platform is built on lies” that “leave a trail of dead children,” said Sen. Ron Wyden (Ore.), the top Democrat on the Senate Finance Committee. “There are consequences for lying to Congress.” Watchdog group American Oversight on Thursday <a href="https://www.documentcloud.org/documents/28585103-letter-to-ag-todd-blanche-and-us-attorney-jeanine-pirro-regarding-apparent-false-statements-by-rfk-jr/" target="_blank">asked the Justice Department</a> to investigate Kennedy’s testimony for false statements. The Health and Human Services Department told the AP that “any claim or insinuation” Kennedy “lied under oath or to Congress” based on these letters is “not only false but outright defamatory.” </p><h2 id="what-next-4">What next? </h2><p>“Lying to Congress is a crime, whether or not the witness is under oath,” Georgetown law professor Josh Chafetz told The Guardian. But this Justice Department is “unlikely” to prosecute Kennedy.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ The Ebola outbreak: ‘a perfect storm’ ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Over 100 days into the Ebola outbreak in the Democratic Republic of Congo (DRC), “the response is still struggling to keep pace”, said Liz Cookman in <a href="https://www.independent.co.uk/news/world/africa/ebola-congo-outbreak-virus-100-days-b3037227.html" target="_blank">The Independent</a>. It’s estimated that more than 2,500 people have now died, with the death toll accelerating sharply in recent weeks. </p><p>It is the fastest-growing Ebola outbreak on record, spreading much quicker than the deadliest crisis to date, the West African epidemic of 2014 to 2016, which killed more than 11,000 people. To put it in context, that outbreak took a year to reach 2,000 deaths. </p><h2 id="destabilised-by-conflict">Destabilised by conflict</h2><p>“The situation is bad,” said Devi Sridhar in <a href="https://www.theguardian.com/commentisfree/2026/aug/17/ebola-kills-thousands-drc-perfect-storm-virus" target="_blank">The Guardian</a>. The mortality rate seems to be nearly 50%. More than half of victims are dying without receiving care. Children make up almost a third of all deaths. </p><p>Yet this outbreak isn’t attracting much attention abroad. Compared with the 2014 outbreak, the current silence is “astounding”. That year, Ebola was one of the most Googled terms in the world; this year, “no one wants to hear about infectious diseases”. Things are only going to get worse. A “perfect storm of factors” is making the spread hard to contain. The virus is the Bundibugyo species, for which there is currently no licensed vaccine or specific treatment, although clinical trials are under way. </p><p>The location of the outbreak has made it worse, said Matthew Mpoke Bigg in <a href="https://www.nytimes.com/2026/05/17/world/africa/what-to-know-ebola-africa.html" target="_blank">The New York Times</a>. Uganda has succeeded in eliminating an outbreak; but Ituri province in north-eastern Congo is unstable, with ongoing conflict and roaming militias. More than 900,000 people have been displaced, while the region’s gold mines draw workers from a wide area. The virus has now spread to six provinces across the DRC. There are fears that it could spread to South Sudan, and to the Congolese capital, Kinshasa, one of Africa’s biggest cities. </p><h2 id="dismantling-of-usaid">Dismantling of USAID</h2><p>The situation in DRC has been “disastrously compounded” by cuts to Western aid, said <a href="https://www.theguardian.com/commentisfree/2026/aug/19/the-guardian-view-on-the-ebola-outbreak-in-the-drc-a-case-study-in-why-international-aid-matters" target="_blank">The Guardian</a>, above all by the US. The <a href="https://theweek.com/politics/usaid-trump-administration-humanitarian-problems-world">dismantling of USAID</a> has weakened health infrastructure and surveillance capacity, while Washington’s <a href="https://theweek.com/speedreads/924210/trump-officially-begins-withdrawal-from-who">withdrawal from the World Health Organisation</a> has also undermined the response. European countries, too, have started to treat international aid as “luxury expenditure”. </p><p>The 2014 outbreak laid bare the risk of Ebola spreading in the region and beyond. In the wake of the Covid pandemic, countless pieties were uttered about disease control. Yet here we are again. “Subsequent actions by governments have belied those words” leaving the DRC exposed to an epidemic that could soon spiral “out of control”.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/the-ebola-outbreak-a-perfect-storm</link>
                                                                            <description>
                            <![CDATA[ This has been the fastest-growing outbreak of the disease ever, but the silence around it is ‘astounding’ ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">KzsPFp6SeYjwGikb28BGfi</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/5LBwXLThfuExTjfaoJBzGh-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 28 Aug 2026 09:58:51 +0000</pubDate>                                                                                                                                <updated>Fri, 04 Sep 2026 14:00:01 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (The Week UK) ]]></author>                    <dc:creator><![CDATA[ The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/5LBwXLThfuExTjfaoJBzGh-1920-80.jpg">
                                                            <media:credit><![CDATA[Jospin Mwisha / AFP / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[It’s estimated that more than 2,500 people have now died, with the death toll accelerating sharply in recent weeks]]></media:description>                                                            <media:text><![CDATA[A health worker in full protective equipment next to medical supplies]]></media:text>
                                <media:title type="plain"><![CDATA[A health worker in full protective equipment next to medical supplies]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/5LBwXLThfuExTjfaoJBzGh-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Over 100 days into the Ebola outbreak in the Democratic Republic of Congo (DRC), “the response is still struggling to keep pace”, said Liz Cookman in <a href="https://www.independent.co.uk/news/world/africa/ebola-congo-outbreak-virus-100-days-b3037227.html" target="_blank">The Independent</a>. It’s estimated that more than 2,500 people have now died, with the death toll accelerating sharply in recent weeks. </p><p>It is the fastest-growing Ebola outbreak on record, spreading much quicker than the deadliest crisis to date, the West African epidemic of 2014 to 2016, which killed more than 11,000 people. To put it in context, that outbreak took a year to reach 2,000 deaths. </p><h2 id="destabilised-by-conflict">Destabilised by conflict</h2><p>“The situation is bad,” said Devi Sridhar in <a href="https://www.theguardian.com/commentisfree/2026/aug/17/ebola-kills-thousands-drc-perfect-storm-virus" target="_blank">The Guardian</a>. The mortality rate seems to be nearly 50%. More than half of victims are dying without receiving care. Children make up almost a third of all deaths. </p><p>Yet this outbreak isn’t attracting much attention abroad. Compared with the 2014 outbreak, the current silence is “astounding”. That year, Ebola was one of the most Googled terms in the world; this year, “no one wants to hear about infectious diseases”. Things are only going to get worse. A “perfect storm of factors” is making the spread hard to contain. The virus is the Bundibugyo species, for which there is currently no licensed vaccine or specific treatment, although clinical trials are under way. </p><p>The location of the outbreak has made it worse, said Matthew Mpoke Bigg in <a href="https://www.nytimes.com/2026/05/17/world/africa/what-to-know-ebola-africa.html" target="_blank">The New York Times</a>. Uganda has succeeded in eliminating an outbreak; but Ituri province in north-eastern Congo is unstable, with ongoing conflict and roaming militias. More than 900,000 people have been displaced, while the region’s gold mines draw workers from a wide area. The virus has now spread to six provinces across the DRC. There are fears that it could spread to South Sudan, and to the Congolese capital, Kinshasa, one of Africa’s biggest cities. </p><h2 id="dismantling-of-usaid">Dismantling of USAID</h2><p>The situation in DRC has been “disastrously compounded” by cuts to Western aid, said <a href="https://www.theguardian.com/commentisfree/2026/aug/19/the-guardian-view-on-the-ebola-outbreak-in-the-drc-a-case-study-in-why-international-aid-matters" target="_blank">The Guardian</a>, above all by the US. The <a href="https://theweek.com/politics/usaid-trump-administration-humanitarian-problems-world">dismantling of USAID</a> has weakened health infrastructure and surveillance capacity, while Washington’s <a href="https://theweek.com/speedreads/924210/trump-officially-begins-withdrawal-from-who">withdrawal from the World Health Organisation</a> has also undermined the response. European countries, too, have started to treat international aid as “luxury expenditure”. </p><p>The 2014 outbreak laid bare the risk of Ebola spreading in the region and beyond. In the wake of the Covid pandemic, countless pieties were uttered about disease control. Yet here we are again. “Subsequent actions by governments have belied those words” leaving the DRC exposed to an epidemic that could soon spiral “out of control”.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ FDA approves landmark pancreatic cancer drug ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-4">What happened</h2><p>The Food and Drug Administration on Wednesday <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer" target="_blank">approved</a> a first-of-its-kind drug for advanced pancreatic cancer, one of the deadliest types of cancer and among the hardest to treat. The FDA’s expedited <a href="https://theweek.com/health/pill-offers-hope-pancreatic-cancer">approval of daraxonrasib</a>, a daily pill developed by Revolution Medicines and sold as Rasonque, followed a clinical trial in which patients on the drug <a href="https://theweek.com/health-and-science/1019386/recent-scientific-breakthroughs">lived a median 13.2 months</a>, twice as long as those who underwent chemotherapy, and with fewer side effects. Some “patients who have gotten the drug through clinical trials have lived for years,” <a href="https://www.nytimes.com/2026/08/26/science/pancreatic-cancer-daraxonrasib-approval.html" target="_blank">The New York Times</a> said.</p><h2 id="who-said-what-4">Who said what</h2><p>Daraxonrasib has “electrified cancer specialists and patients,” the Times said. It’s “not a cure, but it is the first treatment to substantially extend the lives of patients” with a disease <a href="https://theweek.com/health/a-pivotal-moment-for-personalised-cancer-vaccines">long considered among</a> the “most hopeless in medicine.” Nearly all pancreatic tumors are fueled by a mutated cellular protein, KRAS, that’s stubbornly resistant to interventions. Daraxonrasib “uses what’s essentially a molecular glue to bind with multiple KRAS subtypes” and shut them down, <a href="https://www.wral.com/news/ap/03e43-fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve-survival/" target="_blank">The Associated Press</a> said. Revolution is “studying its technology for several other forms of cancer, including lung cancer.” </p><h2 id="what-next-5">What next? </h2><p>Revolution said Rasonque is “now available in the United States at $39,800 for a 30-day ​supply,” <a href="https://www.reuters.com/legal/litigation/revolution-medicines-gets-fda-nod-targeted-pancreatic-cancer-drug-2026-08-26/" target="_blank">Reuters</a> said. The “vast majority of the cost is expected to be covered through insurance,” the Times said.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/fda-approves-landmark-pancreatic-cancer-drug</link>
                                                                            <description>
                            <![CDATA[ A clinical trial saw patients on the drug live a median of 13.2 months ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">jUxDAZLdFHp2vBgdQN56iP</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/xSiKxxEpEi9rKX6BbwBJDY-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 27 Aug 2026 15:05:29 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Peter Weber, The Week US) ]]></author>                    <dc:creator><![CDATA[ Peter Weber, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/468oRmsak796WaimXBHwL9-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Peter has worked as a news and culture writer and editor at The Week since the site&#039;s launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University. He graduated from Northwestern University with degrees in international studies and performance studies and served in the Peace Corps in Honduras.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Peter has lived in Italy and all major quadrants of the continental U.S. and currently resides in Austin, Texas, where he plays bass and rhythm cello in a garage band.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/xSiKxxEpEi9rKX6BbwBJDY-1920-80.jpg">
                                                            <media:credit><![CDATA[Vlad Vulturar / iStock / Getty Images Plus]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The drug costs $39,800 for a 30-day ​supply]]></media:description>                                                            <media:text><![CDATA[Blue pills]]></media:text>
                                <media:title type="plain"><![CDATA[Blue pills]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/xSiKxxEpEi9rKX6BbwBJDY-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-4">What happened</h2><p>The Food and Drug Administration on Wednesday <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer" target="_blank">approved</a> a first-of-its-kind drug for advanced pancreatic cancer, one of the deadliest types of cancer and among the hardest to treat. The FDA’s expedited <a href="https://theweek.com/health/pill-offers-hope-pancreatic-cancer">approval of daraxonrasib</a>, a daily pill developed by Revolution Medicines and sold as Rasonque, followed a clinical trial in which patients on the drug <a href="https://theweek.com/health-and-science/1019386/recent-scientific-breakthroughs">lived a median 13.2 months</a>, twice as long as those who underwent chemotherapy, and with fewer side effects. Some “patients who have gotten the drug through clinical trials have lived for years,” <a href="https://www.nytimes.com/2026/08/26/science/pancreatic-cancer-daraxonrasib-approval.html" target="_blank">The New York Times</a> said.</p><h2 id="who-said-what-4">Who said what</h2><p>Daraxonrasib has “electrified cancer specialists and patients,” the Times said. It’s “not a cure, but it is the first treatment to substantially extend the lives of patients” with a disease <a href="https://theweek.com/health/a-pivotal-moment-for-personalised-cancer-vaccines">long considered among</a> the “most hopeless in medicine.” Nearly all pancreatic tumors are fueled by a mutated cellular protein, KRAS, that’s stubbornly resistant to interventions. Daraxonrasib “uses what’s essentially a molecular glue to bind with multiple KRAS subtypes” and shut them down, <a href="https://www.wral.com/news/ap/03e43-fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve-survival/" target="_blank">The Associated Press</a> said. Revolution is “studying its technology for several other forms of cancer, including lung cancer.” </p><h2 id="what-next-5">What next? </h2><p>Revolution said Rasonque is “now available in the United States at $39,800 for a 30-day ​supply,” <a href="https://www.reuters.com/legal/litigation/revolution-medicines-gets-fda-nod-targeted-pancreatic-cancer-drug-2026-08-26/" target="_blank">Reuters</a> said. The “vast majority of the cost is expected to be covered through insurance,” the Times said.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ‘It’s easy to get injured doing what we love’ ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="sports-medicine-must-get-better-at-treating-women">‘Sports medicine must get better at treating women’</h2><p><strong>Ashley Austin at Newsweek</strong></p><p>Even as “more eyes turn to women’s sports and female athletes surge in popularity, there’s still a great deal that sports medicine doctors don’t know about actually treating women,” says WNBA doctor Ashley Austin. Americans need “increased investment in women’s sports science — not just to improve outcomes for elite athletes but to improve care for women and girls across the healthcare system.” Doctors should learn to “provide care that is truly based on evidence specific to women’s anatomy and physiology.”</p><p><a href="https://www.newsweek.com/womens-sports-are-booming-womens-sports-medicine-must-catch-up-opinion-12343689" target="_blank"><em>Read more</em></a></p><h2 id="are-us-black-ops-targeting-boats-in-the-galapagos">‘Are US black ops targeting boats in the Galapagos?’</h2><p><strong>The Dallas Morning News editorial board</strong></p><p>Attacks on “fishing boats off the coast of Ecuador earlier this year are surrounded by mystery and unanswered questions,” says The Dallas Morning News editorial board. The “evidence is scarce, but it is enough for Congress to start asking questions.” Who “ordered these attacks and to what end”? If there is “indeed some sort of black ops targeting fishermen with no accountability, it will mark another stain in a long, bad history of U.S. intervention in Latin America.”</p><p><a href="https://www.dallasnews.com/opinion/editorials/article/ecuador-fishing-boat-strikes-questions-22401460.php" target="_blank"><em>Read more</em></a></p><h2 id="i-m-a-physicist-congress-is-about-to-close-the-door-that-let-me-in">‘I’m a physicist. Congress is about to close the door that let me in.’</h2><p><strong>Stephanie L. Bailey at The Seattle Times</strong></p><p>Somewhere in the “country, a talented future scientist is about to be overlooked, not for lack of ability, but because no one has decided they’re worth helping,” says Stephanie L. Bailey. Two House bill provisions “would bar federal science agencies from funding the offices and grants that broaden participation in STEM.” Some “argue federal agencies should simply fund the best science and that programs like these distract from that mission,” but “in fact, the opposite is true.”</p><p><a href="https://www.seattletimes.com/opinion/im-a-physicist-congress-is-about-to-close-the-door-that-let-me-in/" target="_blank"><em>Read more</em></a></p><h2 id="my-road-trip-revealed-the-good-and-the-bad-that-hold-america-together">‘My road trip revealed the good and the bad that hold America together’</h2><p><strong>LZ Granderson at the Los Angeles Times</strong></p><p>There is a “commonality I saw on my drive across America: homelessness,” says LZ Granderson. Americans “like to tell ourselves it’s a California problem, a Chicago problem — something that happens in big blue states.” But of the “states I drove through, all but one were red.” We are “teaching the next generation that, in the richest country that has ever existed, it is acceptable that some people are reduced to huddling in storefront entryways overnight.”</p><p><a href="https://www.latimes.com/opinion/story/2026-08-21/road-trip-america-homelessness" target="_blank"><em>Read more</em></a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/instant-opinion-wnba-doctor-galapagos-physicist-homeless</link>
                                                                            <description>
                            <![CDATA[ Opinion, comment and editorials of the day ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">BPKjrv6DgvKzx6bzNurvNc</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/EYyCX7sYdoZ4itB9c3ZJiW-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 26 Aug 2026 18:25:50 +0000</pubDate>                                                                                                                                <updated>Wed, 26 Aug 2026 19:42:22 +0000</updated>
                                                                                                                                            <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/EYyCX7sYdoZ4itB9c3ZJiW-1920-80.jpg">
                                                            <media:credit><![CDATA[Luke Hales / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[WNBA players Cameron Brink and Isobel Borlase play against each other]]></media:description>                                                            <media:text><![CDATA[WNBA players Cameron Brink and Isobel Borlase play against each other. ]]></media:text>
                                <media:title type="plain"><![CDATA[WNBA players Cameron Brink and Isobel Borlase play against each other. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/EYyCX7sYdoZ4itB9c3ZJiW-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="sports-medicine-must-get-better-at-treating-women">‘Sports medicine must get better at treating women’</h2><p><strong>Ashley Austin at Newsweek</strong></p><p>Even as “more eyes turn to women’s sports and female athletes surge in popularity, there’s still a great deal that sports medicine doctors don’t know about actually treating women,” says WNBA doctor Ashley Austin. Americans need “increased investment in women’s sports science — not just to improve outcomes for elite athletes but to improve care for women and girls across the healthcare system.” Doctors should learn to “provide care that is truly based on evidence specific to women’s anatomy and physiology.”</p><p><a href="https://www.newsweek.com/womens-sports-are-booming-womens-sports-medicine-must-catch-up-opinion-12343689" target="_blank"><em>Read more</em></a></p><h2 id="are-us-black-ops-targeting-boats-in-the-galapagos">‘Are US black ops targeting boats in the Galapagos?’</h2><p><strong>The Dallas Morning News editorial board</strong></p><p>Attacks on “fishing boats off the coast of Ecuador earlier this year are surrounded by mystery and unanswered questions,” says The Dallas Morning News editorial board. The “evidence is scarce, but it is enough for Congress to start asking questions.” Who “ordered these attacks and to what end”? If there is “indeed some sort of black ops targeting fishermen with no accountability, it will mark another stain in a long, bad history of U.S. intervention in Latin America.”</p><p><a href="https://www.dallasnews.com/opinion/editorials/article/ecuador-fishing-boat-strikes-questions-22401460.php" target="_blank"><em>Read more</em></a></p><h2 id="i-m-a-physicist-congress-is-about-to-close-the-door-that-let-me-in">‘I’m a physicist. Congress is about to close the door that let me in.’</h2><p><strong>Stephanie L. Bailey at The Seattle Times</strong></p><p>Somewhere in the “country, a talented future scientist is about to be overlooked, not for lack of ability, but because no one has decided they’re worth helping,” says Stephanie L. Bailey. Two House bill provisions “would bar federal science agencies from funding the offices and grants that broaden participation in STEM.” Some “argue federal agencies should simply fund the best science and that programs like these distract from that mission,” but “in fact, the opposite is true.”</p><p><a href="https://www.seattletimes.com/opinion/im-a-physicist-congress-is-about-to-close-the-door-that-let-me-in/" target="_blank"><em>Read more</em></a></p><h2 id="my-road-trip-revealed-the-good-and-the-bad-that-hold-america-together">‘My road trip revealed the good and the bad that hold America together’</h2><p><strong>LZ Granderson at the Los Angeles Times</strong></p><p>There is a “commonality I saw on my drive across America: homelessness,” says LZ Granderson. Americans “like to tell ourselves it’s a California problem, a Chicago problem — something that happens in big blue states.” But of the “states I drove through, all but one were red.” We are “teaching the next generation that, in the richest country that has ever existed, it is acceptable that some people are reduced to huddling in storefront entryways overnight.”</p><p><a href="https://www.latimes.com/opinion/story/2026-08-21/road-trip-america-homelessness" target="_blank"><em>Read more</em></a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ DEI clashes lead to funding cuts for Alzheimer’s research ]]></title>
                                                                                                <dc:content><![CDATA[ <p>With the Trump administration pushing back against a swath of DEI-related federal grants, some research related to major diseases, including Alzheimer’s, is being caught in the crossfire. The most recent round of grant axing resulted in two major universities losing millions in funding related to studying brain disease, and experts say it could put them at a large disadvantage. </p><h2 id="what-research-is-being-impacted">What research is being impacted? </h2><p>In 2025, the U.S. awarded 52% fewer grants related to Alzheimer’s research than in 2024, according to the <a href="https://report.nih.gov/nihdatabook/report/302" target="_blank">National Institutes of Health</a> (NIH), with the number of grants falling from 369 to 177. The figure appears to be on track through 2026 as well, especially given the most recent cuts. </p><p>The newest funding slashes involve grant cancellations for “brain health and Alzheimer’s disease research at two leading research institutions, Emory University and the University of Pittsburgh,” said <a href="https://www.theguardian.com/us-news/2026/aug/17/alzheimers-research-grants-trump-administration" target="_blank">The Guardian</a>. At least “three grants were canceled between the two institutions,” representing $15 million in funds that would’ve <a href="https://theweek.com/health/watching-tv-brain-volume-dementia-alzheimers">been used to study</a> “how discrimination” — or racism — “affects long-term brain health.” </p><p>The topics “we’re measuring are scientifically valid concepts,” Andrea Rosso, an associate professor of epidemiology at the University of Pittsburgh, told The Guardian. Black people are two times more likely to develop dementia, according to the <a href="https://aaic.alz.org/downloads2020/2020_Race_and_Ethnicity_Fact_Sheet.pdf" target="_blank">Alzheimer’s Association</a>. And while these studies “don’t actually measure structural racism,” they do “use that as a framing for why one population is at such high risk.”</p><p>The <a href="https://theweek.com/politics/trump-cracks-down-on-womens-retreats-putting-new-girls-clubs-at-risk">DEI-related funding cuts</a> are also coming alongside additional efforts by the White House to overhaul how grants are awarded. Under newly proposed rules by the Trump administration, any “multiyear grant could be terminated at any point,” and the government “would not be allowed to fund any DEI-related activities or projects or groups that ‘deny the biological reality of sex or the sex binary in humans,’” said <a href="https://www.bostonglobe.com/2026/07/12/metro/federal-funding-trump-science-research/?event=event12" target="_blank">The Boston Globe</a>. </p><h2 id="what-does-this-mean-for-alzheimer-s-patients">What does this mean for Alzheimer’s patients? </h2><p>Many are worried that <a href="https://theweek.com/health/trial-copper-drug-restores-memory-clears-alzheimers-proteins">cutting Alzheimer’s research</a> under the guise of the anti-DEI movement could negatively impact patients, specifically those who are Black. One canceled grant at the University of Pittsburgh “studied how Alzheimer’s disease risk was affected in people who live in divested, predominantly African American neighborhoods,” said The Guardian. The research tracked “socially driven Alzheimer’s disease risk factors by collecting surveys, brain imaging and blood samples.” Another grant at Emory University that was slashed by the White House “studied the impact of racial discrimination on the white matter of the brain, in part surveying participants’ self-reported incidences of discrimination.” </p><p>Behind all of these killed studies are “people waiting for answers, for therapies, for relief, for hope,” said a pain researcher at Mass General Brigham, per the Globe. This comes as the Trump administration has “been open about wanting a smaller NIH,” said <a href="https://www.vox.com/future-perfect/482363/nih-medical-research-grants-cut-2025" target="_blank">Vox</a>, and originally “proposed cutting the agency’s budget for 2026 by 40%.”</p><p>Some researchers say they are considering taking their studies offshore if things do not change. “While I hope to improve the lives of the American people with my research, if I am not able to pursue this aspiration in the U.S., I would rather continue to do so outside of the country,” one Ph.D. student said in comments about the cuts, per the Globe. </p><p>The current state of affairs “demonstrates a lack of understanding of our outcomes versus our exposures,” Ann Cohen, an associate professor of psychiatry at the University of Pittsburgh, said to The Guardian. “That’s epidemiology 101.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/dei-concerns-funding-cuts-alzheimers</link>
                                                                            <description>
                            <![CDATA[ At least two major research institutions have been hit with cuts ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">qTpXXm9BMRAZ83tKLMsn64</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/DeFGhVUG55BvixQEyYzwCo-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 21 Aug 2026 16:30:28 +0000</pubDate>                                                                                                                                <updated>Fri, 21 Aug 2026 20:44:23 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/DeFGhVUG55BvixQEyYzwCo-1920-80.jpg">
                                                            <media:credit><![CDATA[Pat Greenhouse / The Boston Globe / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Harvard professor Dr. Bruce Fischl studies images of the human brain]]></media:description>                                                            <media:text><![CDATA[Harvard professor Dr. Bruce Fischl studies images of the human brain. ]]></media:text>
                                <media:title type="plain"><![CDATA[Harvard professor Dr. Bruce Fischl studies images of the human brain. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/DeFGhVUG55BvixQEyYzwCo-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>With the Trump administration pushing back against a swath of DEI-related federal grants, some research related to major diseases, including Alzheimer’s, is being caught in the crossfire. The most recent round of grant axing resulted in two major universities losing millions in funding related to studying brain disease, and experts say it could put them at a large disadvantage. </p><h2 id="what-research-is-being-impacted">What research is being impacted? </h2><p>In 2025, the U.S. awarded 52% fewer grants related to Alzheimer’s research than in 2024, according to the <a href="https://report.nih.gov/nihdatabook/report/302" target="_blank">National Institutes of Health</a> (NIH), with the number of grants falling from 369 to 177. The figure appears to be on track through 2026 as well, especially given the most recent cuts. </p><p>The newest funding slashes involve grant cancellations for “brain health and Alzheimer’s disease research at two leading research institutions, Emory University and the University of Pittsburgh,” said <a href="https://www.theguardian.com/us-news/2026/aug/17/alzheimers-research-grants-trump-administration" target="_blank">The Guardian</a>. At least “three grants were canceled between the two institutions,” representing $15 million in funds that would’ve <a href="https://theweek.com/health/watching-tv-brain-volume-dementia-alzheimers">been used to study</a> “how discrimination” — or racism — “affects long-term brain health.” </p><p>The topics “we’re measuring are scientifically valid concepts,” Andrea Rosso, an associate professor of epidemiology at the University of Pittsburgh, told The Guardian. Black people are two times more likely to develop dementia, according to the <a href="https://aaic.alz.org/downloads2020/2020_Race_and_Ethnicity_Fact_Sheet.pdf" target="_blank">Alzheimer’s Association</a>. And while these studies “don’t actually measure structural racism,” they do “use that as a framing for why one population is at such high risk.”</p><p>The <a href="https://theweek.com/politics/trump-cracks-down-on-womens-retreats-putting-new-girls-clubs-at-risk">DEI-related funding cuts</a> are also coming alongside additional efforts by the White House to overhaul how grants are awarded. Under newly proposed rules by the Trump administration, any “multiyear grant could be terminated at any point,” and the government “would not be allowed to fund any DEI-related activities or projects or groups that ‘deny the biological reality of sex or the sex binary in humans,’” said <a href="https://www.bostonglobe.com/2026/07/12/metro/federal-funding-trump-science-research/?event=event12" target="_blank">The Boston Globe</a>. </p><h2 id="what-does-this-mean-for-alzheimer-s-patients">What does this mean for Alzheimer’s patients? </h2><p>Many are worried that <a href="https://theweek.com/health/trial-copper-drug-restores-memory-clears-alzheimers-proteins">cutting Alzheimer’s research</a> under the guise of the anti-DEI movement could negatively impact patients, specifically those who are Black. One canceled grant at the University of Pittsburgh “studied how Alzheimer’s disease risk was affected in people who live in divested, predominantly African American neighborhoods,” said The Guardian. The research tracked “socially driven Alzheimer’s disease risk factors by collecting surveys, brain imaging and blood samples.” Another grant at Emory University that was slashed by the White House “studied the impact of racial discrimination on the white matter of the brain, in part surveying participants’ self-reported incidences of discrimination.” </p><p>Behind all of these killed studies are “people waiting for answers, for therapies, for relief, for hope,” said a pain researcher at Mass General Brigham, per the Globe. This comes as the Trump administration has “been open about wanting a smaller NIH,” said <a href="https://www.vox.com/future-perfect/482363/nih-medical-research-grants-cut-2025" target="_blank">Vox</a>, and originally “proposed cutting the agency’s budget for 2026 by 40%.”</p><p>Some researchers say they are considering taking their studies offshore if things do not change. “While I hope to improve the lives of the American people with my research, if I am not able to pursue this aspiration in the U.S., I would rather continue to do so outside of the country,” one Ph.D. student said in comments about the cuts, per the Globe. </p><p>The current state of affairs “demonstrates a lack of understanding of our outcomes versus our exposures,” Ann Cohen, an associate professor of psychiatry at the University of Pittsburgh, said to The Guardian. “That’s epidemiology 101.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A ‘pivotal moment’ for personalised cancer vaccines ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Every cancer has its individual mutations, and scientists have long harboured hopes of developing treatments that can be tailored specifically for each individual patient. And now early results from a final-stage trial of personalised cancer vaccines has the research world holding its breath.</p><p>US pharmaceutical companies Moderna and Merck have been testing <a href="https://www.theweek.com/health/covid-19-mrna-vaccines-cancer">a personalised mRNA vaccine</a> on melanoma patients who had had surgery for their skin cancer. This week, the firms announced that, combined with an established immunotherapy drug, the vaccine had significantly increased the length of time the patients remained cancer-free. This is “a major success in a new field of cancer treatment” that has sent both companies’ shares “surging”, said <a href="https://www.reuters.com/legal/litigation/merck-moderna-say-melanoma-skin-cancer-vaccine-meets-goals-large-trial-2026-08-19/" target="_blank">Reuters</a>.</p><p>The results mark “a landmark moment” for <a href="https://www.theweek.com/health/antarctic-sea-squirt-cancer-melanoma">the treatment of melanoma</a>, one of the deadliest types of skin cancer, said the study’s principal investigator Georgina Long, medical director of the non-profit Melanoma Institute Australia. This is also “a pivotal moment” for cancer research, said Moderna’s chief executive, Stéphane Bancel.</p><h2 id="how-does-the-vaccine-work">How does the vaccine work?</h2><p>It’s made using mRNA technology – as, famously, were some Covid-19 vaccines. But, while the Covid vaccines were created as a standard formulation for everyone, this time it’s created individually for each patient. </p><p>To do that, researchers sequence the DNA of each patient’s tumour (by analysing samples after it’s been removed) and identify its unique mutations. They then “encode selected targets into strands of mRNA”, producing a vaccine designed to teach the recipient’s immune system “to recognise and attack any tumour cells that remain”, said <a href="https://www.thetimes.com/uk/science/article/personalised-vaccine-halts-skin-cancer-bg85938jh" target="_blank">The Times</a>. The result is “a personalised anti-cancer jab” specific to the patient’s tumour, said the <a href="https://www.bbc.co.uk/news/articles/c79gpv7v190o" target="_blank">BBC</a>.</p><h2 id="what-do-we-know-about-the-results">What do we know about the results?</h2><p>Very little. The phase 3 trial involved 1,137 high-risk patients with melanoma, who were randomly assigned to receive either the vaccine and the immunotherapy drug Keytruda, or just Keytruda, for about a year.</p><p>In <a href="https://www.newscientist.com/article/2351872-personalised-melanoma-vaccines-prolong-survival-in-largest-trial-yet/" target="_blank">a similar smaller trial in 2022</a>, Moderna reported that participants who received the vaccine and Keytruda were 44% less likely to develop new tumours or die within three years, compared to those who only received Keytruda.</p><p>Moderna has said that these new trial results “demonstrate statistically significant and clinically meaningful improvements” in survival times for the vaccine group, and that there had been “no new safety concerns”. But we don’t know exactly how much the vaccine increased survival times. </p><p>The results have not been publicly released or peer-reviewed. More findings from the trial will be presented at a medical conference in October.</p><h2 id="what-could-this-mean">What could this mean?</h2><p>“I think it’s fair to call this a breakthrough,” said Marco Gerlinger of the Barts Cancer Institute. These results have “much wider implications” than just for melanoma treatment, he told The Times. They are “proof of principle that personalised cancer vaccines work”,</p><p>The hope is that this personalised vaccine “will work for many other types of cancer”, said <a href="https://www.newscientist.com/article/2585809-will-personalised-mrna-vaccines-transform-cancer-treatments/" target="_blank">New Scientist</a>. Moderna and Merck are already trialling similar personalised mRNA vaccines for types of bladder, kidney and lung cancer. BioNTech, “the other big mRNA company”, is also testing personalised cancer vaccines in human trials. Several of these early-stage trials have produced “promising results”. </p><p>If successful, these vaccines could prevent nearly 50,000 deaths in the US alone, Yale University estimated last year. “The positive hit here leads us ⁠into truly this next phase in immunotherapy,” Karen Knudsen of the Parker Institute for Cancer Immunotherapy told Reuters. “This is an auspicious start – this is where things begin.”</p><h2 id="what-are-the-caveats">What are the caveats?</h2><p>Moderna and Merck have only released an interim analysis, not the full trial data. And experts “emphasise caution” until the dataset has been peer-reviewed, said the BBC. </p><p>The announcement gave Moderna’s shares “their biggest one-day jump on record”, said The Times, while Merck also rallied. But market moves are “imperfect indicators of real-world significance”, said the <a href="https://www.ft.com/content/d8ff1233-01ff-496d-aa18-91233c1db051" target="_blank">Financial Times</a>. It’s “not quite the surprise clinical breakthrough” that the jump might imply. It’s “a big deal for Moderna” but, without all data, it’s “difficult to assess the magnitude, durability, and commercial relevance of benefit”.</p><p>Investors will be watching for the “next important steps”: “detailed clinical results, regulatory progress, and evidence that the technology works across other cancers”, a financial markets analyst told <a href="https://news.sky.com/story/modernas-share-price-nearly-doubles-on-hopes-of-cancer-treatment-breakthrough-13574712" target="_blank">Sky News</a>. Even then, they know that manufacturing personalised vaccines at scale is “expensive and complex”. One <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-mercks-skin-cancer-vaccine-shows-sustained-benefit-after-five-years-2026-01-20/" target="_blank">Reuters</a> report suggested that each vaccine could cost about £147,000. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/a-pivotal-moment-for-personalised-cancer-vaccines</link>
                                                                            <description>
                            <![CDATA[ Early results from final-stage trial of individualised melanoma jab offer hope of more tailor-made cancer treatments ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">jpFi66AoXgZAkYodU557fS</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/FH8i9njq9TPrYVa8y5QPb-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 21 Aug 2026 13:35:28 +0000</pubDate>                                                                                                                                <updated>Mon, 24 Aug 2026 08:16:33 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Harriet Marsden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Harriet Marsden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Harriet Marsden is a senior staff writer and podcast panellist for The Week, mostly covering world news and writing the weekly &lt;a href=&quot;https://theweek.com/globaldigest&quot;&gt;Global Digest&lt;/a&gt; newsletter. Before joining the site in 2023, she was a freelance journalist for seven years, working for The Guardian, The Times and The Independent among others, and regularly appearing on BBC Radio London and Times Radio. She has a particular interest in gender equality and attended the 67th Commission on the Status of Women as a UN Women UK delegate.&lt;/p&gt;&lt;p&gt;In 2021, Harriet was awarded the “journalist-at-large” fellowship by the Local Trust charity, and spent a year travelling independently to some of England’s most deprived areas to write about local culture and community activism. She has a master’s in international journalism from City University, and an undergraduate degree in languages from the University of Cambridge, specialising in Latin American studies. She has also worked as a journalist in Bolivia, Colombia and Spain.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/FH8i9njq9TPrYVa8y5QPb-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[While the Covid vaccines were created as a standard formulation for everyone, this time it’s created individually for each patient]]></media:description>                                                            <media:text><![CDATA[Photo collage of a tailor cutting out fabric overlaid with cancer cell micrography. There are anatomical charts and shelves of medicine in the background.]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a tailor cutting out fabric overlaid with cancer cell micrography. There are anatomical charts and shelves of medicine in the background.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/FH8i9njq9TPrYVa8y5QPb-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Every cancer has its individual mutations, and scientists have long harboured hopes of developing treatments that can be tailored specifically for each individual patient. And now early results from a final-stage trial of personalised cancer vaccines has the research world holding its breath.</p><p>US pharmaceutical companies Moderna and Merck have been testing <a href="https://www.theweek.com/health/covid-19-mrna-vaccines-cancer">a personalised mRNA vaccine</a> on melanoma patients who had had surgery for their skin cancer. This week, the firms announced that, combined with an established immunotherapy drug, the vaccine had significantly increased the length of time the patients remained cancer-free. This is “a major success in a new field of cancer treatment” that has sent both companies’ shares “surging”, said <a href="https://www.reuters.com/legal/litigation/merck-moderna-say-melanoma-skin-cancer-vaccine-meets-goals-large-trial-2026-08-19/" target="_blank">Reuters</a>.</p><p>The results mark “a landmark moment” for <a href="https://www.theweek.com/health/antarctic-sea-squirt-cancer-melanoma">the treatment of melanoma</a>, one of the deadliest types of skin cancer, said the study’s principal investigator Georgina Long, medical director of the non-profit Melanoma Institute Australia. This is also “a pivotal moment” for cancer research, said Moderna’s chief executive, Stéphane Bancel.</p><h2 id="how-does-the-vaccine-work">How does the vaccine work?</h2><p>It’s made using mRNA technology – as, famously, were some Covid-19 vaccines. But, while the Covid vaccines were created as a standard formulation for everyone, this time it’s created individually for each patient. </p><p>To do that, researchers sequence the DNA of each patient’s tumour (by analysing samples after it’s been removed) and identify its unique mutations. They then “encode selected targets into strands of mRNA”, producing a vaccine designed to teach the recipient’s immune system “to recognise and attack any tumour cells that remain”, said <a href="https://www.thetimes.com/uk/science/article/personalised-vaccine-halts-skin-cancer-bg85938jh" target="_blank">The Times</a>. The result is “a personalised anti-cancer jab” specific to the patient’s tumour, said the <a href="https://www.bbc.co.uk/news/articles/c79gpv7v190o" target="_blank">BBC</a>.</p><h2 id="what-do-we-know-about-the-results">What do we know about the results?</h2><p>Very little. The phase 3 trial involved 1,137 high-risk patients with melanoma, who were randomly assigned to receive either the vaccine and the immunotherapy drug Keytruda, or just Keytruda, for about a year.</p><p>In <a href="https://www.newscientist.com/article/2351872-personalised-melanoma-vaccines-prolong-survival-in-largest-trial-yet/" target="_blank">a similar smaller trial in 2022</a>, Moderna reported that participants who received the vaccine and Keytruda were 44% less likely to develop new tumours or die within three years, compared to those who only received Keytruda.</p><p>Moderna has said that these new trial results “demonstrate statistically significant and clinically meaningful improvements” in survival times for the vaccine group, and that there had been “no new safety concerns”. But we don’t know exactly how much the vaccine increased survival times. </p><p>The results have not been publicly released or peer-reviewed. More findings from the trial will be presented at a medical conference in October.</p><h2 id="what-could-this-mean">What could this mean?</h2><p>“I think it’s fair to call this a breakthrough,” said Marco Gerlinger of the Barts Cancer Institute. These results have “much wider implications” than just for melanoma treatment, he told The Times. They are “proof of principle that personalised cancer vaccines work”,</p><p>The hope is that this personalised vaccine “will work for many other types of cancer”, said <a href="https://www.newscientist.com/article/2585809-will-personalised-mrna-vaccines-transform-cancer-treatments/" target="_blank">New Scientist</a>. Moderna and Merck are already trialling similar personalised mRNA vaccines for types of bladder, kidney and lung cancer. BioNTech, “the other big mRNA company”, is also testing personalised cancer vaccines in human trials. Several of these early-stage trials have produced “promising results”. </p><p>If successful, these vaccines could prevent nearly 50,000 deaths in the US alone, Yale University estimated last year. “The positive hit here leads us ⁠into truly this next phase in immunotherapy,” Karen Knudsen of the Parker Institute for Cancer Immunotherapy told Reuters. “This is an auspicious start – this is where things begin.”</p><h2 id="what-are-the-caveats">What are the caveats?</h2><p>Moderna and Merck have only released an interim analysis, not the full trial data. And experts “emphasise caution” until the dataset has been peer-reviewed, said the BBC. </p><p>The announcement gave Moderna’s shares “their biggest one-day jump on record”, said The Times, while Merck also rallied. But market moves are “imperfect indicators of real-world significance”, said the <a href="https://www.ft.com/content/d8ff1233-01ff-496d-aa18-91233c1db051" target="_blank">Financial Times</a>. It’s “not quite the surprise clinical breakthrough” that the jump might imply. It’s “a big deal for Moderna” but, without all data, it’s “difficult to assess the magnitude, durability, and commercial relevance of benefit”.</p><p>Investors will be watching for the “next important steps”: “detailed clinical results, regulatory progress, and evidence that the technology works across other cancers”, a financial markets analyst told <a href="https://news.sky.com/story/modernas-share-price-nearly-doubles-on-hopes-of-cancer-treatment-breakthrough-13574712" target="_blank">Sky News</a>. Even then, they know that manufacturing personalised vaccines at scale is “expensive and complex”. One <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-mercks-skin-cancer-vaccine-shows-sustained-benefit-after-five-years-2026-01-20/" target="_blank">Reuters</a> report suggested that each vaccine could cost about £147,000. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Moderna says skin cancer vaccine trial a success ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-5">What happened</h2><p>Moderna and Merck <a href="https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/" target="_blank">said Wednesday</a> their experimental mRNA cancer vaccine successfully reduced <a href="https://theweek.com/health/antarctic-sea-squirt-cancer-melanoma">recurrence of melanoma</a>, and prevented the deadly skin cancer from spreading to other organs, in a large trial. The results “mark the first successful late-stage trial for a personalized mRNA cancer therapy,” <a href="https://www.wsj.com/health/pharma/moderna-merck-vaccine-succeeds-in-preventing-melanoma-from-returning-540e9e18" target="_blank">The Wall Street Journal</a> said, “validating decades of research” and “paving the way for a potentially new life-extending treatment” for people diagnosed with melanoma and other cancers.</p><h2 id="who-said-what-5">Who said what</h2><p>The ongoing study involves 1,137 high-risk melanoma patients <a href="https://theweek.com/health/rise-cancer-younger-adults">whose cancer was surgically removed</a> and genetically sequenced. The treatment combines Merck’s immunotherapy drug Keytruda with intismeran, a “made-to-order mRNA vaccine” created by analyzing and weaponizing “mutations found in the patients’ own tumors,” <a href="https://www.cnn.com/2026/08/19/health/moderna-merck-mrna-melanoma-vaccine" target="_blank">CNN</a> said. The companies didn’t detail the results, but an <a href="https://theweek.com/speed-reads/1019251/study-moderna-merck-vaccines-could-cut-melanomas-recurrence-by-44-percent">earlier mid-stage trial</a> showed that pairing intismeran with Keytruda reduced the risk of melanoma recurrence or death by 49% versus Keytruda alone. Moderna’s stock closed up 177% Wednesday.</p><h2 id="what-next-6">What next? </h2><p>Moderna and Merck said they planned to “present the details” of their latest “large, closely watched trial” at an “international medical meeting and to regulators,” <a href="https://www.nytimes.com/2026/08/19/science/moderna-merck-mrna-vaccine-melanoma.html" target="_blank">The New York Times</a> said. Investors and researchers “will be watching closely to see how effective and tolerable the vaccine proves to be,” the Journal said. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/moderna-says-skin-cancer-vaccine-success</link>
                                                                            <description>
                            <![CDATA[ The experimental vaccine successfully reduced the recurrence of melanoma, the company said ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">nMmUU7gD3FFPmqjSFoGUY8</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/epgWbZwQRhiagGme4jneiX-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 20 Aug 2026 15:02:29 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Peter Weber, The Week US) ]]></author>                    <dc:creator><![CDATA[ Peter Weber, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/468oRmsak796WaimXBHwL9-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Peter has worked as a news and culture writer and editor at The Week since the site&#039;s launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University. He graduated from Northwestern University with degrees in international studies and performance studies and served in the Peace Corps in Honduras.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Peter has lived in Italy and all major quadrants of the continental U.S. and currently resides in Austin, Texas, where he plays bass and rhythm cello in a garage band.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/epgWbZwQRhiagGme4jneiX-1920-80.jpg">
                                                            <media:credit><![CDATA[Adam Glanzman / Bloomberg via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[An employee works in a lab focused on cancer vaccine research at the Moderna headquarters in Cambridge, Massachusetts]]></media:description>                                                            <media:text><![CDATA[An employee works in a lab focused on cancer vaccine research at the Moderna headquarters in Cambridge, Massachusetts.]]></media:text>
                                <media:title type="plain"><![CDATA[An employee works in a lab focused on cancer vaccine research at the Moderna headquarters in Cambridge, Massachusetts.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/epgWbZwQRhiagGme4jneiX-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-5">What happened</h2><p>Moderna and Merck <a href="https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/" target="_blank">said Wednesday</a> their experimental mRNA cancer vaccine successfully reduced <a href="https://theweek.com/health/antarctic-sea-squirt-cancer-melanoma">recurrence of melanoma</a>, and prevented the deadly skin cancer from spreading to other organs, in a large trial. The results “mark the first successful late-stage trial for a personalized mRNA cancer therapy,” <a href="https://www.wsj.com/health/pharma/moderna-merck-vaccine-succeeds-in-preventing-melanoma-from-returning-540e9e18" target="_blank">The Wall Street Journal</a> said, “validating decades of research” and “paving the way for a potentially new life-extending treatment” for people diagnosed with melanoma and other cancers.</p><h2 id="who-said-what-5">Who said what</h2><p>The ongoing study involves 1,137 high-risk melanoma patients <a href="https://theweek.com/health/rise-cancer-younger-adults">whose cancer was surgically removed</a> and genetically sequenced. The treatment combines Merck’s immunotherapy drug Keytruda with intismeran, a “made-to-order mRNA vaccine” created by analyzing and weaponizing “mutations found in the patients’ own tumors,” <a href="https://www.cnn.com/2026/08/19/health/moderna-merck-mrna-melanoma-vaccine" target="_blank">CNN</a> said. The companies didn’t detail the results, but an <a href="https://theweek.com/speed-reads/1019251/study-moderna-merck-vaccines-could-cut-melanomas-recurrence-by-44-percent">earlier mid-stage trial</a> showed that pairing intismeran with Keytruda reduced the risk of melanoma recurrence or death by 49% versus Keytruda alone. Moderna’s stock closed up 177% Wednesday.</p><h2 id="what-next-6">What next? </h2><p>Moderna and Merck said they planned to “present the details” of their latest “large, closely watched trial” at an “international medical meeting and to regulators,” <a href="https://www.nytimes.com/2026/08/19/science/moderna-merck-mrna-vaccine-melanoma.html" target="_blank">The New York Times</a> said. Investors and researchers “will be watching closely to see how effective and tolerable the vaccine proves to be,” the Journal said. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Orexins: the brain’s Ozempic moment? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A new generation of drugs could transform the lives of people with narcolepsy and offer hope of future treatments for ADHD and depression. </p><p>Orexins help regulate wakefulness, as well as attention, motivation and the brain’s reward system. This month, the US Food and Drug Administration approved the first orexin agonist treatment for narcolepsy. Oveporexton (sold as Orzeyful) is designed to target the cause of the chronic sleep disorder, rather than treat the symptoms with stimulants.</p><p>But “the excitement is not just about narcolepsy”, said <a href="https://www.economist.com/science-and-technology/2026/08/11/the-brain-may-be-about-to-have-its-ozempic-moment" target="_blank">The Economist</a>. Inspired by the success of drugs that mimic glucagon-like <a href="https://theweek.com/health/the-peptide-craze">peptide</a>-1 (GLP-1), developed to treat diabetes and later used for <a href="https://www.theweek.com/business/economy/the-glp-1-economy-how-weight-loss-drugs-are-impacting-major-industries">weight-loss in medication such as Ozempic</a>, drugmakers are “betting” that orexins could “follow a similar path”, potentially leading to treatments for conditions that “burden hundreds of millions” of people.</p><h2 id="what-are-orexins">What are orexins?</h2><p>They are two <a href="https://theweek.com/health/peptides-injectables-grey-market-synthetic-wellness">peptides</a> (chains of amino acids that act as messengers in the brain) that are involved in the body’s sleep-wake system. Specifically, they are neuropeptides. They act as neurotransmitters, or chemicals, that carry messages between neurons. They are involved with reward and motivation.</p><p>Named after the Greek word <em>orexis</em> (appetite), orexins were discovered in 1998 by two teams working independently in the US. The discovery turned “the long march to develop a new kind of sleeping pill into a sprint”, said <a href="https://www.theguardian.com/news/2018/sep/14/finally-a-cure-for-insomnia" target="_blank">The Guardian</a>.</p><p>But their “true role emerged” in 1999, said The Economist. People with narcolepsy were found to lack the specialised neurons that produce orexins, causing “abnormally low levels”. That means the brain “loses the ability to control when the body sleeps”, said <a href="https://time.com/article/2026/08/18/fda-approves-first-drug-to-treat-narcolepsy/" target="_blank">Time</a>.</p><h2 id="how-do-they-work">How do they work?</h2><p>In 2011, researchers at Takeda, a Japanese pharmaceutical company, found a chemical compound that could block the orexin receptor, and so promote sleep. Orexin antagonists were developed as a treatment for insomnia, differing from conventional sleeping pills that induce sedation. </p><p>But “the bigger prize may lie not in blocking orexin’s signal, but restoring it”, said The Economist. The results of Takeda’s trials of oveporexton, published last year in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2405847" target="_blank">The New England Journal of Medicine</a>, “created a stir”. Volunteers were able to stay awake 12.5 to 25 minutes longer with the drug (depending on the dose) than without it. </p><p>The drug “activates the orexin pathway” and “restores the brain’s ability to remain alert”, said Time. Volunteers also had fewer episodes of cataplexy, or loss of muscle control, as well as other symptoms such as hallucinations and irregular sleep. There were “no serious adverse events related to treatment”, said the <a href="https://www.smithsonianmag.com/smart-news/this-newly-approved-narcolepsy-drug-is-the-first-to-target-the-sleep-disorders-root-cause-rather-than-its-symptoms-180989362/" target="_blank">Smithsonian magazine</a>.</p><p>“It’s really a complete revolution,” Emmanuel Mignot, a sleep-medicine professor who led Takeda’s final studies, told <a href="https://www.wsj.com/health/pharma/the-race-to-come-up-with-the-next-big-sleep-drug-473a4a5e" target="_blank">The Wall Street Journal</a>. “The first time patients take it, it’s like the light switch.” One 19-year-old trial participant said: “It was the first time I felt somewhat alive in the last 10 years.” “It’s the best thing that has ever happened to me,” he told <a href="https://www.nature.com/articles/d41586-026-02552-y" target="_blank">Nature</a>.</p><h2 id="what-might-the-future-hold">What might the future hold?</h2><p>In the US and Western Europe, narcolepsy affects about <a href="https://www.nejm.org/doi/full/10.1056/NEJMra1500587" target="_blank">one in 2,000 people</a>, but there is no cure. Existing drugs – “decades-old stimulants and sedatives” – only manage symptoms, said The Wall Street Journal. Oveporexton and its competitors are “designed to treat the disease as a whole”. Morgan Stanley estimates that orexin-based medicines for narcolepsy and other sleep disorders could generate $16 billion a year by 2035, according to <a href="https://sfg.media/en/a/drugmakers-ozempic-wakefulness-attention-motivation/" target="_blank">SF Globe</a>.</p><p>Takeda is testing orexin-targeting drugs for sleep apnea and chronic daytime sleepiness. Alkermes, an Irish biotech company, is testing an orexin drug for ADHD in adults. And this year Eli Lilly (of Mounjaro fame) bought Centessa, a biotech firm with an orexin agonist in trials, in a deal potentially worth up to $7.8 billion. New research has also revealed “the essential role of orexin neurons” in motivation, said <a href="https://www.biotechniques.com/neuroscience/the-neuroscience-of-motivation-how-does-the-brain-sustain-its-drive/" target="_blank">BioTechniques</a>. </p><p>The twice-daily oral drug Orzeyful could be “a boon for the roughly 120,000 people in the United States with narcolepsy type 1”, said the Smithsonian. But its success also “opens the door to the use of orexin-mimicking drugs for other conditions associated with low levels of the chemical”, such as ADHD and depression. “Orzeyful is just the beginning,” said Andy Plump, Takeda’s president of research and development. </p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/orexins-the-brains-ozempic-moment</link>
                                                                            <description>
                            <![CDATA[ Drugs that mimic hormones involved with wakefulness, attention and motivation could transform narcolepsy treatment, and offer hope for depression and ADHD ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">YqXptUaxwQL2NjSfiaFR8J</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/PGnpRupHXN4VXCyVa8PCtP-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 20 Aug 2026 13:42:40 +0000</pubDate>                                                                                                                                <updated>Fri, 21 Aug 2026 15:31:10 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Harriet Marsden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Harriet Marsden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Harriet Marsden is a senior staff writer and podcast panellist for The Week, mostly covering world news and writing the weekly &lt;a href=&quot;https://theweek.com/globaldigest&quot;&gt;Global Digest&lt;/a&gt; newsletter. Before joining the site in 2023, she was a freelance journalist for seven years, working for The Guardian, The Times and The Independent among others, and regularly appearing on BBC Radio London and Times Radio. She has a particular interest in gender equality and attended the 67th Commission on the Status of Women as a UN Women UK delegate.&lt;/p&gt;&lt;p&gt;In 2021, Harriet was awarded the “journalist-at-large” fellowship by the Local Trust charity, and spent a year travelling independently to some of England’s most deprived areas to write about local culture and community activism. She has a master’s in international journalism from City University, and an undergraduate degree in languages from the University of Cambridge, specialising in Latin American studies. She has also worked as a journalist in Bolivia, Colombia and Spain.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/PGnpRupHXN4VXCyVa8PCtP-1920-80.jpg">
                                                            <media:credit><![CDATA[Guido Mieth / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[People with narcolepsy were found to lack the specialised neurons that produce orexins, causing ‘abnormally low levels’ of the neuropeptide]]></media:description>                                                            <media:text><![CDATA[Person placing oral medicine on their tongue]]></media:text>
                                <media:title type="plain"><![CDATA[Person placing oral medicine on their tongue]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/PGnpRupHXN4VXCyVa8PCtP-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A new generation of drugs could transform the lives of people with narcolepsy and offer hope of future treatments for ADHD and depression. </p><p>Orexins help regulate wakefulness, as well as attention, motivation and the brain’s reward system. This month, the US Food and Drug Administration approved the first orexin agonist treatment for narcolepsy. Oveporexton (sold as Orzeyful) is designed to target the cause of the chronic sleep disorder, rather than treat the symptoms with stimulants.</p><p>But “the excitement is not just about narcolepsy”, said <a href="https://www.economist.com/science-and-technology/2026/08/11/the-brain-may-be-about-to-have-its-ozempic-moment" target="_blank">The Economist</a>. Inspired by the success of drugs that mimic glucagon-like <a href="https://theweek.com/health/the-peptide-craze">peptide</a>-1 (GLP-1), developed to treat diabetes and later used for <a href="https://www.theweek.com/business/economy/the-glp-1-economy-how-weight-loss-drugs-are-impacting-major-industries">weight-loss in medication such as Ozempic</a>, drugmakers are “betting” that orexins could “follow a similar path”, potentially leading to treatments for conditions that “burden hundreds of millions” of people.</p><h2 id="what-are-orexins">What are orexins?</h2><p>They are two <a href="https://theweek.com/health/peptides-injectables-grey-market-synthetic-wellness">peptides</a> (chains of amino acids that act as messengers in the brain) that are involved in the body’s sleep-wake system. Specifically, they are neuropeptides. They act as neurotransmitters, or chemicals, that carry messages between neurons. They are involved with reward and motivation.</p><p>Named after the Greek word <em>orexis</em> (appetite), orexins were discovered in 1998 by two teams working independently in the US. The discovery turned “the long march to develop a new kind of sleeping pill into a sprint”, said <a href="https://www.theguardian.com/news/2018/sep/14/finally-a-cure-for-insomnia" target="_blank">The Guardian</a>.</p><p>But their “true role emerged” in 1999, said The Economist. People with narcolepsy were found to lack the specialised neurons that produce orexins, causing “abnormally low levels”. That means the brain “loses the ability to control when the body sleeps”, said <a href="https://time.com/article/2026/08/18/fda-approves-first-drug-to-treat-narcolepsy/" target="_blank">Time</a>.</p><h2 id="how-do-they-work">How do they work?</h2><p>In 2011, researchers at Takeda, a Japanese pharmaceutical company, found a chemical compound that could block the orexin receptor, and so promote sleep. Orexin antagonists were developed as a treatment for insomnia, differing from conventional sleeping pills that induce sedation. </p><p>But “the bigger prize may lie not in blocking orexin’s signal, but restoring it”, said The Economist. The results of Takeda’s trials of oveporexton, published last year in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2405847" target="_blank">The New England Journal of Medicine</a>, “created a stir”. Volunteers were able to stay awake 12.5 to 25 minutes longer with the drug (depending on the dose) than without it. </p><p>The drug “activates the orexin pathway” and “restores the brain’s ability to remain alert”, said Time. Volunteers also had fewer episodes of cataplexy, or loss of muscle control, as well as other symptoms such as hallucinations and irregular sleep. There were “no serious adverse events related to treatment”, said the <a href="https://www.smithsonianmag.com/smart-news/this-newly-approved-narcolepsy-drug-is-the-first-to-target-the-sleep-disorders-root-cause-rather-than-its-symptoms-180989362/" target="_blank">Smithsonian magazine</a>.</p><p>“It’s really a complete revolution,” Emmanuel Mignot, a sleep-medicine professor who led Takeda’s final studies, told <a href="https://www.wsj.com/health/pharma/the-race-to-come-up-with-the-next-big-sleep-drug-473a4a5e" target="_blank">The Wall Street Journal</a>. “The first time patients take it, it’s like the light switch.” One 19-year-old trial participant said: “It was the first time I felt somewhat alive in the last 10 years.” “It’s the best thing that has ever happened to me,” he told <a href="https://www.nature.com/articles/d41586-026-02552-y" target="_blank">Nature</a>.</p><h2 id="what-might-the-future-hold">What might the future hold?</h2><p>In the US and Western Europe, narcolepsy affects about <a href="https://www.nejm.org/doi/full/10.1056/NEJMra1500587" target="_blank">one in 2,000 people</a>, but there is no cure. Existing drugs – “decades-old stimulants and sedatives” – only manage symptoms, said The Wall Street Journal. Oveporexton and its competitors are “designed to treat the disease as a whole”. Morgan Stanley estimates that orexin-based medicines for narcolepsy and other sleep disorders could generate $16 billion a year by 2035, according to <a href="https://sfg.media/en/a/drugmakers-ozempic-wakefulness-attention-motivation/" target="_blank">SF Globe</a>.</p><p>Takeda is testing orexin-targeting drugs for sleep apnea and chronic daytime sleepiness. Alkermes, an Irish biotech company, is testing an orexin drug for ADHD in adults. And this year Eli Lilly (of Mounjaro fame) bought Centessa, a biotech firm with an orexin agonist in trials, in a deal potentially worth up to $7.8 billion. New research has also revealed “the essential role of orexin neurons” in motivation, said <a href="https://www.biotechniques.com/neuroscience/the-neuroscience-of-motivation-how-does-the-brain-sustain-its-drive/" target="_blank">BioTechniques</a>. </p><p>The twice-daily oral drug Orzeyful could be “a boon for the roughly 120,000 people in the United States with narcolepsy type 1”, said the Smithsonian. But its success also “opens the door to the use of orexin-mimicking drugs for other conditions associated with low levels of the chemical”, such as ADHD and depression. “Orzeyful is just the beginning,” said Andy Plump, Takeda’s president of research and development. </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ ‘The grief of loss and our own mortality are always closer than we think’ ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="i-grew-up-watching-hayden-panettiere-her-death-is-a-reckoning">‘I grew up watching Hayden Panettiere. Her death is a reckoning.’</h2><p><strong>Sara Pequeño at USA Today</strong></p><p>The “late-night Aug. 16 notification that Hayden Panettiere died took my breath away,” says Sara Pequeño. Every “so often, a celebrity’s death will feel like an exposed nerve,” and “millennials and Gen Z are still getting used to that feeling.” In the “last years of her life, Panettiere was talking about serious topics that many young women can empathize with.” Hers is “not simply a cautionary tale — it is also a story about the importance of speaking your truth.”</p><p><a href="https://www.usatoday.com/story/opinion/columnist/2026/08/19/hayden-panettiere-death-movies-gen-z/91355444007/" target="_blank"><em>Read more</em></a></p><h2 id="by-disparaging-2020-protests-as-woke-1-liberals-are-following-the-right-wing-s-lead">‘By disparaging 2020 protests as “Woke 1,” liberals are following the right wing’s lead’</h2><p><strong>Andre Gee at The Guardian</strong></p><p>This month has “brought us a referendum on ‘Woke 1’ — a term that reductively brands 2020’s social justice movement — as prominent liberal voices reflect on that time period with disappointing hindsight,” says Andre Gee. “Woke” has “long shifted from Black America’s prideful adjective to a mocking noun that has been weaponized to ridicule Black liberation movements.” Progressive liberals “now adopting that dismissive language while placing confines on the movement for Black lives is damning.”</p><p><a href="https://www.theguardian.com/commentisfree/2026/aug/19/woke-1-aoc-rightwing" target="_blank"><em>Read more</em></a></p><h2 id="you-cannot-rebuild-a-country-with-people-who-are-shattered">‘You cannot rebuild a country with people who are shattered’</h2><p><strong>Lilia Yapparova at The Boston Globe</strong></p><p>“Stigma around mental health care still runs deep in Ukraine,” says Lilia Yapparova. This happens “even though the scale of trauma in Ukraine is extraordinary.” If the nation’s “mental health crisis goes untreated, overlooked grief and loss could become indelible parts of Ukraine’s social fabric, with cascading effects on future generations.” It is “not only soldiers who continue to live in a nightmare of ongoing trauma,” but there is “no systematic, streamlined approach to mental health support in Ukraine.”</p><p><a href="https://www.bostonglobe.com/2026/08/19/opinion/ukraine-mental-health-crisis-treatment/?event=event12" target="_blank"><em>Read more</em></a></p><h2 id="pilots-and-flight-attendants-face-a-real-cancer-risk-frequent-fliers-shouldn-t-panic">‘Pilots and flight attendants face a real cancer risk. Frequent fliers shouldn’t panic.’</h2><p><strong>Vishal R. Patel, Christopher M. Worsham and Anupam Jena at Time</strong></p><p>There’s a “particular unease that comes from seeing that an ordinary part of life has been linked to cancer,” as “pilots and flight attendants die of radiation-related cancers at higher rates than workers in over 500 occupations,” say Vishal R. Patel, Christopher M. Worsham and Anupam Jena. The “next time a flight attendant hands you a coffee at 30,000 feet, there’s no need to fret over the tiny radiation dose,” but “do consider the doses they take on, day after day.” </p><p><a href="https://time.com/article/2026/08/17/pilots-and-flight-attendants-face-a-real-cancer-risk/" target="_blank"><em>Read more</em></a></p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/politics/instant-opinion-hayden-panettiere-woke-ukraine-health-aviation</link>
                                                                            <description>
                            <![CDATA[ Opinion, comment and editorials of the day ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">YrhoVbnd83oiQs7RMcu3e3</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Kx6e6pX2Tg9vKaYufhdpHR-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 19 Aug 2026 17:45:22 +0000</pubDate>                                                                                                                                <updated>Wed, 19 Aug 2026 20:04:33 +0000</updated>
                                                                                                                                            <category><![CDATA[Politics]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Justin Klawans, The Week US) ]]></author>                    <dc:creator><![CDATA[ Justin Klawans, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/MGyWTVLzq79BbxAh4S83gQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and a variety of general news. He has also covered film, television and entertainment news as a freelancer for Collider and United Press International. He has helmed live-blog coverage of the war in Ukraine, interviewed the courtroom artist for the Ghislaine Maxwell trial and once received a single-word statement from director Spike Lee. His reporting has been cited in a variety of outlets including &quot;The Late Show with Stephen Colbert.&quot;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Based in Chicago, he is a big hockey fan and has previously covered NHL analysis and the Chicago Blackhawks for Fansided.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Kx6e6pX2Tg9vKaYufhdpHR-1920-80.jpg">
                                                            <media:credit><![CDATA[Michael Buckner / Variety / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Every ‘so often, a celebrity’s death will feel like an exposed nerve’]]></media:description>                                                            <media:text><![CDATA[Hayden Panettiere at the premiere of “Blonde” in 2022. ]]></media:text>
                                <media:title type="plain"><![CDATA[Hayden Panettiere at the premiere of “Blonde” in 2022. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Kx6e6pX2Tg9vKaYufhdpHR-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="i-grew-up-watching-hayden-panettiere-her-death-is-a-reckoning">‘I grew up watching Hayden Panettiere. Her death is a reckoning.’</h2><p><strong>Sara Pequeño at USA Today</strong></p><p>The “late-night Aug. 16 notification that Hayden Panettiere died took my breath away,” says Sara Pequeño. Every “so often, a celebrity’s death will feel like an exposed nerve,” and “millennials and Gen Z are still getting used to that feeling.” In the “last years of her life, Panettiere was talking about serious topics that many young women can empathize with.” Hers is “not simply a cautionary tale — it is also a story about the importance of speaking your truth.”</p><p><a href="https://www.usatoday.com/story/opinion/columnist/2026/08/19/hayden-panettiere-death-movies-gen-z/91355444007/" target="_blank"><em>Read more</em></a></p><h2 id="by-disparaging-2020-protests-as-woke-1-liberals-are-following-the-right-wing-s-lead">‘By disparaging 2020 protests as “Woke 1,” liberals are following the right wing’s lead’</h2><p><strong>Andre Gee at The Guardian</strong></p><p>This month has “brought us a referendum on ‘Woke 1’ — a term that reductively brands 2020’s social justice movement — as prominent liberal voices reflect on that time period with disappointing hindsight,” says Andre Gee. “Woke” has “long shifted from Black America’s prideful adjective to a mocking noun that has been weaponized to ridicule Black liberation movements.” Progressive liberals “now adopting that dismissive language while placing confines on the movement for Black lives is damning.”</p><p><a href="https://www.theguardian.com/commentisfree/2026/aug/19/woke-1-aoc-rightwing" target="_blank"><em>Read more</em></a></p><h2 id="you-cannot-rebuild-a-country-with-people-who-are-shattered">‘You cannot rebuild a country with people who are shattered’</h2><p><strong>Lilia Yapparova at The Boston Globe</strong></p><p>“Stigma around mental health care still runs deep in Ukraine,” says Lilia Yapparova. This happens “even though the scale of trauma in Ukraine is extraordinary.” If the nation’s “mental health crisis goes untreated, overlooked grief and loss could become indelible parts of Ukraine’s social fabric, with cascading effects on future generations.” It is “not only soldiers who continue to live in a nightmare of ongoing trauma,” but there is “no systematic, streamlined approach to mental health support in Ukraine.”</p><p><a href="https://www.bostonglobe.com/2026/08/19/opinion/ukraine-mental-health-crisis-treatment/?event=event12" target="_blank"><em>Read more</em></a></p><h2 id="pilots-and-flight-attendants-face-a-real-cancer-risk-frequent-fliers-shouldn-t-panic">‘Pilots and flight attendants face a real cancer risk. Frequent fliers shouldn’t panic.’</h2><p><strong>Vishal R. Patel, Christopher M. Worsham and Anupam Jena at Time</strong></p><p>There’s a “particular unease that comes from seeing that an ordinary part of life has been linked to cancer,” as “pilots and flight attendants die of radiation-related cancers at higher rates than workers in over 500 occupations,” say Vishal R. Patel, Christopher M. Worsham and Anupam Jena. The “next time a flight attendant hands you a coffee at 30,000 feet, there’s no need to fret over the tiny radiation dose,” but “do consider the doses they take on, day after day.” </p><p><a href="https://time.com/article/2026/08/17/pilots-and-flight-attendants-face-a-real-cancer-risk/" target="_blank"><em>Read more</em></a></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Bangladesh’s long battle against yaba pills ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A methamphetamine known as the “crazy pill” is wreaking havoc in Bangladesh and fuelling an addiction crisis. The authorities have struggled for some time to crack down on yaba, which is also known as “<a href="https://theweek.com/history/argentina-nazi-files-javier-milei">Nazi</a> speed”. Their efforts are bearing some fruit but tackling the widespread use of the drug remains an uphill battle.</p><h2 id="black-market">Black market</h2><p>Yaba is a street name for pills containing methamphetamine, a powerful, highly addictive stimulant. Users generally crush and smoke the pills, although some swallow them whole. They increase alertness and energy, and raise the heart rate and blood pressure of users. Heavy use can bring on a range of problems, including paranoia, psychosis, seizures, cardiovascular problems, and even death. </p><p>Yaba, which means “crazy pill” in Thai, is “pushing thousands into addiction” in Bangladesh, said <a href="https://www.telegraph.co.uk/global-health/science-and-disease/yaba-pills-addiction-bangladesh-drug-rehabilitation/" target="_blank">The Telegraph</a>. The tablets, which are a blend of the stimulant with caffeine and other adulterants, are particularly common in South and Southeast Asia. </p><p>Bangladesh has become a leading destination and market for yaba because of its geographic proximity to Myanmar, where production of the drug is particularly concentrated. Rebel militias there are increasingly using yaba and crystal meth as “partial payment for smuggled Bangladeshi goods”, said the Dhaka-based newspaper <a href="https://www.thedailystar.net/news/bangladesh/news/yaba-crystal-meth-become-the-new-narco-currency-4237986" target="_blank">The Daily Star</a>.<br /><br />The drug is trafficked westward from Myanmar into Bangladesh, through border areas that are difficult to control. Fishing boats transport Bangladeshi goods to Myanmar and “return with narcotics”. Although most of the drugs are consumed in Bangladesh, some packages are flown on to Oman, <a href="https://theweek.com/world-news/iraq-airstrikes-expand-saudi-arabias-wartime-footprint-region">Saudi Arabia</a> and Dubai.</p><h2 id="daily-drudgery">Daily drudgery</h2><p>Since 2006, yaba has been a common for the poor and the realities of the “daily drudgery, which makes life so hard for so many of Bangladesh’s 178 million people”, means there is “little to dull the allure” of the drug, said The Telegraph.</p><p>“The reason yaba has become so prevalent here is that it is so easy to transport and far cheaper to buy than other drugs,” government social worker Adnan Zobayer told the newspaper. “People get an easy buzz and quickly become dependent.”  </p><p>Authorities in Bangladesh have been fighting for years to stamp out trade in the stimulant. In 2018, the government passed a law which makes possession of yaba punishable by death. They are having some success: enforcement agencies seized 43,562,811 amphetamine-type stimulant tablets, including yaba, last year, up 90.58 % from 22,857,751 in 2024. However, drug lords are still able to “churn out” millions of yaba pills from camps in the jungle borderlands of Myanmar at a “relentless” rate, said The Telegraph.</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/bangladeshs-long-battle-against-yaba-pills</link>
                                                                            <description>
                            <![CDATA[ Locals living in poverty use the drug to escape ‘daily drudgery’ ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">vqsKvgNwMaW6r2FxGZCdRP</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/WXmAsZ8oCNTwEqojSUjauC-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 18 Aug 2026 22:43:48 +0000</pubDate>                                                                                                                                <updated>Wed, 19 Aug 2026 15:40:08 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditorsuk@futurenet.com (Chas Newkey-Burden, The Week UK) ]]></author>                    <dc:creator><![CDATA[ Chas Newkey-Burden, The Week UK ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ &lt;p&gt;Chas Newkey-Burden has been part of The Week Digital team for more than a decade. He writes the content for the UK&#039;s morning newsletter, including Ten Things You Need To Know and Odd News. He has been a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Daily Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books, including internationally bestselling biographies of Adele, Amy Winehouse and Justin Bieber. His most recent books are Running: Cheaper Than Therapy and The Runner’s Code, both published by Bloomsbury. Chas appears regularly on television, radio and podcasts discussing everything from veganism to running and show business.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/WXmAsZ8oCNTwEqojSUjauC-1920-80.jpg">
                                                            <media:credit><![CDATA[Illustration by Julia Wytrazek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Using the orange yaba pills can be fatal]]></media:description>                                                            <media:text><![CDATA[Photo collage of a skull and an orange pill]]></media:text>
                                <media:title type="plain"><![CDATA[Photo collage of a skull and an orange pill]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/WXmAsZ8oCNTwEqojSUjauC-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A methamphetamine known as the “crazy pill” is wreaking havoc in Bangladesh and fuelling an addiction crisis. The authorities have struggled for some time to crack down on yaba, which is also known as “<a href="https://theweek.com/history/argentina-nazi-files-javier-milei">Nazi</a> speed”. Their efforts are bearing some fruit but tackling the widespread use of the drug remains an uphill battle.</p><h2 id="black-market">Black market</h2><p>Yaba is a street name for pills containing methamphetamine, a powerful, highly addictive stimulant. Users generally crush and smoke the pills, although some swallow them whole. They increase alertness and energy, and raise the heart rate and blood pressure of users. Heavy use can bring on a range of problems, including paranoia, psychosis, seizures, cardiovascular problems, and even death. </p><p>Yaba, which means “crazy pill” in Thai, is “pushing thousands into addiction” in Bangladesh, said <a href="https://www.telegraph.co.uk/global-health/science-and-disease/yaba-pills-addiction-bangladesh-drug-rehabilitation/" target="_blank">The Telegraph</a>. The tablets, which are a blend of the stimulant with caffeine and other adulterants, are particularly common in South and Southeast Asia. </p><p>Bangladesh has become a leading destination and market for yaba because of its geographic proximity to Myanmar, where production of the drug is particularly concentrated. Rebel militias there are increasingly using yaba and crystal meth as “partial payment for smuggled Bangladeshi goods”, said the Dhaka-based newspaper <a href="https://www.thedailystar.net/news/bangladesh/news/yaba-crystal-meth-become-the-new-narco-currency-4237986" target="_blank">The Daily Star</a>.<br /><br />The drug is trafficked westward from Myanmar into Bangladesh, through border areas that are difficult to control. Fishing boats transport Bangladeshi goods to Myanmar and “return with narcotics”. Although most of the drugs are consumed in Bangladesh, some packages are flown on to Oman, <a href="https://theweek.com/world-news/iraq-airstrikes-expand-saudi-arabias-wartime-footprint-region">Saudi Arabia</a> and Dubai.</p><h2 id="daily-drudgery">Daily drudgery</h2><p>Since 2006, yaba has been a common for the poor and the realities of the “daily drudgery, which makes life so hard for so many of Bangladesh’s 178 million people”, means there is “little to dull the allure” of the drug, said The Telegraph.</p><p>“The reason yaba has become so prevalent here is that it is so easy to transport and far cheaper to buy than other drugs,” government social worker Adnan Zobayer told the newspaper. “People get an easy buzz and quickly become dependent.”  </p><p>Authorities in Bangladesh have been fighting for years to stamp out trade in the stimulant. In 2018, the government passed a law which makes possession of yaba punishable by death. They are having some success: enforcement agencies seized 43,562,811 amphetamine-type stimulant tablets, including yaba, last year, up 90.58 % from 22,857,751 in 2024. However, drug lords are still able to “churn out” millions of yaba pills from camps in the jungle borderlands of Myanmar at a “relentless” rate, said The Telegraph.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Administration aims to limit childhood vaccines ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-6">What happened</h2><p>President Trump signed a nonbinding executive order this week recommending a radical overhaul of the U.S. childhood vaccine schedule, a policy proposal that health experts warned will only sow more mistrust and confusion about lifesaving immunizations. The order proposes reducing the number of recommended childhood vaccines from 18 to 11, downgrading vaccines for diseases such as Covid, hepatitis A and B, and RSV to optional for most children. It directs government health officials to plan for separating the doses in the measles, mumps, and rubella vaccine, which has been administered as a combined injection for 55 years. The order also authorizes the Justice Department to challenge state vaccine regulations deemed insufficiently respectful of parental objections. Trump claimed without evidence that the combined MMR vaccine can be “quite lethal” if given at once.</p><p>With Health Secretary Robert F. Kennedy Jr. by his side, Trump made several other false claims. He said children were being pumped with “vats” of vaccine—the MMR shot is actually a fraction of a teaspoon—and revived the debunked theory that <a href="https://theweek.com/health/rfk-jr-autism-research-controversy">vaccines cause autism</a>. Pediatricians were aghast. “As <a href="https://theweek.com/science/scientists-renew-the-search-for-measles-drugs-amid-low-vaccination-rates">measles cases</a> reach a 35-year high in the U.S.,” said American Academy of Pediatrics president Dr. Andrew Racine, Trump’s executive order is “not only disheartening but dangerous.” Several states, including New York and Illinois, declared they would keep current childhood immunization rules in place. “We will continue to be guided by the science,” said New York state Health Commissioner James McDonald.</p><h2 id="what-the-columnists-said">What the columnists said</h2><p>Trump claimed “nothing bad can happen from what we’re doing,” said <strong>Jonathan Cohn</strong> in <em><strong>The Bulwark</strong></em>. But “bad things are happening already.” Nearly 2,500 people have contracted measles this year as anti-vax rhetoric has pushed MMR vaccination rates below the community protection threshold. At least two children have died from the disease. And now many more parents will wrongly believe that a proven protection is unsafe, all because “they heard it from the president.”</p><p>Trump insists he isn’t promoting “vaccine skepticism,” said <em><strong>The Wall Street Journal</strong></em> in an editorial. He claims he’s merely aligning the U.S. with other “peer, developed nations” such as <a href="https://theweek.com/world-news/denmark-greenland-arms-trump-russia">Denmark</a>. But governments with “socialized health systems” have fewer vaccine recommendations because they don’t want to pay to cover rarer diseases, such as meningitis, and because problems like mother-to-child transmission of hepatitis B are “less common” there. </p><p>“Almost nothing Trump called for is practical or possible today,” said <strong>Michael Hiltzik</strong> in the <em><strong>Los Angeles Times</strong></em>. No American company even manufactures the individual components for separate measles, mumps, and rubella vaccines. Successive shots would leave kids vulnerable to the diseases for longer. But Trump and Kennedy “have been beating the anti-vaccination drum for years.” They long for the “good old days” before “excessive” immunizations. “They would expose millions of children to severe disease and death” in the name of misguided nostalgia. “In heaven’s name, why?”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/trump-administration-aims-to-limit-childhood-vaccines</link>
                                                                            <description>
                            <![CDATA[ The move comes as measles cases continue to rise ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">SLEPgimHNfVbiLZtK4E95G</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/QsYQRdANFERpiYDuR4L6rc-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 17 Aug 2026 20:03:03 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (The Week US) ]]></author>                    <dc:creator><![CDATA[ The Week US ]]></dc:creator>                                                                                                        <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/QsYQRdANFERpiYDuR4L6rc-1920-80.jpg">
                                                            <media:credit><![CDATA[Anna Moneymaker / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Trump rewrites decades of health policy]]></media:description>                                                            <media:text><![CDATA[Trump holds up a paper with his signature]]></media:text>
                                <media:title type="plain"><![CDATA[Trump holds up a paper with his signature]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/QsYQRdANFERpiYDuR4L6rc-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-6">What happened</h2><p>President Trump signed a nonbinding executive order this week recommending a radical overhaul of the U.S. childhood vaccine schedule, a policy proposal that health experts warned will only sow more mistrust and confusion about lifesaving immunizations. The order proposes reducing the number of recommended childhood vaccines from 18 to 11, downgrading vaccines for diseases such as Covid, hepatitis A and B, and RSV to optional for most children. It directs government health officials to plan for separating the doses in the measles, mumps, and rubella vaccine, which has been administered as a combined injection for 55 years. The order also authorizes the Justice Department to challenge state vaccine regulations deemed insufficiently respectful of parental objections. Trump claimed without evidence that the combined MMR vaccine can be “quite lethal” if given at once.</p><p>With Health Secretary Robert F. Kennedy Jr. by his side, Trump made several other false claims. He said children were being pumped with “vats” of vaccine—the MMR shot is actually a fraction of a teaspoon—and revived the debunked theory that <a href="https://theweek.com/health/rfk-jr-autism-research-controversy">vaccines cause autism</a>. Pediatricians were aghast. “As <a href="https://theweek.com/science/scientists-renew-the-search-for-measles-drugs-amid-low-vaccination-rates">measles cases</a> reach a 35-year high in the U.S.,” said American Academy of Pediatrics president Dr. Andrew Racine, Trump’s executive order is “not only disheartening but dangerous.” Several states, including New York and Illinois, declared they would keep current childhood immunization rules in place. “We will continue to be guided by the science,” said New York state Health Commissioner James McDonald.</p><h2 id="what-the-columnists-said">What the columnists said</h2><p>Trump claimed “nothing bad can happen from what we’re doing,” said <strong>Jonathan Cohn</strong> in <em><strong>The Bulwark</strong></em>. But “bad things are happening already.” Nearly 2,500 people have contracted measles this year as anti-vax rhetoric has pushed MMR vaccination rates below the community protection threshold. At least two children have died from the disease. And now many more parents will wrongly believe that a proven protection is unsafe, all because “they heard it from the president.”</p><p>Trump insists he isn’t promoting “vaccine skepticism,” said <em><strong>The Wall Street Journal</strong></em> in an editorial. He claims he’s merely aligning the U.S. with other “peer, developed nations” such as <a href="https://theweek.com/world-news/denmark-greenland-arms-trump-russia">Denmark</a>. But governments with “socialized health systems” have fewer vaccine recommendations because they don’t want to pay to cover rarer diseases, such as meningitis, and because problems like mother-to-child transmission of hepatitis B are “less common” there. </p><p>“Almost nothing Trump called for is practical or possible today,” said <strong>Michael Hiltzik</strong> in the <em><strong>Los Angeles Times</strong></em>. No American company even manufactures the individual components for separate measles, mumps, and rubella vaccines. Successive shots would leave kids vulnerable to the diseases for longer. But Trump and Kennedy “have been beating the anti-vaccination drum for years.” They long for the “good old days” before “excessive” immunizations. “They would expose millions of children to severe disease and death” in the name of misguided nostalgia. “In heaven’s name, why?”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Stronger, faster, better: the new mRNA flu vaccine ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The Food and Drug Administration (FDA) has approved Moderna’s mRNA flu vaccine, mFLUSIVA. The approval comes despite growing vaccine skepticism, especially toward mRNA vaccines following Covid-19. But research shows that this new vaccine can produce a stronger immune response and be produced more quickly than the traditional flu vaccine.</p><h2 id="how-does-the-mrna-vaccine-differ-from-the-traditional-shot">How does the mRNA vaccine differ from the traditional shot?</h2><p>The approval of mFLUSIVA “demonstrates the continued strength and versatility of our mRNA platform,” Stephane Bancel, Moderna’s CEO, said in a <a href="https://feeds.issuerdirect.com/news-release.html?newsid=4801915282452025&amp;symbol=MRNA" target="_blank"><u>release</u></a>. The <a href="https://theweek.com/health/trump-signs-order-childhood-vaccinations"><u>vaccine</u></a> was shown to be almost 27% more effective against the flu than the standard flu shot. The FDA has authorized mFLUSIVA for adults over the age of 50 after “documented superiority in effectiveness to normal dose flu vaccines,” particularly “for those with underlying diseases,” Jesse Goodman, the FDA’s former top vaccine regulator, said to <a href="https://www.washingtonpost.com/health/2026/08/05/new-type-flu-shot-is-coming-after-fda-approves-mrna-based-vaccine/" target="_blank"><u>The Washington Post</u></a>. </p><p>A move toward mRNA vaccines can create a more effective <em>and</em> faster flu shot. Traditional vaccines are “typically generated in chicken eggs” and are “what we call an inactivated flu vaccine,” Hanover Matz, an immunologist at WashU Medicine in St. Louis and the coauthor of a June <a href="https://www.nature.com/articles/s41590-026-02569-5" target="_blank"><u>study</u></a> comparing the mRNA vaccine to the traditional flu vaccine, said to <a href="https://www.sciencenews.org/article/first-mrna-flu-vaccine-fall-season" target="_blank"><u>Science News</u></a>. Pieces of the virus “are used to teach your immune system how to fight flu,” and “because the virus is raised in chicken eggs, it takes a long time to generate that vaccine.” This method also requires policymakers to “determine what the most likely strains of the flu virus are going to be for the fall season in the Northern Hemisphere,” and they “need to start that production well before the fall to get the vaccine doses ready.” If “there’s a mismatch in strains, there’s really no way they can go back and update the vaccine and change it.”</p><p>By contrast, the mRNA vaccine “contains three RNAs, which each encode the hemagglutinin protein of one of two influenza A strains and one influenza B strain,” said <a href="https://www.iflscience.com/first-ever-mrna-flu-vaccine-finally-approved-by-fda-in-time-for-2026-season-after-they-initially-refused-to-review-it-84318" target="_blank"><u>IFL Science</u></a>. The genetic information “instructs the body to produce a fragment of a virus that then sets off the body’s immune response,” said <a href="https://www.nytimes.com/2026/08/05/health/mrna-flu-vaccine-moderna.html" target="_blank"><u>The New York Times</u></a>. Because the virus does not have to be produced in eggs, mRNA vaccines can be produced much faster and can be adjusted to “rapidly emerging new flu strains, a capacity we have not had before,” Georges C. Benjamin, the executive director of the American Public Health Association, said to the Times.</p><h2 id="what-is-the-future-of-the-mrna-vaccine">What is the future of the mRNA vaccine?</h2><p>Despite the benefits of the mRNA vaccine, it was not an easy route to approval. The mRNA technology, famously used in <a href="https://theweek.com/health/covid-19-mrna-vaccines-cancer"><u>Covid-19 vaccines</u></a>, has been the subject of widespread anti-vaccine misinformation campaigns. The FDA “refused to even review Moderna’s application for approval earlier this year but quickly reversed course after a public outcry,” said the Times. In addition, the approval of mFLUSIVA is “likely to face pushback,” especially from some allies of Health and Human Services Secretary <a href="https://theweek.com/politics/judge-pauses-rfk-jr-vaccines"><u>Robert F. Kennedy, Jr</u></a>. “who have expressed skepticism over mRNA-based coronavirus shots,” said the Post. </p><p>Those in favor of cite the FDA’s approval as a step in the right direction. The FDA is “signaling openness” to mRNA vaccines, Jeanne Marrazzo, the chief executive officer of the Infectious Disease Society of America, said to <a href="https://www.npr.org/2026/08/06/nx-s1-5923342/moderna-mrna-flu-vaccine" target="_blank"><u>NPR</u></a>. It “could set us up not only for improved response to a bad flu season but also to an improved response to any biological threats.” The flu “remains a significant public health challenge,” Bancel said in the release, and “mFLUSIVA provides an important new option for America’s seniors.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/fda-approves-mrna-flu-vaccine</link>
                                                                            <description>
                            <![CDATA[ The jab may be new and improved ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">jKmySDp5TfsYtysXgUXTeS</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/jMJLDxdTaNYKsqabXvtCTD-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 13 Aug 2026 18:21:32 +0000</pubDate>                                                                                                                                <updated>Thu, 13 Aug 2026 21:12:48 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweekonlineeditors@futurenet.com (Devika Rao, The Week US) ]]></author>                    <dc:creator><![CDATA[ Devika Rao, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/94GwEibiRpzEGEeXTfpS8F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective. She graduated from Cornell University in 2021 with a bachelor’s degree in environment and sustainability and a minor in climate change.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Based in New Jersey, Devika spends her free time reading, singing, playing her bass guitar and taking long walks.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/jMJLDxdTaNYKsqabXvtCTD-1920-80.jpg">
                                                            <media:credit><![CDATA[Tomas Kohoutek / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The mRNA flu vaccine can be made much faster than the standard vaccine]]></media:description>                                                            <media:text><![CDATA[mRNA flu vaccine vial]]></media:text>
                                <media:title type="plain"><![CDATA[mRNA flu vaccine vial]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/jMJLDxdTaNYKsqabXvtCTD-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The Food and Drug Administration (FDA) has approved Moderna’s mRNA flu vaccine, mFLUSIVA. The approval comes despite growing vaccine skepticism, especially toward mRNA vaccines following Covid-19. But research shows that this new vaccine can produce a stronger immune response and be produced more quickly than the traditional flu vaccine.</p><h2 id="how-does-the-mrna-vaccine-differ-from-the-traditional-shot">How does the mRNA vaccine differ from the traditional shot?</h2><p>The approval of mFLUSIVA “demonstrates the continued strength and versatility of our mRNA platform,” Stephane Bancel, Moderna’s CEO, said in a <a href="https://feeds.issuerdirect.com/news-release.html?newsid=4801915282452025&amp;symbol=MRNA" target="_blank"><u>release</u></a>. The <a href="https://theweek.com/health/trump-signs-order-childhood-vaccinations"><u>vaccine</u></a> was shown to be almost 27% more effective against the flu than the standard flu shot. The FDA has authorized mFLUSIVA for adults over the age of 50 after “documented superiority in effectiveness to normal dose flu vaccines,” particularly “for those with underlying diseases,” Jesse Goodman, the FDA’s former top vaccine regulator, said to <a href="https://www.washingtonpost.com/health/2026/08/05/new-type-flu-shot-is-coming-after-fda-approves-mrna-based-vaccine/" target="_blank"><u>The Washington Post</u></a>. </p><p>A move toward mRNA vaccines can create a more effective <em>and</em> faster flu shot. Traditional vaccines are “typically generated in chicken eggs” and are “what we call an inactivated flu vaccine,” Hanover Matz, an immunologist at WashU Medicine in St. Louis and the coauthor of a June <a href="https://www.nature.com/articles/s41590-026-02569-5" target="_blank"><u>study</u></a> comparing the mRNA vaccine to the traditional flu vaccine, said to <a href="https://www.sciencenews.org/article/first-mrna-flu-vaccine-fall-season" target="_blank"><u>Science News</u></a>. Pieces of the virus “are used to teach your immune system how to fight flu,” and “because the virus is raised in chicken eggs, it takes a long time to generate that vaccine.” This method also requires policymakers to “determine what the most likely strains of the flu virus are going to be for the fall season in the Northern Hemisphere,” and they “need to start that production well before the fall to get the vaccine doses ready.” If “there’s a mismatch in strains, there’s really no way they can go back and update the vaccine and change it.”</p><p>By contrast, the mRNA vaccine “contains three RNAs, which each encode the hemagglutinin protein of one of two influenza A strains and one influenza B strain,” said <a href="https://www.iflscience.com/first-ever-mrna-flu-vaccine-finally-approved-by-fda-in-time-for-2026-season-after-they-initially-refused-to-review-it-84318" target="_blank"><u>IFL Science</u></a>. The genetic information “instructs the body to produce a fragment of a virus that then sets off the body’s immune response,” said <a href="https://www.nytimes.com/2026/08/05/health/mrna-flu-vaccine-moderna.html" target="_blank"><u>The New York Times</u></a>. Because the virus does not have to be produced in eggs, mRNA vaccines can be produced much faster and can be adjusted to “rapidly emerging new flu strains, a capacity we have not had before,” Georges C. Benjamin, the executive director of the American Public Health Association, said to the Times.</p><h2 id="what-is-the-future-of-the-mrna-vaccine">What is the future of the mRNA vaccine?</h2><p>Despite the benefits of the mRNA vaccine, it was not an easy route to approval. The mRNA technology, famously used in <a href="https://theweek.com/health/covid-19-mrna-vaccines-cancer"><u>Covid-19 vaccines</u></a>, has been the subject of widespread anti-vaccine misinformation campaigns. The FDA “refused to even review Moderna’s application for approval earlier this year but quickly reversed course after a public outcry,” said the Times. In addition, the approval of mFLUSIVA is “likely to face pushback,” especially from some allies of Health and Human Services Secretary <a href="https://theweek.com/politics/judge-pauses-rfk-jr-vaccines"><u>Robert F. Kennedy, Jr</u></a>. “who have expressed skepticism over mRNA-based coronavirus shots,” said the Post. </p><p>Those in favor of cite the FDA’s approval as a step in the right direction. The FDA is “signaling openness” to mRNA vaccines, Jeanne Marrazzo, the chief executive officer of the Infectious Disease Society of America, said to <a href="https://www.npr.org/2026/08/06/nx-s1-5923342/moderna-mrna-flu-vaccine" target="_blank"><u>NPR</u></a>. It “could set us up not only for improved response to a bad flu season but also to an improved response to any biological threats.” The flu “remains a significant public health challenge,” Bancel said in the release, and “mFLUSIVA provides an important new option for America’s seniors.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Trump signs order to limit childhood vaccinations ]]></title>
                                                                                                <dc:content><![CDATA[ <h2 id="what-happened-7">What happened</h2><p>President Donald Trump on Monday signed an executive order proposing a reduction in routine childhood immunizations to 11 from 17, and pushing for the combined measles, mumps and rubella (MMR) vaccine to be split into three separate single-disease shots administered over several doctor visits. This is <a href="https://theweek.com/politics/judge-pauses-rfk-jr-vaccines">Trump’s third attempt</a> to “promote his long-held but discredited theory that childhood shots should be spaced out,” <a href="https://apnews.com/live/trump-politics-news-08-10-2026" target="_blank">The Associated Press</a> said, and a continuation of his fixation on “connecting autism to vaccines,” even though “scientific consensus and decades of studies have firmly concluded there is no link.”</p><h2 id="who-said-what-6">Who said what</h2><p>“Nothing bad can happen from what we’re doing,” <a href="https://www.youtube.com/watch?v=2ztXcKmYR0M" target="_blank">Trump said</a> before signing the order. But pediatricians and public health experts have “long warned” that spreading out vaccinations “will reduce immunization rates and leave children more susceptible to disease,” <a href="https://www.cnn.com/2026/08/10/politics/trump-vaccine-autism-rfk" target="_blank">CNN</a> said.</p><p>Trump’s “renewed focus on vaccines marks a departure” from his administration’s “recent efforts to emphasize less controversial health policies” ahead of November elections, the AP said. Trump’s “own pollsters have warned” that the issue is “unpopular” with voters, <a href="https://www.politico.com/news/2026/08/10/trump-childhood-vaccine-executive-order-01031314" target="_blank">Politico</a> said. But the president’s “personal interest” in changing vaccine policy has been “thrown into high gear by his allegiance with Health Secretary Robert F. Kennedy Jr.,” a <a href="https://theweek.com/health/rfk-mrna-vaccine-stop-effects">longtime vaccine skeptic</a>. </p><h2 id="what-next-7">What next? </h2><p>It’s unclear whether Trump’s order “has any legal power,” <a href="https://www.nytimes.com/live/2026/08/10/us/trump-news#trump-vaccines-executive-order" target="_blank">The New York Times</a> said. Federal immunization recommendations come from the Centers for Disease Control and Prevention and its outside experts, and “only states can require vaccinations for children to enter school or day care.”</p> ]]></dc:content>
                                                                                                                                            <link>https://theweek.com/health/trump-signs-order-childhood-vaccinations</link>
                                                                            <description>
                            <![CDATA[ The White House proposed a drop in vaccinations from 17 to 11 ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">tunVnj2iDoCf4xYD9AiM2d</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/YayYX5h75hKAVdEw9RuUii-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 11 Aug 2026 14:32:18 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                <author><![CDATA[ theweek@futurenet.com (Rafi Schwartz, The Week US) ]]></author>                    <dc:creator><![CDATA[ Rafi Schwartz, The Week US ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/GMjxXiVgZLL2zyycd6jVxU-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion&#039;s news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi&#039;s work has appeared in Rolling Stone, GOOD and The Forward, among others. He is a graduate of the University of Wisconsin, Madison, with a major in religious studies, and a minor in integrated liberal studies.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Rafi lives in the Twin Cities, where he does not bike, run or take part in any team sports. He does, however, have a variety of interests, hobbies and passions.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/YayYX5h75hKAVdEw9RuUii-1920-80.jpg">
                                                            <media:credit><![CDATA[Jim Watson / AFP / Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[President Donald Trump speaks before signing an executive order calling for more research and flexibility on vaccines]]></media:description>                                                            <media:text><![CDATA[US-POLITICS-TRUMPUS Secretary of Health and Human Services Robert F. Kennedy Jr. (R) looks on as President Donald Trump speaks before signing an executive order calling for more research and flexibility on vaccines, in the Oval Office of the White House in Washington, DC, on August 10, 2026. Trump signed an executive order Monday pushing for a rethink of school vaccine mandates and repeating calls for the measles-mumps-rubella vaccine to be separated into three individual shots. Curbing vaccines has been a key priority for Health Secretary Robert F. Kennedy Jr, who founded an anti-vaccine nonprofit and has long promoted a disproven link between immunization and autism. (Photo by Jim WATSON / AFP via Getty Images)]]></media:text>
                                <media:title type="plain"><![CDATA[US-POLITICS-TRUMPUS Secretary of Health and Human Services Robert F. Kennedy Jr. (R) looks on as President Donald Trump speaks before signing an executive order calling for more research and flexibility on vaccines, in the Oval Office of the White House in Washington, DC, on August 10, 2026. Trump signed an executive order Monday pushing for a rethink of school vaccine mandates and repeating calls for the measles-mumps-rubella vaccine to be separated into three individual shots. Curbing vaccines has been a key priority for Health Secretary Robert F. Kennedy Jr, who founded an anti-vaccine nonprofit and has long promoted a disproven link between immunization and autism. (Photo by Jim WATSON / AFP via Getty Images)]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/YayYX5h75hKAVdEw9RuUii-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <h2 id="what-happened-7">What happened</h2><p>President Donald Trump on Monday signed an executive order proposing a reduction in routine childhood immunizations to 11 from 17, and pushing for the combined measles, mumps and rubella (MMR) vaccine to be split into three separate single-disease shots administered over several doctor visits. This is <a href="https://theweek.com/politics/judge-pauses-rfk-jr-vaccines">Trump’s third attempt</a> to “promote his long-held but discredited theory that childhood shots should be spaced out,” <a href="https://apnews.com/live/trump-politics-news-08-10-2026" target="_blank">The Associated Press</a> said, and a continuation of his fixation on “connecting autism to vaccines,” even though “scientific consensus and decades of studies have firmly concluded there is no link.”</p><h2 id="who-said-what-6">Who said what</h2><p>“Nothing bad can happen from what we’re doing,” <a href="https://www.youtube.com/watch?v=2ztXcKmYR0M" target="_blank">Trump said</a> before signing the order. But pediatricians and public health experts have “long warned” that spreading out vaccinations “will reduce immunization rates and leave children more susceptible to disease,” <a href="https://www.cnn.com/2026/08/10/politics/trump-vaccine-autism-rfk" target="_blank">CNN</a> said.</p><p>Trump’s “renewed focus on vaccines marks a departure” from his administration’s “recent efforts to emphasize less controversial health policies” ahead of November elections, the AP said. Trump’s “own pollsters have warned” that the issue is “unpopular” with voters, <a href="https://www.politico.com/news/2026/08/10/trump-childhood-vaccine-executive-order-01031314" target="_blank">Politico</a> said. But the president’s “personal interest” in changing vaccine policy has been “thrown into high gear by his allegiance with Health Secretary Robert F. Kennedy Jr.,” a <a href="https://theweek.com/health/rfk-mrna-vaccine-stop-effects">longtime vaccine skeptic</a>. </p><h2 id="what-next-7">What next? </h2><p>It’s unclear whether Trump’s order “has any legal power,” <a href="https://www.nytimes.com/live/2026/08/10/us/trump-news#trump-vaccines-executive-order" target="_blank">The New York Times</a> said. Federal immunization recommendations come from the Centers for Disease Control and Prevention and its outside experts, and “only states can require vaccinations for children to enter school or day care.”</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
            </channel>
</rss>